text,labels
Genetics,O
of,O
cerebrotendinous,Disease
xanthomatosis,Disease
(,O
CTX,Disease
),O
:,O
an,O
autosomal,O
recessive,O
trait,O
with,O
high,O
gene,O
frequency,O
in,O
Sephardim,O
of,O
Moroccan,O
origin,O
.,O
Five,O
intragenic,O
dimorphisms,O
are,O
now,O
well,O
characterized,O
and,O
the,O
high,O
degree,O
of,O
allelic,O
heterogeneity,O
in,O
HC,Disease
is,O
demonstrated,O
with,O
seven,O
new,O
different,O
mutations,O
making,O
a,O
total,O
of,O
nineteen,O
CPO,O
gene,Disease
defects,Disease
reported,O
so,O
far,O
.,O
.,O
We,O
have,O
cloned,O
cDNAs,O
for,O
the,O
rat,O
gene,O
(,O
Atp7b,O
),O
homologous,O
to,O
the,O
human,O
Wilson,Disease
disease,Disease
gene,O
(,O
ATP7B,O
),O
and,O
have,O
used,O
them,O
to,O
identify,O
a,O
partial,O
deletion,O
in,O
the,O
Atp7b,O
gene,O
in,O
the,O
LEC,O
rat,O
.,O
Defective,O
CTLA,O
-,O
4,O
cycling,O
pathway,O
in,O
Chediak,Disease
-,Disease
Higashi,Disease
syndrome,Disease
:,O
a,O
possible,O
mechanism,O
for,O
deregulation,O
of,O
T,O
lymphocyte,O
activation,O
.,O
Current,O
evidence,O
suggests,O
that,O
aniridia,Disease
(,O
absence,Disease
of,Disease
iris,Disease
),O
is,O
caused,O
by,O
loss,O
of,O
function,O
of,O
one,O
copy,O
of,O
the,O
PAX6,O
gene,O
",",O
which,O
maps,O
to,O
11p13,O
.,O
The,O
clinical,O
diagnosis,O
of,O
AGU,Disease
is,O
often,O
difficult,O
",",O
in,O
particular,O
early,O
in,O
the,O
course,O
of,O
the,O
disease,O
",",O
and,O
most,O
of,O
the,O
patients,O
are,O
diagnosed,O
after,O
the,O
age,O
of,O
5,O
years,O
.,O
1,O
",",O
together,O
with,O
the,O
VWS,Disease
gene,O
at,O
1p32,O
-,O
41,O
",",O
enhances,O
the,O
probability,O
of,O
CP,Disease
in,O
an,O
individual,O
carrying,O
the,O
two,O
at,O
-,O
risk,O
genes,O
.,O
The,O
absence,Disease
of,Disease
functional,Disease
C7,Disease
activity,O
could,O
not,O
be,O
accounted,O
for,O
on,O
the,O
basis,O
of,O
an,O
inhibitor,O
.,O
Thus,O
",",O
there,O
is,O
no,O
evidence,O
that,O
the,O
paternal,O
RB1,O
allele,O
is,O
preferentially,O
retained,O
in,O
retinoblastoma,Disease
",",O
as,O
has,O
been,O
suggested,O
to,O
be,O
the,O
case,O
in,O
osteosarcoma,Disease
.,O
Additional,O
experiments,O
are,O
needed,O
to,O
define,O
the,O
role,O
of,O
CA,O
IX,O
and,O
CA,O
XII,O
enzymes,O
in,O
the,O
regulation,O
of,O
pH,O
in,O
the,O
extracellular,O
microenvironment,O
and,O
its,O
potential,O
impact,O
on,O
cancer,Disease
cell,O
growth,O
.,O
Isolation,O
of,O
the,O
gene,O
for,O
McLeod,Disease
syndrome,Disease
that,O
encodes,O
a,O
novel,O
membrane,O
transport,O
protein,O
.,O
Recurrent,O
hSNF5,O
/,O
INI1,O
alterations,O
were,O
also,O
observed,O
in,O
choroid,Disease
plexus,Disease
carcinomas,Disease
and,O
in,O
a,O
subset,O
of,O
central,O
primitive,O
neuroectodermal,Disease
tumors,Disease
(,O
cPNETs,O
),O
and,O
medulloblastomas,Disease
.,O
These,O
loci,O
have,O
been,O
shown,O
to,O
lie,O
within,O
the,O
DMD,Disease
region,O
covering,O
several,O
hundred,O
kilobases,O
(,O
kb,O
),O
of,O
DNA,O
.,O
This,O
substitution,O
was,O
not,O
seen,O
in,O
any,O
normal,O
individuals,O
and,O
was,O
completely,O
linked,O
to,O
the,O
piebald,Disease
phenotype,O
in,O
the,O
probands,O
family,O
.,O
Thus,O
",",O
other,O
genetic,Disease
defects,Disease
or,O
metabolic,O
factors,O
influencing,O
CETP,O
expression,O
are,O
implicated,O
.,O
To,O
determine,O
the,O
origins,O
of,O
these,O
two,O
mutations,O
in,O
the,O
Cajun,O
population,O
",",O
the,O
TSD,Disease
carrier,O
status,O
was,O
enzymatically,O
determined,O
for,O
90,O
members,O
of,O
four,O
of,O
the,O
six,O
families,O
",",O
and,O
extensive,O
pedigrees,O
were,O
constructed,O
for,O
all,O
carriers,O
.,O
Classic,Disease
(,Disease
complete,Disease
),Disease
lecithin,Disease
cholesterol,Disease
acyltransferase,Disease
(,Disease
LCAT,Disease
),Disease
deficiency,Disease
and,O
Fish,Disease
-,Disease
eye,Disease
disease,Disease
(,O
partial,Disease
LCAT,Disease
deficiency,Disease
),O
are,O
genetic,O
syndromes,O
associated,O
with,O
markedly,O
decreased,O
plasma,O
levels,O
of,O
high,O
density,O
lipoprotein,O
(,O
HDL,O
),O
cholesterol,O
but,O
not,O
with,O
an,O
increased,O
risk,O
of,O
atherosclerotic,Disease
cardiovascular,Disease
disease,Disease
.,O
Myotonic,Disease
dystrophy,Disease
(,O
DM,Disease
),O
is,O
an,O
autosomal,Disease
dominant,Disease
disorder,Disease
resulting,O
from,O
the,O
expansion,O
of,O
a,O
CTG,O
repeat,O
in,O
the,O
3,O
untranslated,O
region,O
of,O
a,O
putative,O
protein,O
kinase,O
(,O
DMPK,O
),O
.,O
Functional,O
differences,O
of,O
the,O
PDS,Disease
gene,O
product,O
are,O
associated,O
with,O
phenotypic,O
variation,O
in,O
patients,O
with,O
Pendred,Disease
syndrome,Disease
and,O
non,Disease
-,Disease
syndromic,Disease
hearing,Disease
loss,Disease
(,O
DFNB4,Disease
),O
.,O
Linkage,O
analysis,O
of,O
5,O
novel,O
van,Disease
der,Disease
Woude,Disease
syndrome,Disease
kindreds,O
to,O
1q32,O
-,O
q41,O
markers,O
further,O
supports,O
locus,O
homogeneity,O
of,O
the,O
disease,O
trait,O
.,O
F8C,O
was,O
also,O
tightly,O
linked,O
to,O
ALD,Disease
with,O
a,O
maximal,O
LOD,O
score,O
of,O
7,O
.,O
Familial,Disease
deficiency,Disease
of,Disease
the,Disease
seventh,Disease
component,Disease
of,Disease
complement,Disease
associated,O
with,O
recurrent,O
bacteremic,Disease
infections,Disease
due,Disease
to,Disease
Neisseria,Disease
.,O
Since,O
the,O
current,O
biochemical,O
techniques,O
for,O
X,Disease
-,Disease
ALD,Disease
carrier,O
detection,O
in,O
affected,O
families,O
lack,O
sufficient,O
reliability,O
",",O
our,O
procedure,O
described,O
for,O
systematic,O
mutation,O
scanning,O
is,O
also,O
capable,O
of,O
improving,O
genetic,O
counseling,O
and,O
prenatal,O
diagnosis,O
We,O
investigated,O
whether,O
the,O
expression,O
of,O
the,O
DCC,O
protein,O
in,O
tumor,Disease
cells,O
is,O
a,O
prognostic,O
marker,O
in,O
colorectal,Disease
carcinoma,Disease
.,O
Heterozygous,O
mutations,O
in,O
the,O
human,O
PAX6,O
gene,O
result,O
in,O
various,O
phenotypes,O
",",O
including,O
aniridia,Disease
",",O
Peters,Disease
anomaly,Disease
",",O
autosomal,Disease
dominant,Disease
keratitis,Disease
",",O
and,O
familial,Disease
foveal,Disease
dysplasia,Disease
.,O
One,O
of,O
five,O
PWS,Disease
/,O
AS,Disease
patients,O
analyzed,O
to,O
date,O
has,O
an,O
identifiable,O
",",O
rearranged,O
HERC2,O
transcript,O
derived,O
from,O
the,O
deletion,O
event,O
.,O
Thus,O
",",O
the,O
range,O
of,O
phenotypic,O
expression,O
observed,O
among,O
affected,O
patients,O
may,O
result,O
in,O
part,O
from,O
different,O
allelic,O
manifestations,O
of,O
APC,Disease
mutations,O
.,O
.,O
CONTEXT,O
Most,O
hereditary,Disease
ovarian,Disease
cancers,Disease
are,O
associated,O
with,O
germline,O
mutations,O
in,O
BRCA1,O
or,O
BRCA2,O
.,O
Our,O
results,O
delineate,O
the,O
clinical,O
features,O
of,O
Pelizaeus,Disease
-,Disease
Merzbacher,Disease
disease,Disease
",",O
define,O
the,O
possible,O
molecular,O
pathology,O
of,O
this,O
dysmyelinating,Disease
disorder,Disease
",",O
and,O
address,O
the,O
molecular,O
classification,O
of,O
inborn,Disease
errors,Disease
of,Disease
myelin,Disease
metabolism,Disease
.,O
Myotonic,Disease
dystrophy,Disease
(,O
DM,Disease
),O
is,O
associated,O
with,O
the,O
expansion,O
of,O
a,O
(,O
CTG,O
),O
n,O
trinucleotide,O
repeat,O
in,O
the,O
3,O
untranslated,O
region,O
(,O
UTR,O
),O
of,O
the,O
DM,Disease
protein,O
kinase,O
gene,O
(,O
DMPK,O
),O
.,O
Mutations,O
in,O
the,O
brain,O
specific,O
P,O
/,O
Q,O
type,O
Ca2,O
+,O
channel,O
alpha1,O
subunit,O
gene,O
",",O
CACNA1A,O
",",O
have,O
been,O
identified,O
in,O
three,O
clinically,O
distinct,O
disorders,O
",",O
viz,O
.,O
episodic,Disease
ataxia,Disease
type,Disease
2,Disease
(,O
EA,Disease
-,Disease
2,Disease
),O
",",O
familial,Disease
hemiplegic,Disease
migraine,Disease
(,O
FHM,Disease
),O
and,O
spinocerebellar,Disease
ataxia,Disease
6,Disease
(,O
SCA6,Disease
),O
.,O
Previous,O
linkage,O
and,O
association,O
studies,O
have,O
suggested,O
the,O
presence,O
of,O
a,O
susceptibility,O
gene,O
for,O
AS,Disease
close,O
to,O
",",O
or,O
within,O
",",O
the,O
cytochrome,O
P450,O
2D6,O
gene,O
(,O
CYP2D6,O
",",O
debrisoquine,O
hydroxylase,O
),O
located,O
at,O
chromosome,O
22q13,O
.,O
1,O
.,O
In,O
the,O
analyses,O
of,O
tumor,Disease
tissues,O
from,O
the,O
propositus,O
and,O
his,O
daughter,O
",",O
a,O
P16INK4A,O
codon,O
94,O
missense,O
point,O
mutation,O
(,O
GCG,O
-,O
-,O
>,O
GAG,O
;,O
Ala,O
-,O
-,O
>,O
Glu,O
),O
was,O
observed,O
with,O
the,O
hereditary,O
TP53,O
mutation,O
.,O
Two,O
of,O
the,O
mutations,O
and,O
three,O
of,O
the,O
rare,O
sequence,O
variants,O
were,O
found,O
among,O
the,O
39,O
women,O
who,O
reported,O
no,O
family,O
history,O
of,O
breast,Disease
or,Disease
ovarian,Disease
cancer,Disease
.,O
The,O
phenotype,O
is,O
likely,O
to,O
be,O
a,O
contiguous,Disease
gene,Disease
syndrome,Disease
involving,O
genes,O
which,O
are,O
paternally,O
expressed,O
only,O
",",O
located,O
in,O
the,O
human,O
15q11,O
-,O
q13,O
region,O
.,O
Although,O
hemochromatosis,Disease
is,O
common,O
in,O
Caucasians,O
",",O
affecting,O
>,O
=,O
1,O
/,O
300,O
individuals,O
of,O
northern,O
European,O
origin,O
",",O
it,O
has,O
not,O
been,O
recognized,O
in,O
other,O
populations,O
.,O
A,O
total,O
of,O
3000,O
men,O
living,O
in,O
Yamaguchi,O
were,O
screened,O
for,O
glucose,Disease
-,Disease
6,Disease
-,Disease
phosphate,Disease
dehydrogenase,Disease
(,Disease
G6PD,Disease
),Disease
deficiency,Disease
using,O
Beutlers,O
spot,O
test,O
and,O
three,O
types,O
of,O
starch,O
gel,O
electrophoresis,O
.,O
Mutation,O
analysis,O
at,O
the,O
A,Disease
-,Disease
T,Disease
locus,O
may,O
help,O
estimate,O
the,O
prognosis,O
of,O
A,Disease
-,Disease
T,Disease
patients,O
.,O
.,O
Characterization,O
of,O
the,O
myotonic,Disease
dystrophy,Disease
region,O
predicts,O
multiple,O
protein,O
isoform,O
-,O
encoding,O
mRNAs,O
.,O
These,O
findings,O
suggest,O
that,O
BRCA1,Disease
abnormalities,Disease
may,O
be,O
involved,O
in,O
the,O
pathogenesis,O
of,O
many,O
breast,Disease
cancers,Disease
",",O
sporadic,O
as,O
well,O
as,O
familial,O
.,O
.,O
Mild,O
and,O
severe,O
muscular,Disease
dystrophy,Disease
associated,O
with,O
deletions,O
in,O
Xp21,O
of,O
the,O
human,O
X,O
chromosome,O
.,O
Penetrances,O
of,O
BRCA1,O
1675delA,O
and,O
1135insA,O
with,O
respect,O
to,O
breast,Disease
cancer,Disease
and,O
ovarian,Disease
cancer,Disease
.,O
In,O
our,O
study,O
",",O
we,O
have,O
determined,O
the,O
ATM,O
mutation,O
spectrum,O
in,O
19,O
classical,O
A,Disease
-,Disease
T,Disease
patients,O
",",O
including,O
some,O
immigrant,O
populations,O
",",O
as,O
well,O
as,O
12,O
of,O
Dutch,O
ethnic,O
origin,O
.,O
On,O
the,O
other,O
hand,O
",",O
the,O
group,O
of,O
normal,O
karyotype,O
patients,O
is,O
heterogeneous,O
",",O
and,O
their,O
features,O
do,O
not,O
strictly,O
correspond,O
to,O
the,O
clinical,O
definition,O
of,O
PWS,Disease
.,O
Loss,O
-,O
of,O
-,O
function,O
mutations,O
in,O
the,O
cathepsin,O
C,O
gene,O
result,O
in,O
periodontal,Disease
disease,Disease
and,O
palmoplantar,Disease
keratosis,Disease
.,O
3x,O
greater,O
if,O
there,O
were,O
at,O
least,O
five,O
cases,O
of,O
breast,Disease
cancer,Disease
in,O
the,O
family,O
.,O
Reintroduced,O
wild,O
-,O
type,O
VHL,Disease
strongly,O
inhibited,O
the,O
overexpression,O
of,O
the,O
CA12,O
gene,O
in,O
the,O
parental,O
renal,Disease
cell,Disease
carcinoma,Disease
cell,O
lines,O
.,O
D2,O
/,O
oSnJ,O
that,O
are,O
sufficient,O
and,O
deficient,Disease
for,Disease
C5,Disease
",",O
respectively,O
.,O
RESULTS,O
The,O
mother,O
presented,O
at,O
age,O
63,O
years,O
with,O
a,O
profoundly,O
abnormal,O
electroretinogram,O
(,O
ERG,O
),O
and,O
adult,O
-,O
onset,O
retinitis,Disease
pigmentosa,Disease
that,O
progressed,O
dramatically,O
over,O
12,O
years,O
",",O
with,O
marked,O
loss,O
of,O
peripheral,O
visual,O
field,O
.,O
In,O
7,O
of,O
15,O
uncultured,O
primary,O
human,O
breast,Disease
carcinomas,Disease
",",O
intragenic,O
deletions,O
were,O
shown,O
in,O
TSG101,O
genomic,O
DNA,O
and,O
transcripts,O
by,O
gel,O
and,O
sequence,O
analysis,O
",",O
and,O
mutations,O
affecting,O
two,O
TSG101,O
alleles,O
were,O
identified,O
in,O
four,O
of,O
these,O
cancers,Disease
.,O
Both,O
mutations,O
in,O
G6PD,O
A,O
-,O
are,O
necessary,O
to,O
produce,O
the,O
G6PD,Disease
deficient,Disease
phenotype,O
.,O
The,O
finding,O
that,O
ATM,O
-,O
heterozygotes,O
have,O
an,O
increased,O
relative,O
risk,O
for,O
breast,Disease
cancer,Disease
was,O
supported,O
by,O
some,O
studies,O
but,O
not,O
confirmed,O
by,O
others,O
.,O
Germline,O
mutations,O
of,O
the,O
BRCA1,O
gene,O
in,O
breast,Disease
and,Disease
ovarian,Disease
cancer,Disease
families,O
provide,O
evidence,O
for,O
a,O
genotype,O
-,O
phenotype,O
correlation,O
.,O
Interestingly,O
",",O
all,O
three,O
subjects,O
were,O
probably,O
heterozygous,O
for,O
both,O
subtotal,Disease
C6,Disease
and,Disease
complete,Disease
C6,Disease
deficiency,Disease
.,O
Protein,Disease
S,Disease
deficiency,Disease
is,O
a,O
recognized,O
risk,O
factor,O
for,O
venous,Disease
thrombosis,Disease
.,O
A,O
2,O
year,O
old,O
female,O
presenting,O
with,O
bilateral,Disease
sporadic,Disease
aniridia,Disease
was,O
found,O
to,O
have,O
an,O
apparently,O
balanced,O
reciprocal,O
translocation,O
with,O
a,O
chromosome,O
11,O
breakpoint,O
within,O
band,O
p13,O
.,O
As,O
we,O
report,O
here,O
",",O
the,O
mutations,O
in,O
the,O
hprt,O
gene,O
of,O
seven,O
L,Disease
-,Disease
N,Disease
patients,O
",",O
selected,O
from,O
an,O
initial,O
survey,O
of,O
28,O
patients,O
",",O
have,O
been,O
characterized,O
and,O
all,O
were,O
found,O
to,O
be,O
distinctly,O
different,O
",",O
as,O
predicted,O
.,O
Thus,O
",",O
a,O
total,O
of,O
45,O
mutations,O
were,O
identified,O
in,O
tumors,Disease
of,O
36,O
patients,O
.,O
A,O
novel,O
C,O
to,O
A,O
mutation,O
in,O
the,O
sterol,O
27,O
-,O
hydroxylase,O
gene,O
(,O
CYP27,O
),O
was,O
identified,O
by,O
sequencing,O
amplified,O
CYP27,O
gene,O
products,O
from,O
a,O
patient,O
with,O
cerebrotendinous,Disease
xanthomatosis,Disease
(,O
CTX,Disease
),O
.,O
On,O
the,O
basis,O
of,O
meiotic,O
recombinants,O
and,O
disease,O
-,O
associated,O
haplotypes,O
",",O
the,O
WFS,Disease
gene,O
was,O
localized,O
to,O
a,O
BAC,O
/,O
P1,O
contig,O
of,O
less,O
than,O
250,O
kb,O
.,O
In,O
this,O
report,O
",",O
four,O
individuals,O
with,O
this,O
syndrome,O
are,O
described,O
carrying,O
germline,O
point,O
mutations,O
in,O
the,O
Wilms,Disease
tumour,Disease
suppressor,O
gene,O
",",O
WT1,O
.,O
Another,O
splice,O
mutation,O
in,O
the,O
PST,O
domain,O
occurred,O
in,O
an,O
aniridia,Disease
patient,O
with,O
anosmia,Disease
(,O
inability,O
to,O
smell,O
),O
.,O
Comparison,O
of,O
940,O
-,O
bp,O
sequence,O
5,O
to,O
the,O
putative,O
translation,O
start,O
site,O
reveals,O
a,O
highly,O
conserved,O
region,O
(,O
78,O
.,O
8,O
%,O
nucleotide,O
identity,O
),O
between,O
Hdh,O
and,O
the,O
HD,Disease
gene,O
from,O
nucleotide,O
-,O
56,O
to,O
-,O
206,O
(,O
of,O
Hdh,O
),O
.,O
Using,O
reverse,O
transcriptase,O
combined,O
with,O
polymerase,O
chain,O
reactions,O
in,O
the,O
analysis,O
of,O
a,O
number,O
of,O
lipoma,Disease
cell,O
lines,O
and,O
primary,Disease
lipomas,Disease
",",O
it,O
appeared,O
that,O
LPP,O
is,O
frequently,O
rearranged,O
also,O
in,O
cases,O
without,O
a,O
cytogenetically,O
detectable,O
involvement,O
of,O
3q27,O
-,O
q28,O
.,O
The,O
finding,O
of,O
a,O
mutation,O
in,O
a,O
family,O
with,O
male,Disease
breast,Disease
cancer,Disease
",",O
not,O
previously,O
thought,O
to,O
be,O
related,O
to,O
BRCA1,O
",",O
also,O
illustrates,O
the,O
potential,O
difficulties,O
of,O
genetic,O
counseling,O
for,O
individuals,O
known,O
to,O
carry,O
mutations,O
.,O
.,O
The,O
Clinical,O
European,O
Network,O
on,O
Brain,Disease
Dysmyelinating,Disease
Disease,Disease
.,O
Familial,Disease
Mediterranean,Disease
fever,Disease
(,O
FMF,Disease
),O
is,O
a,O
recessive,Disease
disorder,Disease
characterized,O
by,O
episodes,O
of,O
fever,Disease
with,O
serositis,Disease
or,O
synovitis,Disease
.,O
Somatic,O
PTEN,O
deletions,O
and,O
mutations,O
were,O
observed,O
in,O
sporadic,Disease
breast,Disease
",",Disease
brain,Disease
",",Disease
prostate,Disease
and,Disease
kidney,Disease
cancer,Disease
cell,O
lines,O
and,O
in,O
several,O
primary,O
tumours,Disease
such,O
as,O
endometrial,Disease
carcinomas,Disease
",",O
malignant,Disease
melanoma,Disease
and,O
thyroid,Disease
tumours,Disease
.,O
Deficiency,Disease
of,Disease
glucose,Disease
-,Disease
6,Disease
-,Disease
phosphate,Disease
dehydrogenase,Disease
(,O
G6PD,O
),O
is,O
usually,O
found,O
at,O
high,O
frequencies,O
in,O
areas,O
of,O
the,O
world,O
where,O
malaria,Disease
has,O
been,O
endemic,O
.,O
Pendrin,O
is,O
closely,O
related,O
to,O
a,O
family,O
of,O
sulfate,O
transport,O
proteins,O
that,O
includes,O
the,O
rat,O
sulfate,O
-,O
anion,O
transporter,O
(,O
encoded,O
by,O
Sat,O
-,O
1,O
;,O
29,O
%,O
amino,O
acid,O
sequence,O
identity,O
),O
",",O
the,O
human,O
diastrophic,Disease
dysplasia,Disease
sulfate,O
transporter,O
(,O
encoded,O
by,O
DTD,O
;,O
32,O
%,O
),O
and,O
the,O
human,O
sulfate,O
transporter,O
downregulated,O
in,O
adenoma,Disease
(,O
encoded,O
by,O
DRA,O
;,O
45,O
%,O
),O
.,O
It,O
leads,O
to,O
demyelination,Disease
in,Disease
the,Disease
central,Disease
and,Disease
peripheral,Disease
nervous,Disease
system,Disease
.,O
To,O
determine,O
if,O
a,O
cathepsin,O
C,O
mutation,O
is,O
also,O
responsible,O
for,O
HMS,Disease
",",O
we,O
sequenced,O
the,O
gene,O
in,O
affected,O
and,O
unaffected,O
subjects,O
from,O
the,O
Cochin,O
isolate,O
in,O
which,O
both,O
the,O
PLS,Disease
and,O
HMS,Disease
phenotypes,O
appear,O
.,O
Apoptosis,O
has,O
recently,O
been,O
recognized,O
as,O
a,O
mode,O
of,O
cell,O
death,O
in,O
Huntington,Disease
disease,Disease
(,O
HD,Disease
),O
.,O
Myotonia,Disease
levior,Disease
is,O
a,O
chloride,Disease
channel,Disease
disorder,Disease
.,O
He,O
was,O
treated,O
for,O
club,Disease
foot,Disease
and,O
hip,Disease
dysplasia,Disease
at,O
birth,O
.,O
If,O
the,O
child,O
survives,O
",",O
he,O
or,O
she,O
should,O
be,O
monitored,O
for,O
the,O
later,O
appearance,O
of,O
colonic,Disease
polyps,Disease
.,O
A,O
previous,O
conceptus,O
in,O
this,O
family,O
was,O
stillborn,Disease
at,O
36,O
weeks,O
",",O
with,O
features,O
of,O
severe,O
type,Disease
II,Disease
GD,Disease
.,O
However,O
",",O
several,O
truncation,O
mutations,O
have,O
been,O
found,O
to,O
occur,O
in,O
the,O
C,O
-,O
terminal,O
half,O
of,O
PAX6,O
in,O
patients,O
with,O
Aniridia,Disease
resulting,O
in,O
mutant,O
proteins,O
that,O
retain,O
the,O
DNA,O
-,O
binding,O
domains,O
but,O
have,O
lost,O
most,O
of,O
the,O
transactivation,O
domain,O
.,O
These,O
findings,O
demonstrated,O
that,O
there,O
can,O
be,O
an,O
abnormal,O
vWF,O
(,O
RiCof,O
less,O
than,O
vWF,O
Ag,O
),O
even,O
in,O
type,Disease
I,Disease
vWD,Disease
",",O
coexisting,O
with,O
a,O
complete,O
set,O
of,O
vWF,O
multimers,O
(,O
platelet,O
discordant,O
),O
;,O
that,O
the,O
abnormal,O
vWF,O
can,O
be,O
shown,O
more,O
clearly,O
in,O
platelets,O
than,O
in,O
plasma,O
or,O
else,O
in,O
plasma,O
after,O
DDAVP,O
infusion,O
;,O
and,O
that,O
DDAVP,O
normalizes,O
the,O
BT,O
only,O
in,O
those,O
patients,O
with,O
normal,O
platelet,O
levels,O
of,O
both,O
vWF,O
Ag,O
and,O
RiCof,O
(,O
platelet,O
normal,O
),O
.,O
.,O
Numerous,O
cytogenetic,O
and,O
allelotype,O
studies,O
have,O
reported,O
frequent,O
loss,O
of,O
heterozygosity,O
on,O
chromosomal,O
arm,O
10q,O
in,O
sporadic,Disease
prostate,Disease
cancer,Disease
.,O
In,O
vitro,O
stimulation,O
of,O
monocytes,O
with,O
the,O
proinflammatory,O
agents,O
interferon,O
(,O
IFN,O
),O
gamma,O
",",O
tumor,Disease
necrosis,O
factor,O
",",O
and,O
lipopolysaccharide,O
induced,O
MEFV,O
expression,O
",",O
whereas,O
the,O
antiinflammatory,O
cytokines,O
interleukin,O
(,O
IL,O
),O
4,O
",",O
IL,O
-,O
10,O
",",O
and,O
transforming,O
growth,O
factor,O
beta,O
inhibited,O
such,O
expression,O
.,O
Two,O
missense,O
Fas,O
variants,O
",",O
not,O
restricted,O
to,O
patients,O
with,O
ALPS,Disease
",",O
were,O
identified,O
.,O
These,O
findings,O
are,O
in,O
contrast,O
to,O
previous,O
results,O
showing,O
that,O
the,O
late,Disease
-,Disease
infantile,Disease
type,Disease
of,Disease
MLD,Disease
is,O
always,O
associated,O
with,O
the,O
complete,O
absence,O
of,O
ARSA,O
activity,O
.,O
There,O
are,O
three,O
other,O
cases,O
reported,O
with,O
a,O
deletion,O
of,O
chromosome,O
8,O
at,O
approximately,O
the,O
same,O
breakpoint,O
",",O
one,O
without,O
LGS,Disease
and,O
some,O
similarities,O
to,O
our,O
cases,O
",",O
the,O
other,O
two,O
with,O
LGS,Disease
.,O
Thirty,O
-,O
eight,O
independent,O
patients,O
were,O
old,O
enough,O
to,O
be,O
classified,O
as,O
DMD,Disease
",",O
BMD,Disease
",",O
or,O
intermediate,O
phenotype,O
and,O
had,O
deletions,O
of,O
exons,O
with,O
sequenced,O
intron,O
/,O
exon,O
boundaries,O
.,O
This,O
is,O
different,O
from,O
numerous,O
previous,O
descriptions,O
of,O
the,O
CT,O
pattern,O
in,O
ALD,Disease
.,O
A,O
comparison,O
of,O
the,O
six,O
mutations,O
in,O
the,O
relative,O
proportions,O
of,O
cases,O
of,O
breast,Disease
and,Disease
ovarian,Disease
cancer,Disease
was,O
suggestive,O
of,O
an,O
effect,O
(,O
P,O
=,O
.,O
069,O
),O
",",O
with,O
57,O
%,O
of,O
women,O
presumed,O
affected,O
because,O
of,O
the,O
1294,O
del,O
40,O
BRCA1,O
mutation,O
having,O
ovarian,Disease
cancer,Disease
",",O
compared,O
with,O
14,O
%,O
of,O
affected,O
women,O
with,O
the,O
splice,O
-,O
site,O
mutation,O
in,O
intron,O
5,O
of,O
BRCA1,O
.,O
Analysis,O
of,O
the,O
comparative,O
map,O
for,O
mice,O
and,O
humans,O
shows,O
that,O
the,O
mouse,O
homologue,O
of,O
the,O
HD,Disease
gene,O
will,O
reside,O
on,O
chromosome,O
5,O
.,O
Among,O
117,O
Japanese,O
hyperalphalipoproteinemic,Disease
subjects,O
(,O
HDL,O
-,O
cholesterol,O
;,O
116,O
.,O
7,O
+,O
/,O
-,O
16,O
.,O
5,O
mg,O
/,O
dl,O
",",O
mean,O
+,O
/,O
-,O
S,O
.,O
D,O
.,O
),O
without,O
the,O
intron,O
14,O
splice,O
defect,O
",",O
three,O
homozygotes,O
(,O
2,O
.,O
5,O
%,O
),O
and,O
34,O
heterozygotes,O
(,O
29,O
.,O
1,O
%,O
),O
were,O
found,O
to,O
have,O
the,O
442D,O
G,O
mutation,O
.,O
METHODS,O
Clinical,O
information,O
",",O
family,O
histories,O
",",O
and,O
blood,O
for,O
DNA,O
analysis,O
were,O
obtained,O
from,O
263,O
women,O
with,O
breast,Disease
cancer,Disease
.,O
We,O
describe,O
a,O
particularly,O
instructive,O
case,O
which,O
raises,O
important,O
issues,O
concerning,O
the,O
mechanisms,O
producing,O
uniparental,Disease
disomy,Disease
and,O
whose,O
evaluation,O
provides,O
evidence,O
that,O
trisomy,O
may,O
precede,O
uniparental,Disease
disomy,Disease
in,O
a,O
fetus,O
.,O
Many,O
individuals,O
with,O
AAPC,Disease
develop,O
relatively,O
few,O
colorectal,Disease
polyps,Disease
but,O
are,O
still,O
at,O
high,O
risk,O
for,O
colorectal,Disease
cancer,Disease
.,O
Molecular,O
characterization,O
of,O
glucose,Disease
-,Disease
6,Disease
-,Disease
phosphate,Disease
dehydrogenase,Disease
(,Disease
G6PD,Disease
),Disease
deficiency,Disease
in,O
patients,O
of,O
Chinese,O
descent,O
and,O
identification,O
of,O
new,O
base,O
substitutions,O
in,O
the,O
human,O
G6PD,O
gene,O
.,O
Neurological,O
mutant,O
mice,O
can,O
often,O
provide,O
model,O
systems,O
for,O
human,O
genetic,Disease
disorders,Disease
.,O
This,O
report,O
describes,O
a,O
child,O
with,O
clinical,O
features,O
of,O
ALPS,Disease
without,O
detectable,O
Fas,O
expression,O
on,O
freshly,O
isolated,O
blood,O
leukocytes,O
.,O
The,O
levels,O
of,O
p19,O
/,O
nm23,O
were,O
compared,O
between,O
resting,O
and,O
mitotically,O
stimulated,O
normal,O
human,O
PBLs,O
and,O
in,O
leukemia,Disease
cells,O
.,O
We,O
searched,O
for,O
criteria,O
that,O
could,O
indicate,O
breast,Disease
cancer,Disease
families,O
with,O
a,O
high,O
prior,O
probability,O
of,O
being,O
caused,O
by,O
the,O
breast,Disease
/,Disease
ovarian,Disease
cancer,Disease
susceptibility,O
locus,O
BRCA1,O
on,O
chromosome,O
17,O
.,O
Molecular,O
evidence,O
for,O
new,O
mutation,O
at,O
the,O
hprt,O
locus,O
in,O
Lesch,Disease
-,Disease
Nyhan,Disease
patients,O
.,O
Friedreich,Disease
ataxia,Disease
",",O
an,O
autosomal,Disease
recessive,Disease
neurodegenerative,Disease
disease,Disease
",",O
is,O
the,O
most,O
common,O
of,O
the,O
inherited,Disease
ataxias,Disease
.,O
The,O
distance,O
between,O
APOC2,O
",",O
CKM,O
and,O
DM,Disease
(,O
of,O
the,O
order,O
of,O
2,O
million,O
base,O
pairs,O
),O
and,O
their,O
known,O
orientation,O
should,O
permit,O
directional,O
chromosome,O
walking,O
and,O
jumping,O
.,O
Despite,O
the,O
early,O
recognition,O
of,O
this,O
disorder,O
",",O
the,O
primary,O
structure,O
of,O
human,O
KHK,O
and,O
the,O
molecular,O
basis,O
of,O
essential,Disease
fructosuria,Disease
have,O
not,O
been,O
previously,O
defined,O
.,O
These,O
findings,O
",",O
and,O
the,O
absence,O
of,O
functionally,O
relevant,O
base,O
changes,O
in,O
healthy,O
controls,O
",",O
emphasize,O
the,O
causal,O
role,O
of,O
this,O
candidate,O
gene,O
in,O
Norrie,Disease
disease,Disease
and,O
pave,O
the,O
way,O
for,O
reliable,O
diagnosis,O
and,O
carrier,O
detection,O
.,O
.,O
We,O
suggest,O
that,O
PLP,O
has,O
a,O
vital,O
function,O
in,O
glial,O
cell,O
development,O
",",O
distinct,O
from,O
its,O
later,O
role,O
in,O
myelin,O
assembly,O
",",O
and,O
that,O
this,O
dichotomy,O
of,O
action,O
may,O
explain,O
the,O
clinical,O
spectrum,O
of,O
Pelizaeus,Disease
-,Disease
Merzbacher,Disease
disease,Disease
.,O
.,O
Using,O
DNA,O
as,O
the,O
starting,O
material,O
",",O
we,O
screened,O
the,O
ATM,O
gene,O
in,O
92,O
A,Disease
-,Disease
T,Disease
patients,O
",",O
using,O
an,O
optimized,O
single,O
-,O
strand,O
conformation,O
polymorphism,O
(,O
SSCP,O
),O
technique,O
that,O
detected,O
all,O
previously,O
known,O
mutations,O
in,O
the,O
polymerase,O
chain,O
reaction,O
(,O
PCR,O
),O
segments,O
being,O
analyzed,O
.,O
Three,O
of,O
these,O
patients,O
had,O
pure,O
spinal,Disease
SEP,Disease
abnormalities,Disease
and,O
in,O
the,O
remaining,O
two,O
patients,O
SEPs,O
showed,O
signs,O
of,O
involvement,O
of,O
both,O
the,O
spinal,O
and,O
cerebral,O
somatosensory,O
tracts,O
.,O
In,O
the,O
present,O
work,O
these,O
three,O
cases,O
",",O
each,O
with,O
severe,Disease
neonatal,Disease
jaundice,Disease
",",O
are,O
reported,O
.,O
Hypotonia,Disease
and,O
laxity,Disease
of,Disease
joints,Disease
are,O
common,O
and,O
may,O
necessitate,O
supportive,O
measures,O
.,O
Loss,O
of,O
the,O
wild,O
-,O
type,O
allele,O
in,O
>,O
90,O
%,O
of,O
tumors,Disease
from,O
patients,O
with,O
inherited,O
BRCA1,O
mutations,O
indicates,O
tumor,Disease
suppressive,O
function,O
.,O
Ataxia,Disease
-,Disease
telangiectasia,Disease
is,O
a,O
hereditary,Disease
multisystemic,Disease
disease,Disease
resulting,O
from,O
mutations,O
of,O
ataxia,Disease
telangiectasia,Disease
",",O
mutated,O
(,O
ATM,O
),O
and,O
is,O
characterized,O
by,O
neurodegeneration,Disease
",",O
cancer,Disease
",",O
immune,Disease
defects,Disease
",",O
and,O
hypersensitivity,Disease
to,Disease
ionizing,Disease
radiation,Disease
.,O
The,O
intron,O
7,O
donor,O
splice,O
site,O
transition,O
:,O
a,O
second,O
Tay,Disease
-,Disease
Sachs,Disease
disease,Disease
mutation,O
in,O
French,O
Canada,O
.,O
Biochemical,O
characterization,O
has,O
shown,O
that,O
most,O
of,O
the,O
G6PD,Disease
deficiency,Disease
in,O
this,O
population,O
is,O
accounted,O
for,O
by,O
G6PD,O
Mediterranean,O
.,O
However,O
",",O
both,O
models,O
lack,O
other,O
frequent,O
DM,Disease
symptoms,O
including,O
the,O
fibre,O
-,O
type,O
dependent,O
atrophy,Disease
",",O
myotonia,Disease
",",O
cataract,Disease
and,O
male,Disease
-,Disease
infertility,Disease
.,O
Molecular,O
studies,O
with,O
the,O
DNA,O
probe,O
pML34,O
confirmed,O
that,O
only,O
a,O
single,O
Prader,Disease
Willi,Disease
critical,O
region,O
(,O
PWCR,O
15q11,O
.,O
2,O
-,O
q12,O
),O
copy,O
was,O
present,O
.,O
Loss,O
of,O
heterozygosity,O
data,O
from,O
familial,Disease
tumors,Disease
suggest,O
that,O
BRCA1,O
",",O
a,O
gene,O
that,O
confers,O
susceptibility,O
to,O
ovarian,Disease
and,Disease
early,Disease
-,Disease
onset,Disease
breast,Disease
cancer,Disease
",",O
encodes,O
a,O
tumor,Disease
suppressor,O
.,O
Here,O
we,O
report,O
a,O
PWS,Disease
family,O
in,O
which,O
the,O
father,O
is,O
mosaic,O
for,O
an,O
IC,O
deletion,O
on,O
his,O
paternal,O
chromosome,O
.,O
X,Disease
-,Disease
linked,Disease
spastic,Disease
paraplegia,Disease
and,O
Pelizaeus,Disease
-,Disease
Merzbacher,Disease
disease,Disease
are,O
allelic,Disease
disorders,Disease
at,O
the,O
proteolipid,O
protein,O
locus,O
.,O
Carrier,O
detection,O
of,O
pyruvate,Disease
carboxylase,Disease
deficiency,Disease
in,O
fibroblasts,O
and,O
lymphocytes,O
.,O
Mutation,O
analysis,O
of,O
ACTC,O
revealed,O
an,O
Ala295Ser,O
mutation,O
in,O
exon,O
5,O
close,O
to,O
2,O
missense,O
mutations,O
recently,O
described,O
to,O
cause,O
the,O
inherited,O
form,O
of,O
idiopathic,Disease
dilated,Disease
cardiomyopathy,Disease
(,O
IDC,Disease
),O
.,O
Pyruvate,O
carboxylase,O
(,O
E,O
.,O
C,O
.,O
6,O
.,O
4,O
.,O
1,O
.,O
1,O
),O
activity,O
was,O
determined,O
in,O
the,O
circulating,O
peripheral,O
lymphocytes,O
and,O
cultured,O
skin,O
fibroblasts,O
from,O
the,O
family,O
of,O
a,O
patient,O
with,O
hepatic,O
",",O
cerebral,O
",",O
renal,O
cortical,O
",",O
leukocyte,O
",",O
and,O
fibroblast,O
pyruvate,Disease
carboxylase,Disease
deficiency,Disease
(,O
PC,Disease
Portland,Disease
deficiency,Disease
),O
.,O
Six,O
tumours,Disease
retained,O
the,O
paternal,O
allele,O
and,O
three,O
retained,O
the,O
maternal,O
allele,O
.,O
The,O
severity,O
of,O
the,O
disease,O
correlates,O
with,O
the,O
position,O
of,O
the,O
inherited,O
APC,Disease
mutation,O
(,O
genotype,O
-,O
phenotype,O
correlation,O
),O
.,O
Classical,Disease
galactosemia,Disease
is,O
caused,O
by,O
a,O
deficiency,O
in,O
activity,O
of,O
the,O
enzyme,O
galactose,O
-,O
1,O
-,O
phosphate,O
uridyl,O
transferase,O
(,O
GALT,O
),O
",",O
which,O
",",O
in,O
turn,O
",",O
is,O
caused,O
by,O
mutations,O
at,O
the,O
GALT,O
gene,O
.,O
For,O
case,O
-,O
control,O
studies,O
",",O
617,O
unrelated,O
individuals,O
with,O
AS,Disease
(,O
361,O
probands,O
from,O
sibling,O
-,O
pair,O
and,O
parent,O
-,O
case,O
trio,O
families,O
and,O
256,O
unrelated,O
non,O
-,O
familial,O
sporadic,O
cases,O
),O
and,O
402,O
healthy,O
ethnically,O
matched,O
controls,O
were,O
employed,O
.,O
Polymorphisms,O
of,O
the,O
CYP2D6,O
gene,O
increase,O
susceptibility,O
to,O
ankylosing,Disease
spondylitis,Disease
.,O
We,O
conducted,O
an,O
association,O
study,O
of,O
IDDM,Disease
in,O
a,O
large,O
number,O
of,O
Japanese,O
subjects,O
with,O
multiple,O
polymorphisms,O
in,O
INS,O
region,O
.,O
(,O
Over,O
),O
correction,O
of,O
FMR1,Disease
deficiency,Disease
with,O
YAC,O
transgenics,O
:,O
behavioral,O
and,O
physical,O
features,O
.,O
The,O
present,O
results,O
and,O
our,O
previous,O
data,O
on,O
LOH,O
in,O
a,O
recurring,O
desmoid,Disease
tumor,Disease
suggest,O
that,O
the,O
heterozygous,O
mutant,O
/,O
wild,O
-,O
type,O
condition,O
of,O
the,O
APC,Disease
gene,O
may,O
give,O
rise,O
to,O
benign,Disease
tumors,Disease
",",O
and,O
that,O
functional,O
loss,O
of,O
this,O
gene,O
leads,O
to,O
development,O
of,O
tumors,Disease
not,O
only,O
in,O
the,O
colon,O
but,O
also,O
in,O
other,O
various,O
parts,O
of,O
the,O
body,O
in,O
FAP,Disease
patients,O
.,O
.,O
The,O
family,O
does,O
not,O
appear,O
to,O
be,O
remarkable,O
in,O
the,O
spectrum,O
of,O
tumours,Disease
",",O
and,O
there,O
is,O
loss,O
of,O
the,O
wild,O
-,O
type,O
allele,O
in,O
a,O
leiomyosarcoma,Disease
from,O
the,O
proband,O
.,O
On,O
the,O
other,O
hand,O
",",O
hereditary,O
mutations,O
of,O
TP57KIP2,O
",",O
P15INK4B,O
",",O
and,O
P16INK4A,O
",",O
which,O
affect,O
the,O
cell,O
cycle,O
similar,O
to,O
TP53,O
",",O
were,O
observed,O
in,O
some,O
types,O
of,O
cancer,Disease
.,O
A,O
de,O
novo,O
unbalanced,O
reciprocal,O
translocation,O
identified,O
as,O
paternal,O
in,O
origin,O
in,O
the,O
Prader,Disease
-,Disease
Willi,Disease
syndrome,Disease
.,O
Identification,O
and,O
rapid,O
detection,O
of,O
three,O
Tay,Disease
-,Disease
Sachs,Disease
mutations,O
in,O
the,O
Moroccan,O
Jewish,O
population,O
.,O
The,O
majority,O
of,O
patients,O
with,O
Canavan,Disease
disease,Disease
are,O
from,O
an,O
Ashkenazi,O
Jewish,O
background,O
.,O
These,O
families,O
contain,O
either,O
a,O
total,O
of,O
three,O
or,O
more,O
cases,O
of,O
early,O
-,O
onset,O
(,O
before,O
age,O
60,O
years,O
),O
breast,Disease
cancer,Disease
or,O
ovarian,Disease
cancer,Disease
.,O
Mentally,Disease
retarded,Disease
female,O
patients,O
with,O
a,O
full,O
mutation,O
showed,O
FMRP,O
expression,O
in,O
only,O
some,O
of,O
their,O
hair,O
roots,O
(,O
<,O
55,O
%,O
),O
",",O
and,O
no,O
overlap,O
with,O
normal,O
female,O
controls,O
was,O
observed,O
.,O
The,O
protein,O
deficient,O
in,O
Lowe,Disease
syndrome,Disease
is,O
a,O
phosphatidylinositol,O
-,O
4,O
",",O
5,O
-,O
bisphosphate,O
5,O
-,O
phosphatase,O
.,O
Thirty,O
-,O
seven,O
families,O
with,O
four,O
or,O
more,O
cases,O
of,O
breast,Disease
cancer,Disease
or,O
breast,Disease
and,Disease
ovarian,Disease
cancer,Disease
were,O
analyzed,O
for,O
mutations,O
in,O
BRCA1,O
.,O
Recombinations,O
in,O
individuals,O
homozygous,O
by,O
descent,O
localize,O
the,O
Friedreich,Disease
ataxia,Disease
locus,O
in,O
a,O
cloned,O
450,O
-,O
kb,O
interval,O
.,O
This,O
disorder,O
is,O
associated,O
with,O
variable,O
levels,O
of,O
arginine,O
vasopressin,O
(,O
AVP,O
),O
and,O
diabetes,Disease
insipidus,Disease
of,O
varying,O
severity,O
",",O
which,O
responds,O
to,O
exogenous,O
AVP,O
.,O
The,O
homozygous,O
32,O
deltaT,O
deletion,O
was,O
identified,O
in,O
the,O
only,O
known,O
patient,O
of,O
African,O
-,O
American,O
origin,O
with,O
Canavan,Disease
disease,Disease
.,O
Both,O
factors,O
depend,O
on,O
the,O
intellectual,O
resources,O
of,O
the,O
mother,O
with,O
PKU,Disease
.,O
Twenty,O
-,O
six,O
G6PD,Disease
deficient,Disease
individuals,O
were,O
identified,O
.,O
We,O
also,O
report,O
a,O
mutation,O
of,O
the,O
same,O
exon,O
6,O
CTSC,O
codon,O
(,O
2126C,O
-,O
-,O
>,O
T,O
),O
in,O
a,O
Turkish,O
family,O
with,O
classical,O
PLS,Disease
.,O
W474C,O
amino,O
acid,O
substitution,O
affects,O
early,O
processing,O
of,O
the,O
alpha,O
-,O
subunit,O
of,O
beta,O
-,O
hexosaminidase,O
A,O
and,O
is,O
associated,O
with,O
subacute,O
G,Disease
(,Disease
M2,Disease
),Disease
gangliosidosis,Disease
.,O
On,O
the,O
basis,O
of,O
a,O
sperm,O
typing,O
study,O
performed,O
in,O
patients,O
of,O
Japanese,O
descent,O
with,O
Machado,Disease
-,Disease
Joseph,Disease
disease,Disease
(,O
MJD,Disease
),O
",",O
it,O
was,O
reported,O
that,O
disease,O
alleles,O
are,O
preferentially,O
transmitted,O
during,O
meiosis,O
.,O
PCR,O
amplification,O
from,O
genomic,O
DNA,O
and,O
automated,O
sequencing,O
of,O
the,O
entire,O
coding,O
region,O
(,O
66,O
exons,O
),O
and,O
splice,O
junctions,O
detected,O
77,O
mutations,O
(,O
85,O
%,O
),O
in,O
90,O
A,Disease
-,Disease
T,Disease
chromosomes,O
.,O
Significant,O
within,O
-,O
family,O
association,O
of,O
CYP2D6,O
*,O
4,O
alleles,O
and,O
AS,Disease
was,O
demonstrated,O
.,O
Pelizaeus,Disease
-,Disease
Merzbacher,Disease
Disease,Disease
(,O
PMD,Disease
),O
is,O
an,O
X,Disease
-,Disease
linked,Disease
developmental,Disease
defect,Disease
of,Disease
myelination,Disease
affecting,O
the,O
central,O
nervous,O
system,O
and,O
segregating,O
with,O
the,O
proteolipoprotein,O
(,O
PLP,O
),O
locus,O
.,O
3,O
and,O
encodes,O
a,O
403,O
amino,O
acid,O
dual,O
specificity,O
phosphatase,O
(,O
protein,O
tyrosine,O
phosphatase,O
;,O
PTPase,O
),O
",",O
was,O
shown,O
recently,O
to,O
play,O
a,O
broad,O
role,O
in,O
human,O
malignancy,Disease
.,O
We,O
present,O
the,O
clinical,O
and,O
laboratory,O
findings,O
in,O
an,O
institutionalised,O
adult,O
patient,O
originally,O
referred,O
for,O
autism,Disease
.,O
Inherited,Disease
colorectal,Disease
polyposis,Disease
and,O
cancer,Disease
risk,O
of,O
the,O
APC,O
I1307K,O
polymorphism,O
.,O
Women,O
who,O
carry,O
a,O
mutation,O
in,O
the,O
BRCA1,O
gene,O
(,O
on,O
chromosome,O
17q21,O
),O
",",O
have,O
an,O
80,O
%,O
risk,O
of,O
breast,Disease
cancer,Disease
and,O
a,O
40,O
%,O
risk,O
of,O
ovarian,Disease
cancer,Disease
by,O
the,O
age,O
of,O
70,O
(,O
ref,O
.,O
1,O
),O
.,O
WASP,O
gene,O
mutations,O
in,O
Wiskott,Disease
-,Disease
Aldrich,Disease
syndrome,Disease
and,O
X,Disease
-,Disease
linked,Disease
thrombocytopenia,Disease
.,O
It,O
is,O
flanked,O
by,O
the,O
tightly,O
linked,O
genetic,O
markers,O
ERCC1,O
proximally,O
and,O
D19S51,O
distally,O
;,O
these,O
define,O
the,O
DM,Disease
critical,O
region,O
.,O
Phenylketonuria,Disease
(,O
PKU,Disease
),O
is,O
an,O
autosomal,Disease
recessive,Disease
human,Disease
genetic,Disease
disorder,Disease
caused,O
by,O
a,O
deficiency,Disease
of,Disease
hepatic,Disease
phenylalanine,Disease
hydroxylase,Disease
(,O
PAH,O
",",O
phenylalanine,O
4,O
-,O
monooxygenase,O
",",O
EC,O
1,O
.,O
14,O
.,O
16,O
.,O
1,O
),O
.,O
Two,O
years,O
later,O
he,O
was,O
re,O
-,O
examined,O
because,O
we,O
thought,O
his,O
features,O
fitted,O
the,O
PWS,Disease
-,O
like,O
phenotype,O
associated,O
with,O
maternal,O
UPD,Disease
(,O
14,O
),O
.,O
Our,O
results,O
indicate,O
that,O
the,O
pathogenesis,O
of,O
C7D,Disease
is,O
heterogeneous,O
like,O
most,O
of,O
the,O
other,O
deficiencies,Disease
of,Disease
complement,Disease
components,Disease
.,O
.,O
We,O
analyzed,O
four,O
multiplex,O
VWS,Disease
families,O
.,O
The,O
presence,O
of,O
hypopigmentation,Disease
correlated,O
with,O
a,O
small,O
interstitial,O
deletion,O
on,O
the,O
proximal,O
long,O
arm,O
of,O
chromosome,O
15,O
;,O
however,O
",",O
this,O
deletion,O
was,O
also,O
found,O
in,O
individuals,O
who,O
did,O
not,O
meet,O
the,O
full,O
criteria,O
for,O
hypopigmentation,Disease
.,O
This,O
treatment,O
could,O
prove,O
effective,O
in,O
up,O
to,O
15,O
%,O
of,O
patients,O
with,O
DMD,Disease
.,O
.,O
The,O
gene,O
responsible,O
for,O
Huntington,Disease
disease,Disease
has,O
been,O
localized,O
to,O
a,O
2,O
.,O
We,O
report,O
carrier,O
identification,O
and,O
a,O
prenatal,O
diagnosis,O
using,O
DNA,O
polymorphisms,O
in,O
2,O
families,O
with,O
X,Disease
-,Disease
linked,Disease
Pelizaeus,Disease
-,Disease
Merzbacher,Disease
disease,Disease
(,O
PMD,Disease
),O
.,O
The,O
identification,O
of,O
three,O
separate,O
families,O
in,O
which,O
PLP,O
is,O
duplicated,O
at,O
a,O
noncontiguous,O
site,O
suggests,O
that,O
such,O
duplications,O
could,O
be,O
a,O
relatively,O
common,O
but,O
previously,O
undetected,O
cause,O
of,O
genetic,Disease
disorders,Disease
.,O
Single,O
point,O
mutations,O
were,O
also,O
found,O
in,O
G6PD,O
Metaponto,O
(,O
Southern,O
Italy,O
),O
and,O
in,O
G6PD,O
Ilesha,O
(,O
Nigeria,O
),O
",",O
which,O
are,O
asymptomatic,O
",",O
and,O
in,O
G6PD,O
Chatham,O
",",O
which,O
was,O
observed,O
in,O
an,O
Indian,O
boy,O
with,O
neonatal,Disease
jaundice,Disease
.,O
Mutations,O
in,O
a,O
novel,O
gene,O
(,O
WFS1,O
),O
encoding,O
a,O
putative,O
transmembrane,O
protein,O
were,O
found,O
in,O
all,O
affected,O
individuals,O
in,O
six,O
WFS,Disease
families,O
",",O
and,O
these,O
mutations,O
were,O
associated,O
with,O
the,O
disease,O
phenotype,O
.,O
The,O
human,O
gene,O
for,O
histidase,O
(,O
histidine,O
ammonia,O
-,O
lyase,O
;,O
HAL,O
),O
",",O
the,O
enzyme,O
deficient,O
in,O
histidinemia,Disease
",",O
was,O
assigned,O
to,O
human,O
chromosome,O
12,O
by,O
Southern,O
blot,O
analysis,O
of,O
human,O
X,O
mouse,O
somatic,O
cell,O
hybrid,O
DNA,O
.,O
The,O
red,O
-,O
green,O
visual,O
pigment,O
gene,O
region,O
in,O
adrenoleukodystrophy,Disease
.,O
Moreover,O
",",O
although,O
the,O
scale,O
of,O
the,O
study,O
is,O
limited,O
",",O
there,O
is,O
a,O
possibility,O
that,O
PET,O
can,O
detect,O
an,O
insidious,Disease
lesion,Disease
which,O
is,O
undetectable,O
by,O
computed,O
tomogram,O
(,O
CT,O
),O
or,O
MRI,O
analysis,O
",",O
and,O
that,O
the,O
higher,O
level,O
of,O
tau,O
reflects,O
the,O
process,O
of,O
neuronal,Disease
degeneration,Disease
in,O
ALD,Disease
.,O
A,O
glycine250,O
-,O
-,O
>,O
aspartate,O
substitution,O
in,O
the,O
alpha,O
-,O
subunit,O
of,O
hexosaminidase,O
A,O
causes,O
juvenile,O
-,O
onset,O
Tay,Disease
-,Disease
Sachs,Disease
disease,Disease
in,O
a,O
Lebanese,O
-,O
Canadian,O
family,O
.,O
Canavan,Disease
disease,Disease
is,O
an,O
autosomal,Disease
recessive,Disease
leukodystrophy,Disease
caused,O
by,O
the,O
deficiency,Disease
of,Disease
aspartoacylase,Disease
(,O
ASPA,O
),O
.,O
Cardiac,O
Na,O
(,O
+,O
),O
channel,O
dysfunction,O
in,O
Brugada,Disease
syndrome,Disease
is,O
aggravated,O
by,O
beta,O
(,O
1,O
),O
-,O
subunit,O
.,O
This,O
correction,O
of,O
the,O
defects,O
in,O
A,Disease
-,Disease
T,Disease
cells,O
provides,O
further,O
evidence,O
of,O
the,O
multiplicity,O
of,O
effector,O
functions,O
of,O
the,O
ATM,O
protein,O
and,O
suggests,O
possible,O
approaches,O
to,O
gene,O
therapy,O
.,O
.,O
A,O
mutation,O
in,O
autosomal,Disease
dominant,Disease
myotonia,Disease
congenita,Disease
affects,O
pore,O
properties,O
of,O
the,O
muscle,O
chloride,O
channel,O
.,O
This,O
percentage,O
of,O
CTNNB1,O
mutations,O
is,O
greater,O
than,O
in,O
all,O
other,O
human,O
tumours,Disease
examined,O
thus,O
far,O
",",O
and,O
directly,O
implicates,O
beta,O
-,O
catenin,O
/,O
LEF,O
misregulation,O
as,O
the,O
major,O
cause,O
of,O
hair,O
matrix,O
cell,O
tumorigenesis,O
in,O
humans,O
.,O
.,O
The,O
specific,O
processing,O
and,O
accumulation,O
of,O
toxic,O
fragments,O
of,O
N,O
-,O
terminal,O
huntingtin,O
in,O
HD,Disease
-,O
affected,O
striatal,O
neurons,O
",",O
especially,O
in,O
their,O
neuronal,O
processes,O
and,O
axonal,O
terminals,O
",",O
may,O
contribute,O
to,O
the,O
selective,O
neuropathology,O
of,O
HD,Disease
.,O
.,O
The,O
authors,O
describe,O
two,O
cases,O
of,O
clear,O
cell,O
papillary,Disease
cystadenoma,Disease
of,Disease
the,Disease
epididymis,Disease
",",O
both,O
of,O
which,O
were,O
initially,O
confused,O
with,O
metastatic,Disease
renal,Disease
cell,Disease
carcinoma,Disease
.,O
Direct,O
sequencing,O
of,O
amplified,O
C9,O
cDNA,O
and,O
DNA,O
revealed,O
a,O
nonsense,O
substitution,O
(,O
CGA,O
-,O
-,O
>,O
TGA,O
),O
at,O
codon,O
95,O
in,O
exon,O
4,O
in,O
the,O
four,O
C9,Disease
-,Disease
deficient,Disease
individuals,O
.,O
Fatty,O
alcohol,O
NAD,O
+,O
oxidoreductase,O
",",O
the,O
enzyme,O
catalyzing,O
this,O
reaction,O
",",O
was,O
deficient,O
in,O
SLS,Disease
fibroblasts,O
.,O
Together,O
",",O
our,O
findings,O
suggest,O
the,O
specific,O
deficiency,Disease
of,Disease
emerin,Disease
in,O
the,O
nuclear,O
membrane,O
of,O
muscle,O
cells,O
in,O
patients,O
with,O
EDMD,Disease
.,O
.,O
Four,O
cases,O
of,O
adrenoleukodystrophy,Disease
(,O
ALD,Disease
),O
and,O
one,O
case,O
of,O
adrenomyeloneuropathy,Disease
(,O
AMN,Disease
),O
have,O
developed,O
in,O
a,O
kindred,O
over,O
three,O
generations,O
demonstrating,O
that,O
AMN,Disease
is,O
a,O
clinical,O
variant,O
of,O
ALD,Disease
.,O
In,O
the,O
G6PD,Disease
-,Disease
deficient,Disease
group,O
",",O
the,O
incidence,O
of,O
cortical,Disease
and,Disease
total,Disease
cataracts,Disease
was,O
also,O
increased,O
.,O
Pediatric,Disease
alveolar,Disease
rhabdomyosarcoma,Disease
is,O
characterized,O
by,O
a,O
chromosomal,O
translocation,O
that,O
fuses,O
parts,O
of,O
the,O
PAX3,O
and,O
FKHR,O
genes,O
.,O
Two,O
of,O
seventeen,O
mutated,O
T,Disease
-,Disease
PLL,Disease
samples,O
had,O
a,O
previously,O
reported,O
A,Disease
-,Disease
T,Disease
allele,O
.,O
X,Disease
-,Disease
Linked,Disease
adrenoleukodystrophy,Disease
(,O
ALD,Disease
),O
is,O
a,O
genetic,Disease
disease,Disease
associated,O
with,O
demyelination,Disease
of,Disease
the,Disease
central,Disease
nervous,Disease
system,Disease
",",O
adrenal,Disease
insufficiency,Disease
",",O
and,O
accumulation,O
of,O
very,O
long,O
chain,O
fatty,O
acids,O
in,O
tissue,O
and,O
body,O
fluids,O
.,O
Based,O
on,O
its,O
chromosomal,O
position,O
",",O
this,O
gene,O
is,O
a,O
candidate,O
for,O
conferring,O
susceptibility,O
to,O
diabetes,Disease
.,O
The,O
observed,O
increase,O
in,O
ventilation,O
and,O
inspiratory,O
drive,O
may,O
contribute,O
to,O
the,O
improved,O
activity,O
level,O
reported,O
by,O
parents,O
of,O
PWS,Disease
children,O
during,O
growth,O
hormone,O
therapy,O
Both,O
patients,O
had,O
a,O
family,O
history,O
of,O
breast,Disease
or,Disease
ovarian,Disease
cancer,Disease
.,O
To,O
investigate,O
its,O
possible,O
role,O
",",O
we,O
have,O
analyzed,O
the,O
coding,O
exons,O
of,O
the,O
Wilms,Disease
tumor,Disease
suppressor,O
gene,O
(,O
WT1,O
),O
for,O
germline,O
mutations,O
.,O
Although,O
the,O
link,O
between,O
the,O
BRCA1,O
tumour,Disease
-,O
suppressor,O
gene,O
and,O
hereditary,Disease
breast,Disease
and,Disease
ovarian,Disease
cancer,Disease
is,O
established,O
",",O
the,O
role,O
",",O
if,O
any,O
",",O
of,O
BRCA1,O
in,O
non,Disease
-,Disease
familial,Disease
cancers,Disease
is,O
unclear,O
.,O
Linkage,O
studies,O
in,O
this,O
family,O
revealed,O
one,O
example,O
of,O
probable,O
recombination,O
between,O
the,O
loci,O
for,O
WAS,Disease
and,O
G,O
-,O
6,O
-,O
PD,O
among,O
three,O
informative,O
subjects,O
",",O
suggesting,O
that,O
these,O
two,O
loci,O
may,O
not,O
be,O
closely,O
linked,O
on,O
the,O
X,O
-,O
chromosome,O
.,O
.,O
Aberrant,O
splicing,O
of,O
phenylalanine,O
hydroxylase,O
mRNA,O
:,O
the,O
major,O
cause,O
for,O
phenylketonuria,Disease
in,O
parts,O
of,O
southern,O
Europe,O
.,O
Analysis,O
of,O
the,O
canine,O
dystrophin,O
gene,O
in,O
normal,O
and,O
GRMD,Disease
dogs,O
has,O
failed,O
to,O
demonstrate,O
any,O
detectable,O
loss,O
of,O
exons,O
.,O
In,O
this,O
family,O
affected,O
individuals,O
developed,O
unilateral,Disease
tumors,Disease
and,O
",",O
as,O
a,O
result,O
of,O
linkage,O
analysis,O
",",O
unaffected,O
mutation,O
carriers,O
were,O
also,O
identified,O
within,O
the,O
pedigree,O
.,O
Exclusion,O
of,O
linkage,O
between,O
familial,Disease
Mediterranean,Disease
fever,Disease
and,O
the,O
human,O
serum,O
amyloid,O
A,O
(,O
SAA,O
),O
gene,O
cluster,O
.,O
To,O
fill,O
this,O
gap,O
",",O
we,O
sequenced,O
the,O
G6PD,O
gene,O
of,O
43,O
G6PD,Disease
-,Disease
deficient,Disease
Chinese,O
whose,O
G6PD,O
was,O
well,O
characterized,O
biochemically,O
.,O
We,O
conducted,O
detailed,O
mutational,O
analyses,O
of,O
29,O
unrelated,O
Japanese,O
patients,O
with,O
ALD,Disease
by,O
genomic,O
Southern,O
blot,O
analysis,O
and,O
direct,O
nucleotide,O
sequence,O
analysis,O
of,O
reverse,O
transcriptase,O
-,O
polymerase,O
chain,O
reaction,O
products,O
derived,O
from,O
total,O
RNA,O
that,O
was,O
extracted,O
from,O
cultured,O
skin,O
fibroblasts,O
",",O
lymphoblastoid,O
cells,O
",",O
or,O
peripheral,O
blood,O
leukocytes,O
.,O
We,O
studied,O
80,O
women,O
in,O
whom,O
breast,Disease
cancer,Disease
was,O
diagnosed,O
before,O
the,O
age,O
of,O
35,O
",",O
and,O
who,O
were,O
not,O
selected,O
on,O
the,O
basis,O
of,O
family,O
history,O
.,O
We,O
report,O
a,O
novel,O
TSD,Disease
allele,O
in,O
the,O
French,O
-,O
Canadian,O
population,O
associated,O
with,O
the,O
infantile,O
form,O
of,O
the,O
disease,O
.,O
Identification,O
of,O
mutations,O
in,O
Danish,O
choroideremia,Disease
families,O
.,O
Constitutional,O
von,Disease
Hippel,Disease
-,Disease
Lindau,Disease
(,O
VHL,Disease
),O
gene,O
deletions,O
detected,O
in,O
VHL,Disease
families,O
by,O
fluorescence,O
in,O
situ,O
hybridization,O
.,O
The,O
concept,O
of,O
segregation,O
distortion,O
",",O
where,O
there,O
is,O
preferential,O
transmission,O
of,O
the,O
larger,O
allele,O
at,O
the,O
DM,Disease
locus,O
",",O
has,O
been,O
put,O
forward,O
to,O
explain,O
partially,O
the,O
maintenance,O
of,O
DM,Disease
in,O
the,O
population,O
.,O
These,O
results,O
suggest,O
the,O
possibility,O
of,O
a,O
unique,O
origin,O
for,O
a,O
mutation,O
responsible,O
for,O
many,O
or,O
most,O
cases,O
of,O
VWS,Disease
.,O
Linkage,O
analysis,O
with,O
flanking,O
markers,O
was,O
used,O
to,O
assess,O
OCRL,Disease
carrier,O
status,O
in,O
women,O
at,O
risk,O
.,O
The,O
clinical,O
use,O
of,O
molecular,O
analyses,O
in,O
recessive,Disease
disorders,Disease
relies,O
on,O
the,O
exact,O
characterization,O
of,O
both,O
mutant,O
alleles,O
in,O
the,O
affected,O
patient,O
.,O
Gross,O
haemoglobinuria,Disease
and,O
jaundice,Disease
occurred,O
only,O
after,O
receiving,O
postoperative,O
transfusion,O
of,O
whole,O
blood,O
.,O
Infection,O
-,O
induced,O
hemolysis,Disease
and,O
chronic,Disease
hemolytic,Disease
anemia,Disease
seem,O
to,O
be,O
due,O
to,O
markedly,O
impaired,O
enzyme,O
activity,O
and,O
thermal,O
instability,O
.,O
Mutations,O
at,O
the,O
phenylalanine,O
hydroxylase,O
(,O
PAH,O
),O
locus,O
are,O
the,O
major,O
cause,O
of,O
hyperphenylalaninemia,Disease
.,O
METHODS,O
Eight,O
patients,O
with,O
adult,O
-,O
onset,O
ALD,Disease
underwent,O
clinical,O
examination,O
",",O
brain,O
and,O
spine,O
MRI,O
",",O
and,O
SEP,O
and,O
MEP,O
studies,O
before,O
and,O
after,O
3,O
years,O
of,O
Lorenzos,O
oil,O
dietary,O
therapy,O
.,O
Of,O
these,O
",",O
31,O
had,O
severe,O
G6PD,Disease
deficiency,Disease
",",O
nine,O
had,O
mild,O
to,O
moderate,O
deficiency,O
",",O
and,O
three,O
had,O
a,O
non,O
-,O
deficient,O
electrophoretic,O
variant,O
.,O
This,O
idea,O
is,O
based,O
partly,O
on,O
the,O
phenotype,O
of,O
homozygous,O
Krox20,O
(,O
Egr2,O
),O
knockout,O
mice,O
",",O
which,O
display,O
hypomyelination,Disease
of,Disease
the,Disease
PNS,Disease
and,O
a,O
block,O
of,O
Schwann,O
cells,O
at,O
an,O
early,O
stage,O
of,O
differentiation,O
.,O
The,O
loss,O
of,O
wild,O
-,O
type,O
BRCA1,O
in,O
tumours,Disease
of,O
individuals,O
carrying,O
one,O
nonfunctional,O
BRCA1,O
allele,O
suggests,O
that,O
BRCA1,O
encodes,O
a,O
tumour,Disease
suppressor,O
that,O
may,O
inhibit,O
the,O
proliferation,O
of,O
mammary,O
epithelial,O
cells,O
.,O
PWS,Disease
becomes,O
apparent,O
when,O
genes,O
on,O
the,O
paternally,O
inherited,O
chromosome,O
are,O
not,O
expressed,O
.,O
A,O
new,O
molecular,Disease
lesion,Disease
has,O
been,O
identified,O
in,O
exon,O
7,O
of,O
the,O
PAH,O
gene,O
in,O
a,O
Hungarian,O
PKU,Disease
patient,O
by,O
direct,O
sequencing,O
of,O
PCR,O
-,O
amplified,O
DNA,O
.,O
Recently,O
",",O
mutations,O
of,O
the,O
cathepsin,O
C,O
gene,O
have,O
been,O
identified,O
as,O
the,O
underlying,O
genetic,Disease
defect,Disease
in,O
PLS,Disease
.,O
A,O
comparison,O
of,O
genotypes,O
",",O
ARSA,O
activities,O
",",O
and,O
clinical,O
data,O
on,O
4,O
individuals,O
carrying,O
the,O
allele,O
of,O
81,O
patients,O
with,O
MLD,Disease
examined,O
",",O
further,O
validates,O
the,O
concept,O
that,O
different,O
degrees,O
of,O
residual,O
ARSA,O
activity,O
are,O
the,O
basis,O
of,O
phenotypical,O
variation,O
in,O
MLD,Disease
.,O
.,O
L,Disease
-,Disease
N,Disease
patients,O
fail,O
to,O
reproduce,O
and,O
the,O
heterozygous,O
state,O
appears,O
to,O
confer,O
no,O
selective,O
advantage,O
.,O
Identification,O
of,O
constitutional,O
WT1,O
mutations,O
",",O
in,O
patients,O
with,O
isolated,O
diffuse,Disease
mesangial,Disease
sclerosis,Disease
",",O
and,O
analysis,O
of,O
genotype,O
/,O
phenotype,O
correlations,O
by,O
use,O
of,O
a,O
computerized,O
mutation,O
database,O
.,O
The,O
rare,Disease
diseases,Disease
ataxia,Disease
-,Disease
telangiectasia,Disease
(,O
AT,Disease
),O
",",O
caused,O
by,O
mutations,O
in,O
the,O
ATM,O
gene,O
",",O
and,O
Nijmegen,Disease
breakage,Disease
syndrome,Disease
(,O
NBS,Disease
),O
",",O
with,O
mutations,O
in,O
the,O
p95,O
/,O
nbs1,O
gene,O
",",O
share,O
a,O
variety,O
of,O
phenotypic,Disease
abnormalities,Disease
such,O
as,O
chromosomal,Disease
instability,Disease
",",O
radiation,O
sensitivity,O
and,O
defects,O
in,O
cell,O
-,O
cycle,O
checkpoints,O
in,O
response,O
to,O
ionizing,O
radiation,O
.,O
We,O
studied,O
the,O
relationship,O
between,O
the,O
autosomal,O
recessive,O
trait,O
familial,Disease
Mediterranean,Disease
fever,Disease
(,O
FMF,Disease
),O
and,O
the,O
serum,O
amyloid,O
A,O
(,O
SAA,O
),O
genes,O
by,O
comparing,O
alleles,O
of,O
a,O
highly,O
polymorphic,O
dinucleotide,O
repeat,O
and,O
a,O
conventional,O
restriction,O
fragment,O
length,O
polymorphism,O
(,O
RFLP,O
),O
in,O
the,O
SAA,O
gene,O
cluster,O
in,O
Israeli,O
FMF,Disease
kindreds,O
.,O
Heterozygous,Disease
C2,Disease
deficiency,Disease
associated,O
with,O
angioedema,Disease
",",O
myasthenia,Disease
gravis,Disease
",",O
and,O
systemic,Disease
lupus,Disease
erythematosus,Disease
.,O
To,O
date,O
",",O
however,O
",",O
linkage,O
studies,O
have,O
attempted,O
only,O
to,O
identify,O
chromosomal,O
loci,O
that,O
cause,O
or,O
increase,O
the,O
risk,O
of,O
developing,O
BPAD,Disease
.,O
Partial,O
gene,O
deletion,O
is,O
the,O
major,O
cause,O
of,O
mutation,O
leading,O
to,O
Duchenne,Disease
muscular,Disease
dystrophy,Disease
(,O
DMD,Disease
),O
and,O
Becker,Disease
muscular,Disease
dystrophy,Disease
(,O
BMD,Disease
),O
.,O
The,O
observation,O
of,O
the,O
same,O
APC,Disease
mutation,O
in,O
five,O
families,O
from,O
the,O
same,O
geographic,O
area,O
demonstrates,O
a,O
founder,O
effect,O
.,O
Characterisation,O
of,O
molecular,O
defects,O
in,O
X,Disease
-,Disease
linked,Disease
amelogenesis,Disease
imperfecta,Disease
(,O
AIH1,O
),O
.,O
Significant,O
differences,O
were,O
found,O
between,O
PWS,Disease
patients,O
",",O
SIB,O
controls,O
",",O
and,O
WC,O
controls,O
in,O
the,O
prevalence,O
of,O
febrile,O
convulsions,O
",",O
fever,O
-,O
associated,O
symptoms,O
",",O
and,O
temperature,O
less,O
than,O
94,O
degrees,O
F,O
.,O
Criteria,O
for,O
hypopigmentation,Disease
included,O
the,O
presence,O
of,O
type,O
I,O
or,O
II,O
skin,O
",",O
the,O
lightest,O
skin,O
type,O
in,O
the,O
family,O
by,O
history,O
",",O
and,O
iris,O
translucency,O
on,O
globe,O
transillumination,O
.,O
Both,O
small,O
-,O
sized,O
and,O
normal,O
-,O
sized,O
platelets,O
were,O
present,O
",",O
suggesting,O
that,O
",",O
unlike,O
the,O
vast,O
majority,O
of,O
WAS,Disease
carriers,O
",",O
she,O
does,O
not,O
manifest,O
nonrandom,O
X,O
-,O
chromosome,O
inactivation,O
in,O
the,O
thrombopoietic,O
cell,O
lineage,O
.,O
A,O
strong,O
candidate,O
for,O
the,O
17q,O
-,O
linked,O
BRCA1,O
gene,O
",",O
which,O
influences,O
susceptibility,O
to,O
breast,Disease
and,Disease
ovarian,Disease
cancer,Disease
",",O
has,O
been,O
identified,O
by,O
positional,O
cloning,O
methods,O
.,O
This,O
disorder,O
may,O
account,O
for,O
up,O
to,O
10,O
%,O
of,O
cases,O
of,O
hereditary,Disease
deafness,Disease
.,O
First,O
case,O
of,O
C9,Disease
deficiency,Disease
in,O
Europe,O
.,O
These,O
results,O
provide,O
a,O
new,O
insight,O
into,O
the,O
role,O
of,O
mutant,O
PAX6,O
in,O
causing,O
aniridia,Disease
.,O
.,O
Mutational,O
analysis,O
of,O
the,O
HGO,O
gene,O
in,O
Finnish,O
alkaptonuria,Disease
patients,O
.,O
This,O
initial,O
delineation,O
of,O
human,O
mutations,O
in,O
VLCAD,O
suggests,O
that,O
VLCAD,Disease
deficiency,Disease
reduces,O
myocardial,O
fatty,O
acid,O
beta,O
-,O
oxidation,O
and,O
energy,O
production,O
and,O
is,O
associated,O
with,O
cardiomyopathy,Disease
and,O
sudden,Disease
death,Disease
in,O
childhood,O
.,O
No,O
protein,O
was,O
detected,O
in,O
two,O
individuals,O
with,O
severe,O
WAS,Disease
.,O
The,O
most,O
common,O
phenotypic,O
features,O
",",O
present,O
in,O
more,O
than,O
a,O
third,O
of,O
our,O
patients,O
with,O
TWIST,O
mutations,O
",",O
are,O
coronal,Disease
synostosis,Disease
",",O
brachycephaly,Disease
",",O
low,Disease
frontal,Disease
hairline,Disease
",",O
facial,Disease
asymmetry,Disease
",",O
ptosis,Disease
",",O
hypertelorism,Disease
",",O
broad,Disease
great,Disease
toes,Disease
",",O
and,O
clinodactyly,Disease
.,O
To,O
guard,O
against,O
the,O
possible,O
problem,O
of,O
differential,O
PCR,O
amplification,O
rates,O
based,O
on,O
the,O
lengths,O
of,O
the,O
alleles,O
",",O
the,O
sperm,O
were,O
also,O
typed,O
at,O
another,O
closely,O
linked,O
marker,O
whose,O
allele,O
size,O
was,O
unrelated,O
to,O
the,O
allele,O
size,O
at,O
the,O
DM,Disease
locus,O
.,O
However,O
",",O
the,O
mutant,O
WT1,O
(,O
tmT396,O
),O
protein,O
accounted,O
for,O
only,O
5,O
%,O
of,O
WT1,O
in,O
both,O
heterozygous,O
embryonic,O
stem,O
cells,O
and,O
the,O
WT,Disease
.,O
Their,O
relatives,O
were,O
described,O
with,O
respect,O
to,O
absence,O
/,O
presence,O
of,O
breast,Disease
and,Disease
/,Disease
or,Disease
ovarian,Disease
cancer,Disease
.,O
In,O
colon,Disease
carcinoma,Disease
cells,O
",",O
loss,O
of,O
APC,O
leads,O
to,O
the,O
accumulation,O
of,O
betacatenin,O
in,O
the,O
nucleus,O
",",O
where,O
it,O
binds,O
to,O
and,O
activates,O
the,O
Tcf,O
-,O
4,O
transcription,O
factor,O
(,O
reviewed,O
in,O
[,O
1,O
],O
[,O
2,O
],O
),O
.,O
Neither,O
antilymphocytic,O
autoantibodies,O
nor,O
chromosomal,Disease
abnormalities,Disease
were,O
found,O
.,O
Four,O
patients,O
had,O
a,O
germ,O
-,O
line,O
E1317Q,O
missense,O
variant,O
of,O
APC,O
that,O
was,O
not,O
present,O
in,O
controls,O
;,O
one,O
of,O
these,O
individuals,O
had,O
an,O
unusually,O
large,O
number,O
of,O
metaplastic,Disease
polyps,Disease
of,Disease
the,Disease
colorectum,Disease
.,O
von,Disease
Willebrand,Disease
factor,O
(,O
vWF,O
),O
is,O
a,O
multimeric,O
glycoprotein,O
that,O
mediates,O
the,O
adhesion,O
of,O
platelets,O
to,O
the,O
subendothelium,O
by,O
binding,O
to,O
platelet,O
glycoprotein,O
Ib,O
.,O
We,O
describe,O
a,O
patient,O
with,O
typical,O
clinical,O
features,O
of,O
the,O
fragile,Disease
X,Disease
syndrome,Disease
",",O
but,O
without,O
cytogenetic,O
expression,O
of,O
the,O
fragile,Disease
X,Disease
or,O
an,O
amplified,O
CCG,O
trinucleotide,O
repeat,O
fragment,O
.,O
OBJECTIVE,O
To,O
define,O
the,O
mutation,O
causing,O
galactosemia,Disease
in,O
patients,O
of,O
black,O
American,O
origin,O
who,O
have,O
no,O
galactose,O
-,O
1,O
-,O
phosphate,O
uridyltransferase,O
(,O
GALT,O
),O
activity,O
in,O
erythrocytes,O
but,O
good,O
clinical,O
outcome,O
.,O
Recent,O
studies,O
demonstrated,O
the,O
existence,O
of,O
a,O
genetically,O
distinct,O
",",O
usually,O
lethal,O
form,O
of,O
the,O
Schwartz,Disease
-,Disease
Jampel,Disease
syndrome,Disease
(,O
SJS,Disease
),O
of,O
myotonia,Disease
and,O
skeletal,Disease
dysplasia,Disease
",",O
which,O
we,O
called,O
SJS,Disease
type,Disease
2,Disease
.,O
Partial,O
HPRT,Disease
deficiencies,Disease
are,O
associated,O
with,O
gouty,Disease
arthritis,Disease
",",O
while,O
absence,O
of,O
activity,O
results,O
in,O
Lesch,Disease
-,Disease
Nyhan,Disease
syndrome,Disease
(,O
L,Disease
-,Disease
N,Disease
),O
.,O
These,O
data,O
provide,O
further,O
evidence,O
for,O
extensive,O
allelic,O
heterogeneity,O
in,O
MPS,Disease
IVA,Disease
in,O
British,O
-,O
Irish,O
patients,O
and,O
provide,O
evidence,O
for,O
their,O
transmission,O
to,O
Australia,O
by,O
British,O
-,O
Irish,O
migrants,O
.,O
.,O
Several,O
polymorphisms,O
within,O
the,O
human,O
DM,Disease
kinase,O
gene,O
have,O
been,O
identified,O
",",O
and,O
PCR,O
assays,O
to,O
detect,O
two,O
of,O
these,O
are,O
described,O
.,O
A,O
defined,O
fragment,O
of,O
human,O
chromosome,O
10,O
was,O
transferred,O
via,O
microcell,O
fusion,O
into,O
a,O
prostate,Disease
adenocarcinoma,Disease
cell,O
line,O
.,O
Our,O
results,O
indicate,O
that,O
DMPK,O
may,O
be,O
necessary,O
for,O
the,O
maintenance,O
of,O
skeletal,O
muscle,O
structure,O
and,O
function,O
and,O
suggest,O
that,O
a,O
decrease,O
in,O
DMPK,O
levels,O
may,O
contribute,O
to,O
DM,Disease
pathology,O
.,O
.,O
The,O
result,O
suggests,O
that,O
the,O
number,O
of,O
colorectal,Disease
polyps,Disease
in,O
FAP,Disease
patients,O
may,O
be,O
associated,O
with,O
a,O
difference,O
in,O
the,O
stability,O
or,O
biological,O
function,O
of,O
the,O
truncated,O
APC,Disease
protein,O
.,O
.,O
Decrease,O
in,O
GTP,O
cyclohydrolase,O
I,O
gene,O
expression,O
caused,O
by,O
inactivation,O
of,O
one,O
allele,O
in,O
hereditary,Disease
progressive,Disease
dystonia,Disease
with,O
marked,O
diurnal,O
fluctuation,O
.,O
Denys,Disease
-,Disease
Drash,Disease
syndrome,Disease
is,O
a,O
rare,O
human,O
condition,O
in,O
which,O
severe,O
urogenital,Disease
aberrations,Disease
result,O
in,O
renal,Disease
failure,Disease
",",O
pseudohermaphroditism,Disease
",",O
and,O
Wilms,Disease
tumor,Disease
(,O
nephroblastoma,Disease
),O
.,O
VHL,O
-,O
negative,O
786,O
-,O
0,O
RCC,Disease
cells,O
are,O
tumorigenic,O
in,O
nude,O
mice,O
which,O
is,O
suppressed,O
by,O
the,O
reintroduction,O
of,O
VHL,Disease
.,O
One,O
mildly,O
affected,O
BMD,Disease
patient,O
possesses,O
a,O
deletion,O
of,O
at,O
least,O
110,O
kb,O
including,O
exons,O
of,O
the,O
DMD,Disease
gene,O
.,O
Prevalence,O
of,O
p16,O
and,O
CDK4,O
germline,O
mutations,O
in,O
48,O
melanoma,Disease
-,O
prone,O
families,O
in,O
France,O
.,O
Our,O
observation,O
of,O
differently,O
sized,O
repeats,O
in,O
various,O
DM,Disease
tissues,O
from,O
the,O
same,O
individual,O
may,O
explain,O
why,O
the,O
size,O
of,O
the,O
mutation,O
observed,O
in,O
lymphocytes,O
does,O
not,O
necessarily,O
correlate,O
with,O
the,O
severity,O
and,O
nature,O
of,O
symptoms,O
.,O
As,O
expected,O
",",O
the,O
molecular,O
analyses,O
indicate,O
loss,O
of,O
one,O
allele,O
at,O
the,O
MCC,O
and,O
APC,Disease
loci,O
.,O
The,O
C6,O
/,O
C7,O
marker,O
haplotypes,O
associated,O
with,O
most,O
C7,Disease
defects,Disease
are,O
tabulated,O
.,O
.,O
Huntington,Disease
disease,Disease
(,O
HD,Disease
),O
is,O
a,O
severe,O
autosomal,Disease
dominant,Disease
neurodegenerative,Disease
disorder,Disease
associated,O
with,O
a,O
novel,O
gene,O
(,O
IT15,O
),O
.,O
Molecular,O
defects,O
leading,O
to,O
human,O
complement,Disease
component,Disease
C6,Disease
deficiency,Disease
in,O
an,O
African,O
-,O
American,O
family,O
.,O
Mutations,O
in,O
Prph2,O
have,O
been,O
shown,O
to,O
result,O
in,O
a,O
variety,O
of,O
photoreceptor,Disease
dystrophies,Disease
",",O
including,O
autosomal,Disease
dominant,Disease
retinitis,Disease
pigmentosa,Disease
and,O
macular,Disease
dystrophy,Disease
.,O
We,O
analysed,O
13,O
independent,O
patients,O
with,O
clinical,O
diagnosis,O
of,O
AAS,Disease
.,O
Functional,O
link,O
between,O
ataxia,Disease
-,Disease
telangiectasia,Disease
and,O
Nijmegen,Disease
breakage,Disease
syndrome,Disease
gene,O
products,O
.,O
It,O
is,O
therefore,O
concluded,O
that,O
the,O
R496H,O
mutation,O
of,O
ARSA,O
does,O
not,O
negatively,O
influence,O
the,O
activity,O
of,O
ARSA,O
and,O
is,O
not,O
a,O
cause,O
of,O
MLD,Disease
In,O
addition,O
",",O
we,O
found,O
seven,O
individuals,O
with,O
hypohaptoglobinemia,Disease
in,O
three,O
families,O
",",O
and,O
the,O
genotypes,O
of,O
six,O
of,O
the,O
seven,O
individuals,O
were,O
found,O
to,O
be,O
Hp2,O
/,O
Hpdel,O
.,O
The,O
identification,O
of,O
a,O
mouse,O
X,O
-,O
linked,O
mutant,O
showing,O
muscular,Disease
dystrophy,Disease
",",O
mdx,O
",",O
has,O
provided,O
a,O
candidate,O
mouse,O
genetic,O
homologue,O
to,O
the,O
DMD,Disease
locus,O
;,O
the,O
relatively,O
mild,O
pathological,O
features,O
of,O
mdx,O
suggest,O
it,O
may,O
have,O
more,O
in,O
common,O
with,O
mutations,O
of,O
the,O
Becker,Disease
muscular,Disease
dystrophy,Disease
type,O
at,O
the,O
same,O
human,O
locus,O
",",O
however,O
.,O
Putative,O
X,Disease
-,Disease
linked,Disease
adrenoleukodystrophy,Disease
gene,O
shares,O
unexpected,O
homology,O
with,O
ABC,O
transporters,O
.,O
Since,O
a,O
mutation,O
at,O
cDNA,O
nucleotide,O
2302,O
(,O
2302insC,O
),O
had,O
been,O
previously,O
described,O
",",O
this,O
region,O
of,O
the,O
ATP7B,O
gene,O
may,O
be,O
susceptible,O
to,O
gene,O
rearrangements,O
causing,O
Wilson,Disease
disease,Disease
.,O
The,O
same,O
mutation,O
was,O
found,O
in,O
one,O
additional,O
melanoma,Disease
among,O
28,O
melanomas,Disease
analyzed,O
.,O
Nevertheless,O
",",O
E148Q,O
helps,O
account,O
for,O
recessive,O
inheritance,O
in,O
an,O
Ashkenazi,O
family,O
previously,O
reported,O
as,O
an,O
unusual,O
case,O
of,O
dominantly,O
inherited,O
FMF,Disease
.,O
Loss,O
of,O
APC,Disease
function,O
was,O
recently,O
shown,O
to,O
result,O
in,O
enhanced,O
beta,O
-,O
catenin,O
-,O
/,O
Tcf,O
-,O
mediated,O
transcription,O
in,O
colon,O
epithelial,O
cells,O
.,O
Hemizygous,O
mice,O
carrying,O
a,O
replacement,O
mutation,O
in,O
exon,O
2,O
of,O
the,O
ND,Disease
gene,O
developed,O
retrolental,O
structures,O
in,O
the,O
vitreous,O
body,O
and,O
showed,O
an,O
overall,O
disorganization,O
of,O
the,O
retinal,O
ganglion,O
cell,O
layer,O
.,O
Tumor,Disease
suppression,O
and,O
apoptosis,O
of,O
human,O
prostate,Disease
carcinoma,Disease
mediated,O
by,O
a,O
genetic,O
locus,O
within,O
human,O
chromosome,O
10pter,O
-,O
q11,O
.,O
These,O
observations,O
suggest,O
a,O
role,O
for,O
FH,O
and,O
/,O
or,O
FH,O
receptors,O
in,O
the,O
pathogenesis,O
of,O
idiopathic,O
HUS,Disease
.,O
.,O
Although,O
we,O
found,O
no,O
FEN1,O
mutations,O
",",O
a,O
frameshift,O
mutation,O
in,O
MSH3,O
was,O
observed,O
in,O
an,O
endometrial,Disease
carcinoma,Disease
and,O
in,O
an,O
endometrial,Disease
carcinoma,Disease
cell,O
line,O
.,O
In,O
addition,O
",",O
locus,O
DXYS12,O
was,O
found,O
to,O
be,O
closely,O
linked,O
with,O
TCD,Disease
(,O
lod,O
3,O
.,O
31,O
at,O
0,O
recombination,O
distance,O
),O
.,O
Direct,O
DNA,O
sequencing,O
was,O
done,O
to,O
screen,O
the,O
entire,O
coding,O
region,O
of,O
the,O
WFS1,O
gene,O
in,O
30,O
patients,O
from,O
19,O
British,O
kindreds,O
with,O
Wolfram,Disease
syndrome,Disease
.,O
CONCLUSIONS,O
The,O
incidence,O
of,O
each,O
of,O
the,O
germline,O
mutations,O
in,O
these,O
prostate,Disease
cancer,Disease
patients,O
closely,O
matched,O
their,O
incidence,O
(,O
about,O
1,O
%,O
),O
in,O
the,O
general,O
Ashkenazi,O
Jewish,O
population,O
.,O
We,O
have,O
created,O
two,O
deletion,O
mutations,O
in,O
mice,O
to,O
understand,O
PWS,Disease
and,O
the,O
mechanism,O
of,O
this,O
IC,O
.,O
The,O
remaining,O
12,O
patients,O
represent,O
possible,O
phenocopies,O
for,O
HD,Disease
.,O
Age,O
of,O
onset,O
(,O
AO,O
),O
of,O
Huntington,Disease
disease,Disease
(,O
HD,Disease
),O
is,O
known,O
to,O
be,O
correlated,O
with,O
the,O
length,O
of,O
an,O
expanded,O
CAG,O
repeat,O
in,O
the,O
HD,Disease
gene,O
.,O
Inherited,Disease
complement,Disease
deficiencies,Disease
are,O
associated,O
with,O
a,O
variety,O
of,O
connective,O
tissue,O
diseases,O
.,O
Germ,O
-,O
line,O
and,O
somatic,O
truncating,O
mutations,O
of,O
the,O
APC,Disease
gene,O
are,O
thought,O
to,O
initiate,O
colorectal,Disease
tumor,Disease
formation,O
in,O
familial,Disease
adenomatous,Disease
polyposis,Disease
syndrome,Disease
and,O
sporadic,O
colorectal,O
carcinogenesis,O
",",O
respectively,O
.,O
A,O
genome,O
-,O
wide,O
search,O
for,O
chromosomal,O
loci,O
linked,O
to,O
mental,O
health,O
wellness,O
in,O
relatives,O
at,O
high,O
risk,O
for,O
bipolar,Disease
affective,Disease
disorder,Disease
among,O
the,O
Old,O
Order,O
Amish,O
.,O
We,O
have,O
identified,O
14,O
families,O
with,O
ataxia,Disease
-,Disease
telangiectasia,Disease
(,O
A,Disease
-,Disease
T,Disease
),O
in,O
which,O
mutation,O
of,O
the,O
ATM,O
gene,O
is,O
associated,O
with,O
a,O
less,O
severe,O
clinical,O
and,O
cellular,O
phenotype,O
(,O
approximately,O
10,O
%,O
-,O
15,O
%,O
of,O
A,Disease
-,Disease
T,Disease
families,O
identified,O
in,O
the,O
United,O
Kingdom,O
),O
.,O
A,O
pair,O
of,O
female,O
monozygotic,O
(,O
MZ,O
),O
twins,O
",",O
heterozygous,O
carriers,O
for,O
a,O
deletion,O
in,O
the,O
DMD,Disease
gene,O
and,O
discordant,O
for,O
the,O
clinical,O
manifestations,O
of,O
Duchenne,Disease
muscular,Disease
dystrophy,Disease
",",O
were,O
analyzed,O
by,O
molecular,O
studies,O
",",O
in,O
situ,O
hybridization,O
",",O
and,O
methylation,O
pattern,O
of,O
X,O
chromosomes,O
to,O
search,O
for,O
opposite,O
X,O
inactivation,O
as,O
an,O
explanation,O
of,O
their,O
clinical,O
discordance,O
.,O
RESULTS,O
A,O
statistically,O
significant,O
excess,O
risk,O
of,O
cancer,Disease
was,O
seen,O
among,O
the,O
patients,O
with,O
CHH,Disease
(,O
standardized,O
incidence,O
ratio,O
6,O
.,O
9,O
",",O
95,O
%,O
confidence,O
interval,O
2,O
.,O
3,O
to,O
16,O
),O
",",O
which,O
was,O
mainly,O
attributable,O
to,O
non,Disease
-,Disease
Hodgkins,Disease
lymphoma,Disease
(,O
standardized,O
incidence,O
ratio,O
90,O
",",O
95,O
%,O
confidence,O
interval,O
18,O
to,O
264,O
),O
.,O
While,O
only,O
5,O
%,O
of,O
sporadic,Disease
Wilms,Disease
tumours,Disease
have,O
intragenic,O
WT1,O
mutations,O
",",O
>,O
90,O
%,O
of,O
patients,O
with,O
the,O
Denys,Disease
-,Disease
Drash,Disease
syndrome,Disease
(,O
renal,Disease
nephropathy,Disease
",",O
gonadal,Disease
anomaly,Disease
",",O
predisposition,Disease
to,Disease
WT,Disease
),O
carry,O
constitutional,O
intragenic,O
WT1,O
mutations,O
.,O
Localisation,O
of,O
the,O
myotonic,Disease
dystrophy,Disease
locus,O
to,O
19q13,O
.,O
2,O
-,O
19q13,O
.,O
3,O
and,O
its,O
relationship,O
to,O
twelve,O
polymorphic,O
loci,O
on,O
19q,O
.,O
We,O
have,O
analyzed,O
20,O
breast,Disease
-,Disease
ovarian,Disease
cancer,Disease
families,O
",",O
the,O
majority,O
of,O
which,O
show,O
positive,O
evidence,O
of,O
linkage,O
to,O
chromosome,O
17q12,O
for,O
germ,O
-,O
line,O
mutations,O
in,O
the,O
BRCA1,O
gene,O
.,O
We,O
describe,O
the,O
first,O
cases,O
",",O
to,O
our,O
knowledge,O
",",O
of,O
C9,Disease
deficiency,Disease
in,O
Europe,O
that,O
were,O
detected,O
in,O
a,O
Swiss,O
family,O
",",O
of,O
which,O
two,O
members,O
-,O
-,O
one,O
with,O
a,O
complete,O
deficiency,O
and,O
the,O
other,O
with,O
approximately,O
half,O
-,O
normal,O
C9,O
levels,O
-,O
-,O
experienced,O
bacterial,Disease
meningitis,Disease
.,O
Furthermore,O
",",O
SNRPN,O
was,O
mapped,O
to,O
the,O
minimal,O
deletion,O
interval,O
that,O
is,O
critical,O
for,O
PWS,Disease
.,O
Childhood,O
ALD,Disease
is,O
the,O
more,O
severe,O
form,O
",",O
with,O
onset,O
of,O
neurological,O
symptoms,O
between,O
5,O
-,O
12,O
years,O
of,O
age,O
.,O
Historically,O
",",O
Pelizaeus,Disease
-,Disease
Merzbacher,Disease
disease,Disease
has,O
encompassed,O
a,O
host,O
of,O
neurologic,Disease
disorders,Disease
that,O
present,O
with,O
a,O
deficit,Disease
of,Disease
myelin,Disease
",",O
the,O
membrane,O
elaborated,O
by,O
glial,O
cells,O
that,O
encircles,O
and,O
successively,O
enwraps,O
axons,O
.,O
We,O
have,O
identified,O
303,O
patients,O
with,O
ALD,Disease
in,O
217,O
kindreds,O
.,O
The,O
duration,O
of,O
disease,O
is,O
correlated,O
with,O
wheelchair,O
use,O
and,O
the,O
presence,O
of,O
diabetes,Disease
",",O
scoliosis,Disease
",",O
bladder,Disease
symptoms,Disease
and,O
impaired,Disease
proprioception,Disease
",",O
and,O
vibration,O
sense,O
but,O
no,O
other,O
complications,O
studied,O
.,O
.,O
Adrenoleukodystrophy,Disease
:,O
survey,O
of,O
303,O
cases,O
:,O
biochemistry,O
",",O
diagnosis,O
",",O
and,O
therapy,O
.,O
These,O
data,O
are,O
compatible,O
with,O
the,O
VHL,Disease
gene,O
functioning,O
as,O
a,O
recessive,O
tumour,Disease
suppressor,O
gene,O
.,O
Mice,O
lacking,O
the,O
myotonic,Disease
dystrophy,Disease
protein,O
kinase,O
develop,O
a,O
late,O
onset,O
progressive,O
myopathy,Disease
.,O
Heterozygotes,O
for,O
the,O
ATM,O
gene,O
have,O
no,O
clinical,O
expression,O
of,O
A,Disease
-,Disease
T,Disease
but,O
may,O
be,O
cancer,Disease
prone,O
with,O
a,O
moderate,O
increase,O
in,O
in,O
vitro,O
radiosensitivity,O
.,O
In,O
16,O
families,O
with,O
myotonic,Disease
dystrophy,Disease
(,O
DM,Disease
),O
a,O
novel,O
approach,O
based,O
on,O
use,O
of,O
allele,O
-,O
specific,O
oligonucleotides,O
has,O
been,O
employed,O
to,O
study,O
the,O
linkage,O
relationship,O
between,O
the,O
apolipoprotein,O
E,O
(,O
APOE,O
),O
gene,O
and,O
DM,Disease
.,O
These,O
mice,O
should,O
help,O
increase,O
our,O
understanding,O
of,O
hypobetalipoproteinemia,Disease
",",O
atherogenesis,Disease
",",O
and,O
the,O
etiology,O
of,O
exencephalus,Disease
and,O
hydrocephalus,Disease
.,O
.,O
Restriction,O
fragment,O
length,O
polymorphism,O
alleles,O
for,O
the,O
ADH2,O
",",O
ADH3,O
",",O
EGF,O
",",O
FG,O
alpha,O
and,O
FG,O
beta,O
loci,O
and,O
blood,O
group,O
antigens,O
for,O
the,O
MNS,O
locus,O
were,O
determined,O
in,O
a,O
panel,O
of,O
12,O
Finnish,O
AGU,Disease
families,O
.,O
The,O
objective,O
of,O
this,O
study,O
was,O
to,O
provide,O
more,O
accurate,O
frequency,O
estimates,O
of,O
breast,Disease
cancer,Disease
susceptibility,O
gene,O
1,O
(,O
BRCA1,O
),O
germline,O
alterations,O
in,O
the,O
ovarian,Disease
cancer,Disease
population,O
.,O
AMN,Disease
is,O
a,O
milder,O
form,O
of,O
the,O
disease,O
with,O
onset,O
at,O
15,O
-,O
30,O
years,O
of,O
age,O
and,O
a,O
more,O
progressive,O
course,O
.,O
Here,O
we,O
present,O
four,O
novel,O
PAX6,O
missense,O
mutations,O
",",O
two,O
in,O
association,O
with,O
atypical,O
phenotypes,O
ectopia,Disease
pupillae,Disease
(,O
displaced,Disease
pupils,Disease
),O
and,O
congenital,Disease
nystagmus,Disease
(,O
searching,Disease
gaze,Disease
),O
",",O
and,O
two,O
in,O
association,O
with,O
more,O
recognizable,O
aniridia,Disease
phenotypes,O
.,O
The,O
spectrum,O
of,O
mutations,O
presented,O
here,O
should,O
help,O
to,O
improve,O
the,O
clinical,O
management,O
of,O
retinoblastoma,Disease
and,O
to,O
understand,O
the,O
molecular,O
mechanisms,O
leading,O
to,O
tumorigenesis,O
.,O
.,O
Gc,O
-,O
protein,O
levels,O
were,O
normal,O
in,O
the,O
patient,O
and,O
together,O
with,O
normal,O
chromosomal,O
banding,O
studies,O
make,O
it,O
unlikely,O
that,O
a,O
chromosomal,O
deletion,O
caused,O
analbuminemia,Disease
.,O
The,O
identification,O
of,O
four,O
genomic,O
rearrangements,O
among,O
30,O
mutations,O
suggests,O
that,O
genomic,O
rearrangements,O
are,O
frequent,O
germline,O
APC,Disease
mutations,O
.,O
.,O
Considering,O
conserved,O
synteny,O
",",O
we,O
were,O
able,O
to,O
map,O
the,O
human,O
gene,O
to,O
chromosome,O
3q,O
in,O
six,O
alkaptonuria,Disease
pedigrees,O
of,O
Slovak,O
origin,O
.,O
.,O
Of,O
44,O
patients,O
",",O
nine,O
(,O
20,O
%,O
),O
had,O
facial,Disease
angiofibromas,Disease
",",O
tumours,Disease
primarily,O
occurring,O
in,O
association,O
with,O
tuberous,Disease
sclerosis,Disease
.,O
This,O
cohort,O
underwent,O
follow,O
-,O
up,O
for,O
cancer,Disease
incidence,O
through,O
the,O
Finnish,O
Cancer,O
Registry,O
to,O
the,O
end,O
of,O
1995,O
.,O
A,O
number,O
of,O
ARSA,O
gene,O
mutations,O
responsible,O
for,O
MLD,Disease
have,O
been,O
identified,O
.,O
Insertional,O
mutation,O
by,O
transposable,O
element,O
",",O
L1,O
",",O
in,O
the,O
DMD,Disease
gene,O
results,O
in,O
X,Disease
-,Disease
linked,Disease
dilated,Disease
cardiomyopathy,Disease
.,O
In,O
contrast,O
",",O
goiter,Disease
was,O
present,O
in,O
only,O
11,O
affected,O
individuals,O
",",O
who,O
interestingly,O
had,O
a,O
normal,O
result,O
of,O
the,O
perchlorate,O
discharge,O
test,O
whenever,O
performed,O
.,O
A,O
missense,O
mutation,O
has,O
been,O
identified,O
in,O
the,O
human,O
phenylalanine,O
hydroxylase,O
[,O
PAH,O
;,O
phenylalanine,O
4,O
-,O
monooxygenase,O
;,O
L,O
-,O
phenylalanine,O
",",O
tetrahydrobiopterin,O
oxygen,O
oxidoreductase,O
(,O
4,O
-,O
hydroxylating,O
),O
",",O
EC,O
1,O
.,O
14,O
.,O
16,O
.,O
1,O
],O
gene,O
in,O
a,O
Chinese,O
patient,O
with,O
classic,O
phenylketonuria,Disease
(,O
PKU,Disease
),O
.,O
We,O
found,O
relatively,O
small,O
decreases,O
of,O
DM,Disease
kinase,O
RNA,O
in,O
the,O
total,O
RNA,O
pool,O
from,O
muscle,O
;,O
however,O
",",O
these,O
reductions,O
were,O
not,O
disease,O
specific,O
.,O
Eight,O
mutations,O
",",O
one,O
of,O
which,O
(,O
R408Q,O
),O
is,O
new,O
",",O
were,O
found,O
to,O
account,O
for,O
93,O
%,O
of,O
the,O
163,O
independent,O
FMF,Disease
alleles,O
",",O
with,O
both,O
FMF,Disease
alleles,O
identified,O
in,O
89,O
%,O
of,O
the,O
patients,O
.,O
The,O
present,O
results,O
question,O
the,O
sensitivity,O
of,O
the,O
perchlorate,O
test,O
for,O
the,O
diagnosis,O
of,O
Pendred,Disease
syndrome,Disease
and,O
support,O
the,O
use,O
of,O
a,O
molecular,O
analysis,O
of,O
the,O
PDS,Disease
gene,O
in,O
the,O
assessment,O
of,O
individuals,O
with,O
severe,O
to,O
profound,O
congenital,Disease
hearing,Disease
loss,Disease
associated,O
with,O
inner,Disease
ear,Disease
morphological,Disease
anomaly,Disease
even,O
in,O
the,O
absence,O
of,O
a,O
thyroid,Disease
goiter,Disease
.,O
.,O
Stable,O
interaction,O
between,O
the,O
products,O
of,O
the,O
BRCA1,O
and,O
BRCA2,O
tumor,Disease
suppressor,O
genes,O
in,O
mitotic,O
and,O
meiotic,O
cells,O
.,O
Mutations,O
at,O
the,O
ataxia,Disease
-,Disease
telangiectasia,Disease
(,O
A,Disease
-,Disease
T,Disease
),O
locus,O
on,O
chromosome,O
band,O
11q22,O
cause,O
a,O
distinctive,O
autosomal,Disease
recessive,Disease
syndrome,Disease
in,O
homozygotes,O
and,O
predispose,O
heterozygotes,O
to,O
cancer,Disease
",",O
ischemic,Disease
heart,Disease
disease,Disease
",",O
and,O
early,O
mortality,O
.,O
Missense,O
mutations,O
in,O
the,O
functional,O
domain,O
of,O
Mxi1,O
in,O
these,O
cases,O
may,O
be,O
involved,O
in,O
the,O
pathogenesis,O
of,O
neurofibrosarcoma,Disease
.,O
.,O
To,O
determine,O
whether,O
there,O
could,O
be,O
protective,O
alleles,O
that,O
prevent,O
or,O
reduce,O
the,O
risk,O
of,O
developing,O
BPAD,Disease
",",O
similar,O
to,O
what,O
is,O
observed,O
in,O
other,O
genetic,Disease
disorders,Disease
",",O
we,O
used,O
mental,O
health,O
wellness,O
(,O
absence,O
of,O
any,O
psychiatric,Disease
disorder,Disease
),O
as,O
the,O
phenotype,O
in,O
our,O
genome,O
-,O
wide,O
linkage,O
scan,O
of,O
several,O
large,O
multigeneration,O
Old,O
Order,O
Amish,O
pedigrees,O
exhibiting,O
an,O
extremely,O
high,O
incidence,O
of,O
BPAD,Disease
.,O
There,O
was,O
no,O
evidence,O
of,O
premature,Disease
atherosclerosis,Disease
in,O
the,O
families,O
with,O
CETP,Disease
deficiency,Disease
.,O
An,O
intrachromosomal,O
insertion,O
causing,O
5q22,O
deletion,O
and,O
familial,Disease
adenomatous,Disease
polyposis,Disease
coli,Disease
in,O
two,O
generations,O
.,O
Genetic,O
mapping,O
of,O
the,O
breast,Disease
-,Disease
ovarian,Disease
cancer,Disease
syndrome,Disease
to,O
a,O
small,O
interval,O
on,O
chromosome,O
17q12,O
-,O
21,O
:,O
exclusion,O
of,O
candidate,O
genes,O
EDH17B2,O
and,O
RARA,O
.,O
While,O
this,O
is,O
the,O
first,O
complete,O
report,O
on,O
the,O
occurrence,O
of,O
thrombocytopenia,Disease
in,O
a,O
carrier,O
female,O
of,O
WAS,Disease
as,O
the,O
result,O
of,O
atypical,O
lyonization,O
",",O
it,O
also,O
suggests,O
that,O
expression,O
of,O
the,O
WAS,Disease
gene,O
occurs,O
at,O
(,O
or,O
extends,O
up,O
to,O
),O
a,O
later,O
stage,O
than,O
the,O
multipotent,O
stem,O
cell,O
along,O
the,O
hematopoietic,O
differentiation,O
pathway,O
.,O
.,O
We,O
also,O
examined,O
29,O
human,O
tumor,Disease
cell,O
lines,O
consisting,O
of,O
12,O
esophageal,Disease
cancers,Disease
",",O
7,O
glioma,Disease
/,O
glioblastomas,Disease
and,O
10,O
others,O
for,O
Mxi1,O
mutations,O
in,O
exons,O
1,O
",",O
2,O
",",O
4,O
(,O
HLH,O
domain,O
),O
",",O
5,O
and,O
6,O
.,O
Erythrocyte,O
glucose,O
-,O
6,O
-,O
phosphate,O
dehydrogenase,O
(,O
G6PD,O
),O
was,O
characterized,O
in,O
blood,O
samples,O
obtained,O
from,O
97,O
randomly,O
selected,O
males,O
with,O
enzyme,Disease
deficiency,Disease
from,O
various,O
regions,O
of,O
Guangdong,O
Province,O
",",O
China,O
.,O
Previous,O
study,O
disclosed,O
that,O
flow,O
cytometric,O
analysis,O
of,O
intracellular,O
WASP,O
expression,O
(,O
FCM,O
-,O
WASP,O
analysis,O
),O
in,O
lymphocytes,O
was,O
useful,O
for,O
the,O
diagnosis,O
of,O
WAS,Disease
patients,O
.,O
The,O
myotonic,Disease
dystrophy,Disease
(,O
DM,Disease
),O
mutation,O
is,O
an,O
unstable,O
(,O
CTG,O
),O
n,O
repeat,O
",",O
present,O
at,O
a,O
copy,O
number,O
of,O
5,O
-,O
37,O
repeats,O
on,O
normal,O
chromosomes,O
but,O
amplified,O
to,O
50,O
-,O
3000,O
copies,O
on,O
DM,Disease
chromosomes,O
.,O
3,O
region,O
is,O
maintained,O
but,O
gene,O
order,O
is,O
not,O
",",O
suggesting,O
at,O
least,O
three,O
possible,O
sites,O
for,O
the,O
corresponding,O
mouse,O
HD,Disease
gene,O
.,O
Occasional,O
missense,O
mutations,O
in,O
ATM,O
were,O
also,O
found,O
in,O
tumour,Disease
DNA,O
from,O
patients,O
with,O
B,Disease
-,Disease
cell,Disease
non,Disease
-,Disease
Hodgkins,Disease
lymphomas,Disease
(,O
B,Disease
-,Disease
NHL,Disease
),O
and,O
a,O
B,Disease
-,Disease
NHL,Disease
cell,O
line,O
.,O
von,Disease
Willebrand,Disease
factor,Disease
(,Disease
vWf,Disease
),Disease
deficiency,Disease
causes,O
severe,O
von,Disease
Willebrand,Disease
disease,Disease
in,O
humans,O
.,O
METHODS,O
DNA,O
samples,O
from,O
500,O
unrelated,O
Jews,O
of,O
European,O
or,O
non,O
-,O
European,O
origin,O
",",O
with,O
or,O
without,O
a,O
personal,O
and,O
/,O
or,O
family,O
history,O
of,O
neoplasia,Disease
",",O
were,O
examined,O
for,O
the,O
I1307K,O
variant,O
by,O
the,O
allele,O
-,O
specific,O
oligonucleotide,O
(,O
ASO,O
),O
method,O
.,O
The,O
PAX6,O
gene,O
is,O
involved,O
in,O
ocular,O
morphogenesis,O
",",O
and,O
PAX6,O
mutations,O
have,O
been,O
detected,O
in,O
various,O
types,O
of,O
ocular,Disease
anomalies,Disease
",",O
including,O
aniridia,Disease
",",O
Peters,Disease
anomaly,Disease
",",O
corneal,Disease
dystrophy,Disease
",",O
congenital,Disease
cataract,Disease
",",O
and,O
foveal,Disease
hypoplasia,Disease
.,O
These,O
findings,O
suggest,O
that,O
the,O
TSD,Disease
gene,O
proliferated,O
among,O
the,O
antecedents,O
of,O
modern,O
Ashkenazi,O
Jewry,O
after,O
the,O
Second,O
Diaspora,O
(,O
70,O
A,O
.,O
D,O
.,O
),O
and,O
before,O
their,O
major,O
migrations,O
to,O
regions,O
of,O
Poland,O
and,O
Russia,O
(,O
before,O
1100,O
A,O
.,O
D,O
.,O
),O
.,O
All,O
the,O
TCD,Disease
males,O
and,O
carrier,O
females,O
studied,O
have,O
the,O
same,O
DXYS1,O
allele,O
in,O
coupling,O
with,O
TCD,Disease
.,O
The,O
Type,O
II,O
C2,O
null,O
allele,O
(,O
C2Q0,O
),O
is,O
linked,O
to,O
two,O
major,O
histocompatibility,O
haplotypes,O
(,O
MHC,O
),O
that,O
differ,O
from,O
the,O
MHC,O
of,O
the,O
more,O
common,O
Type,Disease
I,Disease
C2,Disease
deficiency,Disease
.,O
No,O
differences,O
were,O
noted,O
in,O
any,O
variable,O
between,O
the,O
PWS,Disease
patients,O
and,O
the,O
ND,O
controls,O
",",O
suggesting,O
that,O
these,O
abnormalities,O
are,O
not,O
unique,O
to,O
PWS,Disease
",",O
but,O
can,O
occur,O
in,O
any,O
neurodevelopmentally,Disease
handicapped,Disease
individual,O
",",O
further,O
suggesting,O
these,O
do,O
not,O
necessarily,O
reflect,O
syndrome,O
-,O
specific,O
hypothalamic,Disease
abnormalities,Disease
.,O
.,O
We,O
describe,O
a,O
19,O
-,O
year,O
-,O
old,O
woman,O
with,O
typical,O
MG,Disease
and,O
heterozygous,O
C2,Disease
deficiency,Disease
",",O
along,O
with,O
HLA,O
typing,O
of,O
the,O
patient,O
and,O
her,O
immediate,O
family,O
.,O
.,O
The,O
corresponding,O
ovarian,Disease
cancer,Disease
risks,O
were,O
0,O
.,O
We,O
describe,O
two,O
sibs,O
with,O
typical,O
PWS,Disease
presenting,O
deletion,O
of,O
SNRPN,O
detected,O
by,O
fluorescence,O
in,O
situ,O
hybridization,O
(,O
FISH,O
),O
.,O
These,O
results,O
provide,O
further,O
examples,O
of,O
mutations,O
in,O
PLP,O
that,O
cause,O
Pelizaeus,Disease
-,Disease
Merzbacher,Disease
disease,Disease
and,O
illustrate,O
the,O
value,O
of,O
SSCP,O
in,O
genetic,O
analysis,O
.,O
.,O
Phenotype,O
heterogeneity,O
among,O
hemizygotes,O
in,O
a,O
family,O
biochemically,O
screened,O
for,O
adrenoleukodystrophy,Disease
.,O
7,O
for,O
colorectal,Disease
neoplasia,Disease
(,O
both,O
P,O
=,O
.,O
01,O
),O
.,O
He,O
was,O
found,O
to,O
be,O
homozygous,O
",",O
and,O
both,O
healthy,O
parents,O
heterozygous,O
",",O
for,O
the,O
R279W,O
mutation,O
in,O
DTDST,O
",",O
and,O
his,O
fibroblasts,O
showed,O
a,O
sulphate,O
incorporation,O
defect,O
typical,O
of,O
DTDST,Disease
disorders,Disease
.,O
Galactosemia,Disease
is,O
an,O
autosomal,Disease
recessive,Disease
disorder,Disease
of,Disease
human,Disease
galactose,Disease
metabolism,Disease
caused,O
by,O
deficiency,Disease
of,Disease
the,Disease
enzyme,Disease
galactose,Disease
-,Disease
1,Disease
-,Disease
phosphate,Disease
uridyl,Disease
transferase,Disease
(,O
GALT,O
),O
.,O
It,O
differs,O
from,O
this,O
and,O
both,O
the,O
classical,O
and,O
connatal,O
forms,O
of,O
PMD,Disease
in,O
that,O
it,O
is,O
relatively,O
mild,O
in,O
form,O
",",O
onset,O
is,O
delayed,O
beyond,O
age,O
2,O
years,O
",",O
nystagmus,Disease
is,O
absent,O
",",O
tremors,Disease
are,O
prominent,O
",",O
mental,Disease
retardation,Disease
is,O
not,O
severe,O
",",O
some,O
patients,O
show,O
dementia,Disease
or,O
personality,Disease
disorders,Disease
",",O
the,O
disease,O
is,O
progressive,O
rather,O
than,O
static,O
in,O
some,O
",",O
and,O
several,O
females,O
show,O
signs,O
of,O
disease,O
.,O
We,O
have,O
performed,O
a,O
mutation,O
survey,O
of,O
the,O
RB1,O
gene,O
in,O
232,O
patients,O
with,O
hereditary,Disease
or,Disease
non,Disease
hereditary,Disease
retinoblastoma,Disease
.,O
We,O
describe,O
a,O
novel,O
family,O
with,O
ALPS,Disease
in,O
which,O
three,O
affected,O
siblings,O
carry,O
two,O
distinct,O
missense,O
mutations,O
on,O
both,O
the,O
Fas,O
gene,O
alleles,O
and,O
show,O
lack,O
of,O
Fas,O
-,O
induced,O
apoptosis,O
.,O
In,O
individuals,O
with,O
mutations,O
in,O
either,O
region,O
2,O
or,O
region,O
3,O
",",O
the,O
average,O
number,O
of,O
adenomas,Disease
tended,O
to,O
be,O
lower,O
than,O
those,O
in,O
individuals,O
with,O
mutations,O
in,O
region,O
1,O
",",O
although,O
age,O
at,O
diagnosis,O
was,O
similar,O
.,O
The,O
findings,O
in,O
this,O
family,O
suggest,O
that,O
delGAG291,O
is,O
part,O
of,O
the,O
cause,O
of,O
Japanese,O
ALD,Disease
with,O
phenotypic,O
variations,O
.,O
No,O
well,O
-,O
characterized,O
intragenic,O
rearrangement,O
of,O
APC,O
has,O
been,O
described,O
",",O
and,O
the,O
prevalence,O
of,O
this,O
type,O
of,O
mutation,O
in,O
FAP,Disease
patients,O
is,O
not,O
clear,O
.,O
Pendred,Disease
syndrome,Disease
is,O
the,O
most,O
common,O
form,O
of,O
syndromic,Disease
deafness,Disease
and,O
characterized,O
by,O
congenital,O
sensorineural,Disease
hearing,Disease
loss,Disease
and,O
goitre,Disease
.,O
Multipoint,O
linkage,O
analysis,O
of,O
choroideremia,Disease
(,O
TCD,Disease
),O
and,O
seven,O
X,O
chromosomal,O
restriction,O
fragment,O
length,O
polymorphisms,O
(,O
RFLPs,O
),O
was,O
carried,O
out,O
in,O
18,O
Finnish,O
TCD,Disease
families,O
.,O
This,O
is,O
the,O
first,O
report,O
of,O
diagnosis,O
of,O
maternal,O
UPD,Disease
(,O
14,O
),O
based,O
on,O
clinical,O
features,O
.,O
Interestingly,O
",",O
all,O
CHM,Disease
gene,O
mutations,O
detected,O
thus,O
far,O
in,O
choroideremia,Disease
patients,O
give,O
rise,O
to,O
the,O
introduction,O
of,O
a,O
premature,O
stop,O
codon,O
.,O
.,O
Male,Disease
genital,Disease
defects,Disease
also,O
were,O
evident,O
and,O
there,O
was,O
a,O
single,O
case,O
of,O
Wilms,Disease
tumor,Disease
in,O
which,O
the,O
transcript,O
of,O
the,O
nontargeted,O
allele,O
showed,O
an,O
exon,O
9,O
skipping,O
event,O
",",O
implying,O
a,O
causal,O
link,O
between,O
Wt1,Disease
dysfunction,Disease
and,O
Wilms,Disease
tumorigenesis,Disease
in,O
mice,O
.,O
The,O
TSG101,O
tumor,Disease
susceptibility,O
gene,O
is,O
located,O
in,O
chromosome,O
11,O
band,O
p15,O
and,O
is,O
mutated,O
in,O
human,O
breast,Disease
cancer,Disease
.,O
The,O
remaining,O
26,O
patients,O
were,O
identified,O
as,O
having,O
21,O
independent,O
mutations,O
",",O
including,O
12,O
novel,O
mutations,O
resulting,O
in,O
small,O
nucleotide,O
alterations,O
in,O
the,O
ALD,Disease
gene,O
.,O
Here,O
we,O
investigate,O
the,O
rate,O
of,O
BRCA2,O
mutation,O
in,O
sporadic,Disease
breast,Disease
cancers,Disease
and,O
in,O
a,O
set,O
of,O
cell,O
lines,O
that,O
represent,O
twelve,O
other,O
tumour,Disease
types,O
.,O
In,O
DMD,Disease
families,O
four,O
crossovers,O
were,O
observed,O
in,O
38,O
informative,O
meioses,O
between,O
C7,O
and,O
the,O
DMD,Disease
locus,O
(,O
theta,O
=,O
0,O
.,O
12,O
",",O
z,O
max,O
=,O
+,O
2,O
.,O
72,O
),O
.,O
Adrenal,Disease
insufficiency,Disease
(,O
Addisons,Disease
disease,Disease
),O
is,O
frequently,O
associated,O
with,O
AMN,Disease
or,O
cerebral,Disease
ALD,Disease
and,O
may,O
remain,O
the,O
only,O
clinical,O
expression,O
of,O
ALD,Disease
(,O
8,O
%,O
of,O
cases,O
),O
.,O
A,O
genetic,O
linkage,O
map,O
of,O
six,O
polymorphic,O
DNA,O
markers,O
close,O
to,O
the,O
gene,O
(,O
APC,O
),O
for,O
familial,Disease
adenomatous,Disease
polyposis,Disease
(,O
FAP,Disease
),O
on,O
chromosome,O
5q,O
is,O
reported,O
.,O
Autosomal,Disease
dominant,Disease
myotonia,Disease
congenita,Disease
is,O
an,O
inherited,Disease
disorder,Disease
of,Disease
skeletal,Disease
muscle,Disease
caused,O
by,O
mutations,O
in,O
a,O
voltage,O
-,O
gated,O
Cl,O
-,O
channel,O
gene,O
(,O
CLCN1,O
",",O
7q35,O
),O
.,O
CONCLUSIONS,O
DCC,O
is,O
a,O
prognostic,O
marker,O
in,O
patients,O
with,O
stage,Disease
II,Disease
or,Disease
stage,Disease
III,Disease
colorectal,Disease
cancer,Disease
.,O
The,O
high,O
population,O
frequency,O
of,O
DM,Disease
can,O
at,O
present,O
not,O
be,O
explained,O
by,O
the,O
contribution,O
of,O
asymptomatic,O
cases,O
in,O
the,O
younger,O
generations,O
of,O
known,O
families,O
",",O
but,O
is,O
probably,O
caused,O
by,O
the,O
events,O
in,O
the,O
ancestral,O
generations,O
.,O
.,O
Mice,O
with,O
a,O
larger,O
deletion,O
involving,O
both,O
Snrpn,O
and,O
the,O
putative,O
PWS,O
-,O
IC,O
lack,O
expression,O
of,O
the,O
imprinted,O
genes,O
Zfp127,O
(,O
mouse,O
homologue,O
of,O
ZNF127,O
),O
",",O
Ndn,O
and,O
Ipw,O
",",O
and,O
manifest,O
several,O
phenotypes,O
common,O
to,O
PWS,Disease
infants,O
.,O
Isolation,O
of,O
molecular,O
probes,O
associated,O
with,O
the,O
chromosome,O
15,O
instability,O
in,O
the,O
Prader,Disease
-,Disease
Willi,Disease
syndrome,Disease
.,O
Mucopolysaccharidosis,Disease
IVA,Disease
(,O
MPS,Disease
IVA,Disease
),O
is,O
an,O
autosomal,Disease
recessive,Disease
lysosomal,Disease
storage,Disease
disorder,Disease
caused,O
by,O
a,O
genetic,Disease
defect,Disease
in,O
N,O
-,O
acetylgalactosamine,O
-,O
6,O
-,O
sulfate,O
sulfatase,O
(,O
GALNS,O
),O
.,O
Thus,O
",",O
we,O
screened,O
16,O
endometrial,Disease
carcinomas,Disease
with,O
microsatellite,O
instability,O
for,O
alterations,O
in,O
FEN1,O
(,O
the,O
human,O
homolog,O
of,O
RTH,O
),O
and,O
in,O
MSH3,O
(,O
refs,O
12,O
-,O
14,O
),O
.,O
He,O
had,O
episodes,O
of,O
hemolytic,Disease
crisis,Disease
several,O
times,O
after,O
upper,Disease
respiratory,Disease
infection,Disease
.,O
We,O
have,O
detected,O
a,O
submicroscopic,O
11p13,O
deletion,O
in,O
a,O
child,O
with,O
inherited,O
aniridia,Disease
who,O
subsequently,O
presented,O
with,O
Wilms,Disease
tumor,Disease
in,O
a,O
horseshoe,O
kidney,O
",",O
only,O
revealed,O
at,O
surgery,O
.,O
We,O
speculate,O
that,O
classic,Disease
galactosemia,Disease
mutations,O
appear,O
to,O
differ,O
between,O
Japanese,O
and,O
Caucasian,O
patients,O
.,O
The,O
children,O
share,O
common,O
clinical,O
features,O
including,O
splenomegaly,Disease
and,O
lymphadenopathy,Disease
",",O
but,O
only,O
one,O
developed,O
severe,O
autoimmune,Disease
manifestations,Disease
.,O
This,O
frequency,O
was,O
higher,O
than,O
the,O
frequency,O
expected,O
from,O
the,O
probability,O
of,O
the,O
repeat,O
contractions,O
(,O
6,O
.,O
4,O
%,O
),O
and,O
the,O
size,O
of,O
DM,Disease
sib,O
population,O
(,O
1,O
.,O
54,O
DM,Disease
offspring,O
per,O
DM,Disease
parent,O
",",O
in,O
968,O
DM,Disease
parents,O
),O
.,O
These,O
findings,O
suggest,O
that,O
some,O
sequences,O
located,O
in,O
the,O
distal,O
part,O
of,O
the,O
gene,O
and,O
",",O
in,O
particular,O
",",O
some,O
DMD,Disease
isoforms,O
expressed,O
in,O
the,O
brain,O
may,O
be,O
related,O
to,O
the,O
cognitive,Disease
impairment,Disease
associated,O
with,O
DMD,Disease
.,O
.,O
Germline,O
mutations,O
in,O
the,O
ATM,O
gene,O
are,O
responsible,O
for,O
the,O
autosomal,Disease
recessive,Disease
disorder,Disease
ataxia,Disease
-,Disease
telangiectasia,Disease
(,O
A,Disease
-,Disease
T,Disease
),O
.,O
3,O
region,O
",",O
to,O
examine,O
these,O
markers,O
for,O
association,O
with,O
the,O
Wilson,Disease
disease,Disease
gene,O
(,O
WND,Disease
),O
.,O
Our,O
results,O
show,O
that,O
(,O
quantitative,O
),O
Southern,O
blot,O
analysis,O
is,O
a,O
sensitive,O
method,O
for,O
detecting,O
germline,O
deletions,O
of,O
the,O
VHL,Disease
gene,O
and,O
should,O
be,O
implemented,O
in,O
routine,O
DNA,O
diagnosis,O
for,O
VHL,Disease
disease,Disease
.,O
These,O
findings,O
suggest,O
that,O
the,O
expression,O
of,O
HD,Disease
is,O
modulated,O
by,O
the,O
normal,O
HD,Disease
allele,O
or,O
by,O
a,O
closely,O
linked,O
locus,O
.,O
.,O
We,O
identified,O
four,O
germline,O
mutations,O
in,O
three,O
breast,Disease
cancer,Disease
families,O
and,O
in,O
one,O
breast,Disease
-,Disease
ovarian,Disease
cancer,Disease
family,O
.,O
among,O
these,O
were,O
one,O
frameshift,O
mutation,O
",",O
one,O
nonsense,O
mutation,O
",",O
one,O
novel,O
splice,O
site,O
mutation,O
",",O
and,O
one,O
missense,O
mutation,O
.,O
Thus,O
",",O
this,O
disorder,O
appears,O
as,O
a,O
variant,O
of,O
Thomsens,Disease
disease,Disease
due,O
to,O
mutations,O
leading,O
to,O
low,O
clinical,O
expressivity,O
.,O
Most,O
VCFS,Disease
/,O
DGS,Disease
patients,O
have,O
a,O
similar,O
3,O
Mb,O
deletion,O
",",O
some,O
have,O
a,O
nested,O
distal,O
deletion,O
breakpoint,O
resulting,O
in,O
a,O
1,O
.,O
In,O
conclusion,O
",",O
we,O
demonstrated,O
that,O
a,O
point,O
mutation,O
in,O
a,O
lariat,O
branchpoint,O
consensus,O
sequence,O
causes,O
a,O
null,O
allele,O
in,O
a,O
patient,O
with,O
FED,Disease
.,O
Oral,O
contraceptives,O
and,O
the,O
risk,O
of,O
hereditary,Disease
ovarian,Disease
cancer,Disease
.,O
The,O
results,O
from,O
a,O
multiply,O
informative,O
crossover,O
localize,O
the,O
NDP,Disease
gene,O
proximal,O
to,O
DXS7,O
.,O
Attenuated,Disease
adenomatous,Disease
polyposis,Disease
coli,Disease
patients,O
have,O
"""",O
multiple,O
"""",O
colorectal,Disease
adenomas,Disease
(,O
typically,O
fewer,O
than,O
100,O
),O
without,O
the,O
florid,O
phenotype,O
of,O
classical,O
FAP,Disease
.,O
Immunoreactive,O
DM,O
-,O
kinase,O
protein,O
of,O
53,O
kD,O
is,O
present,O
at,O
low,O
levels,O
in,O
skeletal,O
and,O
cardiac,O
muscle,O
extracts,O
of,O
DM,Disease
patients,O
and,O
normal,O
controls,O
.,O
Sera,O
from,O
eight,O
family,O
members,O
who,O
were,O
apparently,O
heterozygous,O
for,O
C5,Disease
deficiency,Disease
gave,O
normal,O
chemotactic,O
scores,O
.,O
Molecular,O
characterization,O
of,O
glucose,Disease
-,Disease
6,Disease
-,Disease
phosphate,Disease
dehydrogenase,Disease
(,Disease
G6PD,Disease
),Disease
deficiency,Disease
by,O
natural,O
and,O
amplification,O
created,O
restriction,O
sites,O
:,O
five,O
mutations,O
account,O
for,O
most,O
G6PD,Disease
deficiency,Disease
cases,O
in,O
Taiwan,O
.,O
We,O
recently,O
reported,O
that,O
HFE,O
",",O
the,O
protein,O
defective,O
in,O
HH,Disease
",",O
was,O
physically,O
associated,O
with,O
the,O
transferrin,O
receptor,O
(,O
TfR,O
),O
in,O
duodenal,O
crypt,O
cells,O
and,O
proposed,O
that,O
mutations,O
in,O
HFE,O
attenuate,O
the,O
uptake,O
of,O
transferrin,O
-,O
bound,O
iron,O
from,O
plasma,O
by,O
duodenal,O
crypt,O
cells,O
",",O
leading,O
to,O
up,O
-,O
regulation,O
of,O
transporters,O
for,O
dietary,O
iron,O
.,O
This,O
approach,O
allowed,O
us,O
to,O
identify,O
one,O
phase,O
-,O
known,O
recombination,O
and,O
one,O
probable,O
historic,O
recombination,O
on,O
haplotypes,O
from,O
Reunion,O
Island,O
patients,O
",",O
both,O
of,O
which,O
place,O
three,O
of,O
the,O
five,O
markers,O
proximal,O
to,O
FRDA,Disease
.,O
Detection,O
of,O
a,O
novel,O
missense,O
mutation,O
and,O
second,O
recurrent,O
mutation,O
in,O
the,O
CACNA1A,O
gene,O
in,O
individuals,O
with,O
EA,Disease
-,Disease
2,Disease
and,O
FHM,Disease
.,O
Defective,O
CD95,O
/,O
APO,O
-,O
1,O
/,O
Fas,O
signal,O
complex,O
formation,O
in,O
the,O
human,O
autoimmune,Disease
lymphoproliferative,Disease
syndrome,Disease
",",Disease
type,Disease
Ia,Disease
.,O
The,O
breakpoints,O
of,O
some,O
deletions,O
are,O
delineated,O
within,O
the,O
DXS164,O
locus,O
",",O
and,O
it,O
is,O
evident,O
that,O
the,O
deletions,O
at,O
the,O
DMD,Disease
locus,O
are,O
frequent,O
and,O
extremely,O
large,O
.,O
.,O
Our,O
results,O
indicate,O
that,O
mutations,O
in,O
cardiac,O
ion,O
-,O
channel,O
genes,O
contribute,O
to,O
the,O
risk,O
of,O
developing,O
IVF,Disease
.,O
.,O
Positional,O
cloning,O
experiments,O
have,O
resulted,O
recently,O
in,O
the,O
isolation,O
of,O
a,O
candidate,O
gene,O
for,O
Norrie,Disease
disease,Disease
(,O
pseudoglioma,Disease
;,O
NDP,Disease
),O
",",O
a,O
severe,O
X,Disease
-,Disease
linked,Disease
neurodevelopmental,Disease
disorder,Disease
.,O
Most,O
sporadic,Disease
colorectal,Disease
cancers,Disease
also,O
have,O
two,O
APC,Disease
mutations,O
.,O
Nonsense,O
mutation,O
in,O
exon,O
3,O
of,O
the,O
proteolipid,O
protein,O
gene,O
(,O
PLP,O
),O
in,O
a,O
family,O
with,O
an,O
unusual,O
form,O
of,O
Pelizaeus,Disease
-,Disease
Merzbacher,Disease
disease,Disease
.,O
This,O
locus,O
is,O
also,O
part,O
of,O
the,O
WAGR,Disease
complex,O
(,O
Wilms,Disease
tumor,Disease
",",O
aniridia,Disease
",",O
genitourinary,Disease
abnormalities,Disease
",",O
and,O
mental,Disease
retardation,Disease
),O
.,O
This,O
finding,O
confirms,O
that,O
the,O
fragile,Disease
X,Disease
phenotype,O
can,O
exist,O
",",O
without,O
amplification,O
of,O
the,O
CCG,O
repeat,O
or,O
cytogenetic,O
expression,O
of,O
the,O
fragile,Disease
X,Disease
",",O
and,O
that,O
fragile,Disease
X,Disease
syndrome,Disease
is,O
a,O
genetically,O
homogeneous,O
disorder,O
involving,O
FMR1,O
.,O
In,O
normal,O
individuals,O
the,O
gene,O
contains,O
between,O
13,O
and,O
36,O
CAG,O
repeats,O
",",O
whereas,O
most,O
of,O
the,O
clinically,O
diagnosed,O
patients,O
and,O
all,O
of,O
the,O
affected,O
members,O
of,O
a,O
family,O
with,O
the,O
clinical,O
and,O
pathological,O
diagnosis,O
of,O
MJD,Disease
show,O
expansion,O
of,O
the,O
repeat,O
-,O
number,O
(,O
from,O
68,O
-,O
79,O
),O
.,O
Sulfate,O
transport,O
is,O
not,O
impaired,O
in,O
pendred,Disease
syndrome,Disease
thyrocytes,O
.,O
In,O
studies,O
of,O
eight,O
kindred,O
",",O
the,O
28,O
-,O
base,O
pair,O
deletion,O
was,O
observed,O
in,O
all,O
C2Q0,O
alleles,O
associated,O
with,O
the,O
common,O
type,O
I,O
deficient,O
complotype,O
/,O
haplotype,O
;,O
this,O
deletion,O
was,O
not,O
present,O
in,O
normal,O
C2,O
nor,O
in,O
type,Disease
II,Disease
C2,Disease
-,Disease
deficient,Disease
genes,O
.,O
Determination,O
of,O
30,O
X,Disease
-,Disease
linked,Disease
adrenoleukodystrophy,Disease
mutations,O
",",O
including,O
15,O
not,O
previously,O
described,O
.,O
A,O
linkage,O
study,O
in,O
30,O
Becker,Disease
muscular,Disease
dystrophy,Disease
(,O
BMD,Disease
),O
kindreds,O
using,O
three,O
cloned,O
DNA,O
sequences,O
from,O
the,O
X,O
chromosome,O
which,O
demonstrate,O
restriction,O
fragment,O
length,O
polymorphisms,O
(,O
RFLPs,O
),O
",",O
suggests,O
that,O
the,O
BMD,Disease
gene,O
is,O
located,O
on,O
the,O
short,O
arm,O
of,O
the,O
X,O
chromosome,O
",",O
in,O
the,O
p21,O
region,O
.,O
We,O
have,O
examined,O
the,O
frequency,O
of,O
four,O
of,O
these,O
polymorphisms,O
Gln356Arg,O
",",O
Pro871Leu,O
",",O
Glu1038Gly,O
and,O
Ser1613Gly,O
in,O
large,O
series,O
of,O
breast,Disease
and,Disease
ovarian,Disease
cancer,Disease
cases,O
and,O
matched,O
controls,O
.,O
These,O
findings,O
establish,O
that,O
some,O
neuropathological,Disease
abnormalities,Disease
seen,O
in,O
A,Disease
-,Disease
T,Disease
patients,O
also,O
are,O
present,O
in,O
Atm,O
mutant,O
mice,O
.,O
In,O
SCA1,Disease
",",O
saccade,O
amplitude,O
was,O
significantly,O
increased,O
",",O
resulting,O
in,O
hypermetria,Disease
.,O
These,O
results,O
confirm,O
the,O
previously,O
found,O
high,O
frequency,O
of,O
the,O
intron,O
9,O
mutation,O
in,O
non,O
-,O
Jewish,O
TSD,Disease
families,O
of,O
British,O
Isles,O
",",O
particularly,O
Irish,O
",",O
origin,O
",",O
and,O
reinforce,O
the,O
need,O
to,O
screen,O
such,O
families,O
for,O
this,O
mutation,O
.,O
2,O
Mb,O
of,O
the,O
HD,Disease
region,O
in,O
YACs,O
",",O
including,O
one,O
continuous,O
segment,O
of,O
2,O
.,O
Our,O
data,O
further,O
support,O
the,O
notion,O
of,O
molecular,O
heterogeneity,O
of,O
galactosemia,Disease
and,O
suggest,O
that,O
galactosemia,Disease
mutations,O
and,O
GALT,O
polymorphisms,O
may,O
be,O
useful,O
tools,O
in,O
highlighting,O
different,O
functional,O
domains,O
in,O
human,O
GALT,O
.,O
.,O
Biochemical,O
and,O
structural,O
analysis,O
of,O
missense,O
mutations,O
in,O
N,O
-,O
acetylgalactosamine,O
-,O
6,O
-,O
sulfate,O
sulfatase,O
causing,O
mucopolysaccharidosis,Disease
IVA,Disease
phenotypes,O
.,O
Moreover,O
",",O
mitotic,O
instability,O
analysis,O
of,O
different,O
human,O
DM,Disease
tissues,O
shows,O
length,O
mosaicism,O
between,O
different,O
cell,O
lineages,O
.,O
C5,O
levels,O
of,O
other,O
family,O
members,O
were,O
either,O
normal,O
or,O
approximately,O
half,O
-,O
normal,O
",",O
consistent,O
with,O
autosomal,O
codominant,O
inheritance,O
of,O
the,O
gene,O
determining,O
C5,Disease
deficiency,Disease
.,O
Somatic,O
von,Disease
Hippel,Disease
-,Disease
Lindau,Disease
mutation,O
in,O
clear,O
cell,O
papillary,Disease
cystadenoma,Disease
of,Disease
the,Disease
epididymis,Disease
.,O
Hence,O
",",O
molecular,O
screening,O
for,O
Wolfram,Disease
syndrome,Disease
in,O
affected,O
families,O
and,O
for,O
Wolfram,Disease
syndrome,Disease
-,O
carrier,O
status,O
in,O
subjects,O
with,O
psychiatric,Disease
disorders,Disease
or,O
diabetes,Disease
mellitus,Disease
will,O
require,O
complete,O
analysis,O
of,O
exon,O
8,O
and,O
upstream,O
exons,O
.,O
.,O
Mutations,O
in,O
the,O
gene,O
ATM,O
are,O
responsible,O
for,O
the,O
genetic,Disease
disorder,Disease
ataxia,Disease
-,Disease
telangiectasia,Disease
(,O
A,Disease
-,Disease
T,Disease
),O
",",O
which,O
is,O
characterized,O
by,O
cerebellar,Disease
dysfunction,Disease
",",O
radiosensitivity,O
",",O
chromosomal,O
instability,O
and,O
cancer,Disease
predisposition,O
.,O
In,O
vitro,O
addition,O
of,O
purified,O
C3,O
to,O
patient,O
serum,O
restored,O
hemolytic,O
complement,O
to,O
normal,O
levels,O
",",O
and,O
plasma,O
infusion,O
during,O
each,O
of,O
four,O
episodes,O
of,O
pneumonia,Disease
significantly,O
enhanced,O
serum,O
opsonic,O
activity,O
for,O
as,O
long,O
as,O
36,O
hours,O
.,O
We,O
then,O
tested,O
six,O
phenotypically,O
normal,O
offspring,O
from,O
four,O
of,O
these,O
VHL,Disease
families,O
two,O
were,O
found,O
to,O
carry,O
the,O
deletion,O
and,O
the,O
other,O
four,O
were,O
deletion,O
-,O
free,O
.,O
Increased,O
incidence,O
of,O
cancer,Disease
in,O
patients,O
with,O
cartilage,Disease
-,Disease
hair,Disease
hypoplasia,Disease
.,O
However,O
",",O
the,O
mutant,O
failed,O
to,O
bind,O
factor,O
VIII,O
",",O
demonstrating,O
that,O
the,O
mutation,O
was,O
functionally,O
related,O
to,O
the,O
observed,O
hemophilia,Disease
phenotype,O
.,O
We,O
studied,O
the,O
molecular,O
basis,O
of,O
C9,Disease
deficiency,Disease
in,O
four,O
Japanese,O
C9,Disease
-,Disease
deficient,Disease
patients,O
who,O
had,O
suffered,O
from,O
meningococcal,Disease
meningitis,Disease
.,O
Similar,O
abnormalities,O
were,O
found,O
in,O
Foxc2,O
(,O
+,O
/,O
-,O
),O
mice,O
",",O
but,O
no,O
disease,O
-,O
associated,O
mutations,O
were,O
identified,O
in,O
the,O
human,O
homolog,O
FKHL14,O
in,O
32,O
ARA,Disease
patients,O
.,O
The,O
DPC4,O
gene,O
",",O
which,O
is,O
located,O
at,O
18q21,O
",",O
has,O
been,O
identified,O
as,O
a,O
tumor,O
-,O
suppressor,O
gene,O
from,O
examination,O
of,O
pancreatic,Disease
cancers,Disease
.,O
X,Disease
-,Disease
linked,Disease
glucose,Disease
-,Disease
6,Disease
-,Disease
phosphate,Disease
dehydrogenase,Disease
deficiency,Disease
in,O
Mus,O
musculus,O
.,O
The,O
results,O
confirm,O
that,O
the,O
C282Y,O
substitution,O
was,O
the,O
main,O
mutation,O
involved,O
in,O
hemochromatosis,Disease
",",O
accounting,O
for,O
85,O
%,O
of,O
carrier,O
chromosomes,O
",",O
whereas,O
the,O
H63D,O
substitution,O
represented,O
39,O
%,O
of,O
the,O
HH,Disease
chromosomes,O
that,O
did,O
not,O
carry,O
the,O
C282Y,O
mutation,O
.,O
Our,O
results,O
show,O
that,O
huntingtin,O
is,O
cleaved,O
by,O
cysteine,O
proteases,O
and,O
suggest,O
that,O
HD,Disease
might,O
be,O
a,O
disorder,Disease
of,Disease
inappropriate,Disease
apoptosis,Disease
.,O
.,O
Clustering,O
of,O
missense,O
mutations,O
in,O
the,O
ataxia,Disease
-,Disease
telangiectasia,Disease
gene,O
in,O
a,O
sporadic,Disease
T,Disease
-,Disease
cell,Disease
leukaemia,Disease
.,O
A,O
portion,O
of,O
the,O
Duchenne,Disease
muscular,Disease
dystrophy,Disease
(,O
DMD,Disease
),O
gene,O
transcript,O
from,O
human,O
fetal,O
skeletal,O
muscle,O
and,O
mouse,O
adult,O
heart,O
was,O
sequenced,O
",",O
representing,O
approximately,O
25,O
percent,O
of,O
the,O
total,O
",",O
14,O
-,O
kb,O
DMD,Disease
transcript,O
.,O
Somatic,O
alterations,O
of,O
the,O
DPC4,O
gene,O
in,O
human,O
colorectal,Disease
cancers,Disease
in,O
vivo,O
.,O
Here,O
",",O
we,O
explore,O
the,O
cell,O
origin,O
and,O
aetiology,O
of,O
this,O
common,O
human,O
skin,Disease
tumour,Disease
.,O
A,O
limited,O
number,O
of,O
point,O
mutations,O
account,O
for,O
most,O
of,O
the,O
PKU,Disease
cases,O
in,O
the,O
European,O
population,O
.,O
Deletion,O
of,O
this,O
IC,O
abolishes,O
local,O
paternally,O
derived,O
gene,O
expression,O
and,O
results,O
in,O
Prader,Disease
-,Disease
Willi,Disease
syndrome,Disease
(,O
PWS,Disease
),O
.,O
Constitutional,O
RB1,O
-,O
gene,O
mutations,O
in,O
patients,O
with,O
isolated,O
unilateral,Disease
retinoblastoma,Disease
.,O
An,O
evaluation,O
of,O
genetic,O
heterogeneity,O
in,O
145,O
breast,Disease
-,Disease
ovarian,Disease
cancer,Disease
families,O
.,O
The,O
homozygous,O
C2,Disease
-,Disease
deficient,Disease
propositus,O
and,O
brother,O
were,O
HLA,O
-,O
A,O
and,O
B,O
homozygous,O
but,O
heterozygous,O
at,O
the,O
HLA,O
-,O
D,O
and,O
glyoxalase,O
I,O
loci,O
.,O
Each,O
family,O
contained,O
(,O
i,O
),O
two,O
cases,O
of,O
gastric,Disease
cancer,Disease
in,O
first,O
degree,O
relatives,O
with,O
one,O
affected,O
before,O
age,O
50,O
years,O
;,O
or,O
(,O
ii,O
),O
three,O
or,O
more,O
cases,O
of,O
gastric,Disease
cancer,Disease
.,O
However,O
",",O
healthy,O
subjects,O
found,O
to,O
be,O
deficient,Disease
in,Disease
Hex,Disease
A,Disease
activity,O
(,O
i,O
.,O
e,O
.,O
",",O
pseudodeficient,O
),O
by,O
means,O
of,O
in,O
vitro,O
biochemical,O
tests,O
have,O
been,O
described,O
.,O
We,O
report,O
in,O
this,O
work,O
the,O
molecular,O
bases,O
of,O
C7D,Disease
in,O
two,O
unrelated,O
Japanese,O
males,O
.,O
One,O
child,O
",",O
now,O
19,O
years,O
old,O
",",O
survived,O
after,O
a,O
resection,O
of,O
a,O
hepatoblastoma,Disease
in,O
infancy,O
and,O
recently,O
was,O
found,O
to,O
have,O
GS,Disease
.,O
A,O
mutation,O
causing,O
alkaptonuria,Disease
in,O
the,O
mouse,O
has,O
mapped,O
to,O
chromosome,O
16,O
.,O
Association,O
studies,O
in,O
two,O
independent,O
samples,O
totaling,O
505,O
individuals,O
revealed,O
that,O
the,O
5,O
-,O
HTT,O
polymorphism,O
accounts,O
for,O
3,O
to,O
4,O
percent,O
of,O
total,O
variation,O
and,O
7,O
to,O
9,O
percent,O
of,O
inherited,O
variance,O
in,O
anxiety,Disease
-,Disease
related,Disease
personality,Disease
traits,Disease
in,O
individuals,O
as,O
well,O
as,O
sibships,O
.,O
.,O
In,O
the,O
present,O
study,O
",",O
the,O
classification,O
of,O
105,O
PAH,O
mutations,O
may,O
allow,O
the,O
prediction,O
of,O
the,O
biochemical,O
phenotype,O
in,O
>,O
10,O
",",O
000,O
genotypes,O
",",O
which,O
may,O
be,O
useful,O
for,O
the,O
management,O
of,O
hyperphenylalaninemia,Disease
in,O
newborns,O
.,O
Using,O
phosphorus,O
magnetic,O
resonance,O
spectroscopy,O
we,O
demonstrated,O
a,O
maximum,O
rate,O
of,O
muscle,O
mitochondrial,O
ATP,O
production,O
(,O
V,O
(,O
max,O
),O
),O
below,O
the,O
normal,O
range,O
in,O
all,O
12,O
FRDA,Disease
patients,O
and,O
a,O
strong,O
negative,O
correlation,O
between,O
mitochondrial,O
V,O
(,O
max,O
),O
and,O
the,O
number,O
of,O
GAA,O
repeats,O
in,O
the,O
smaller,O
allele,O
.,O
Recent,O
studies,O
have,O
shown,O
that,O
hereditary,Disease
hemochromatosis,Disease
(,O
HH,Disease
),O
is,O
likely,O
to,O
be,O
caused,O
by,O
homozygosity,O
for,O
a,O
Cys282Tyr,O
mutation,O
in,O
the,O
HFE,O
gene,O
located,O
4,O
.,O
These,O
results,O
support,O
the,O
use,O
of,O
the,O
human,O
PAH,O
probe,O
in,O
prenatal,O
diagnosis,O
and,O
detection,O
of,O
carriers,O
",",O
to,O
provide,O
new,O
opportunities,O
for,O
the,O
biochemical,O
characterization,O
of,O
normal,O
and,O
mutant,O
enzymes,O
",",O
and,O
in,O
the,O
investigation,O
of,O
alternative,O
genetic,O
therapies,O
for,O
PKU,Disease
.,O
.,O
By,O
expressing,O
chimeric,O
reporter,O
constructs,O
containing,O
a,O
reporter,O
gene,O
fused,O
to,O
a,O
human,O
DMPK,O
3,O
-,O
UTR,O
",",O
we,O
identified,O
both,O
cis,O
and,O
trans,O
effects,O
that,O
are,O
mediated,O
by,O
the,O
DM,Disease
mutation,O
.,O
Clinically,O
observed,O
dysgenesis,O
does,O
not,O
correlate,O
with,O
IOP,O
",",O
however,O
",",O
and,O
the,O
etiology,O
of,O
glaucoma,Disease
development,O
is,O
not,O
understood,O
.,O
Deletions,O
and,O
other,O
abnormalities,O
of,O
human,O
chromosome,O
15q11,O
-,O
q13,O
are,O
associated,O
with,O
two,O
developmental,O
disorders,O
",",O
Prader,Disease
-,Disease
Willi,Disease
syndrome,Disease
(,O
PWS,Disease
),O
and,O
Angelman,Disease
syndrome,Disease
(,O
AS,Disease
),O
.,O
Although,O
the,O
patients,O
studied,O
had,O
typical,O
FRDA,Disease
",",O
one,O
sibpair,O
had,O
the,O
uncommon,O
symptom,O
of,O
retained,O
tendon,O
reflexes,O
.,O
Transgenic,O
mice,O
carrying,O
large,O
human,O
genomic,O
sequences,O
with,O
expanded,O
CTG,O
repeat,O
mimic,O
closely,O
the,O
DM,Disease
CTG,O
repeat,O
intergenerational,O
and,O
somatic,O
instability,O
.,O
We,O
analyzed,O
the,O
HEXA,O
gene,O
of,O
one,O
pseudodeficient,O
subject,O
and,O
identified,O
both,O
a,O
C739,O
-,O
to,O
-,O
T,O
substitution,O
that,O
changes,O
Arg247,O
-,O
-,O
-,O
-,O
Trp,O
on,O
one,O
allele,O
and,O
a,O
previously,O
identified,O
Tay,Disease
-,Disease
Sachs,Disease
disease,Disease
mutation,O
on,O
the,O
second,O
allele,O
.,O
Similarly,O
in,O
8,O
-,O
azaguanine,O
",",O
6,O
-,O
thioguanine,O
",",O
and,O
8,O
-,O
azahypoxanthine,O
",",O
the,O
growth,O
of,O
the,O
patients,O
cells,O
was,O
intermediate,O
between,O
normal,O
and,O
Lesch,Disease
-,Disease
Nyhan,Disease
cells,O
.,O
Molecular,O
analysis,O
of,O
the,O
PDS,Disease
gene,O
was,O
performed,O
in,O
two,O
consanguineous,O
large,O
families,O
from,O
Southern,O
Tunisia,O
comprising,O
a,O
total,O
of,O
23,O
individuals,O
affected,O
with,O
profound,O
congenital,Disease
deafness,Disease
;,O
the,O
same,O
missense,O
mutation,O
",",O
L445W,O
",",O
was,O
identified,O
in,O
all,O
affected,O
individuals,O
.,O
The,O
Prader,Disease
-,Disease
Willi,Disease
syndrome,Disease
(,O
PWS,Disease
),O
critical,O
region,O
on,O
15q11,O
-,O
q13,O
is,O
subject,O
to,O
imprinting,O
.,O
It,O
accounts,O
for,O
one,O
-,O
fourth,O
of,O
the,O
galactosemia,Disease
alleles,O
studied,O
.,O
Hence,O
",",O
41,O
(,O
95,O
%,O
),O
of,O
43,O
mutations,O
resulted,O
in,O
truncation,O
of,O
the,O
APC,Disease
protein,O
.,O
Together,O
the,O
data,O
suggest,O
that,O
the,O
MSH3,O
gene,O
encodes,O
a,O
product,O
that,O
functions,O
in,O
repair,O
of,O
some,O
but,O
not,O
all,O
pre,O
-,O
mutational,O
intermediates,O
",",O
its,O
mutation,O
in,O
tumours,Disease
can,O
result,O
in,O
genomic,O
instability,O
and,O
",",O
as,O
in,O
yeast,O
",",O
MSH3,O
and,O
MSH6,O
are,O
partially,O
redundant,O
for,O
mismatch,O
repair,O
.,O
.,O
The,O
inactivation,O
of,O
the,O
von,Disease
Hippel,Disease
-,Disease
Lindau,Disease
(,Disease
VHL,Disease
),Disease
tumor,Disease
suppressor,O
gene,O
predisposes,O
affected,O
individuals,O
to,O
the,O
human,O
VHL,Disease
cancer,Disease
syndrome,Disease
and,O
is,O
associated,O
with,O
sporadic,Disease
renal,Disease
cell,Disease
carcinomas,Disease
(,O
RCC,Disease
),O
and,O
brain,Disease
hemangioblastomas,Disease
.,O
The,O
consequent,O
severe,O
diarrhoea,Disease
and,O
dehydration,Disease
are,O
usually,O
fatal,O
unless,O
these,O
sugars,O
are,O
eliminated,O
from,O
the,O
diet,O
.,O
In,O
this,O
study,O
",",O
we,O
analyzed,O
two,O
families,O
with,O
FNDI,Disease
using,O
direct,O
automated,O
fluorescent,O
",",O
solid,O
phase,O
",",O
single,O
-,O
stranded,O
DNA,O
sequencing,O
of,O
PCR,O
-,O
amplified,O
AVP,O
-,O
NPII,O
DNA,O
.,O
All,O
available,O
members,O
were,O
clinically,O
assessed,O
and,O
genotyped,O
for,O
19,O
short,O
tandem,O
repeat,O
markers,O
on,O
chromosome,O
1,O
in,O
the,O
VWS,Disease
candidate,O
gene,O
region,O
.,O
A,O
deletion,O
in,O
an,O
individual,O
with,O
retinoblastoma,Disease
was,O
reported,O
to,O
separate,O
the,O
closely,O
linked,O
ESD,O
and,O
retinoblastoma,Disease
(,O
RB1,O
),O
loci,O
",",O
placing,O
ESD,O
proximal,O
to,O
RB1,O
.,O
The,O
seven,O
deficient,O
fibroblast,O
lines,O
were,O
characterized,O
by,O
measuring,O
acyl,O
-,O
coenzyme,O
A,O
dehydrogenation,O
activities,O
",",O
overall,O
palmitic,O
acid,O
oxidation,O
",",O
and,O
VLCAD,O
protein,O
synthesis,O
using,O
pulse,O
-,O
chase,O
",",O
further,O
confirming,O
the,O
diagnosis,O
of,O
VLCAD,Disease
deficiency,Disease
.,O
Duchenne,Disease
muscular,Disease
dystrophy,Disease
and,O
myotonic,Disease
dystrophy,Disease
in,O
the,O
same,O
patient,O
.,O
Patients,O
were,O
selected,O
because,O
they,O
were,O
heterozygous,O
or,O
homozygous,O
for,O
C2,Disease
deficiency,Disease
.,O
We,O
report,O
here,O
the,O
complete,O
genomic,O
organization,O
of,O
the,O
human,O
CLD,Disease
gene,O
which,O
spans,O
approximately,O
39kb,O
",",O
and,O
comprises,O
21,O
exons,O
.,O
Our,O
data,O
suggest,O
a,O
transition,O
in,O
risk,O
such,O
that,O
mutations,O
in,O
the,O
3,O
third,O
of,O
the,O
gene,O
are,O
associated,O
with,O
a,O
lower,O
proportion,O
of,O
ovarian,Disease
cancer,Disease
.,O
Friedreich,Disease
ataxia,Disease
is,O
an,O
autosomal,Disease
recessive,Disease
disorder,Disease
caused,O
by,O
mutations,O
in,O
the,O
FRDA,Disease
gene,O
that,O
encodes,O
a,O
210,O
-,O
amino,O
acid,O
protein,O
called,O
frataxin,O
.,O
Molecular,O
heterogeneity,O
in,O
mucopolysaccharidosis,Disease
IVA,Disease
in,O
Australia,O
and,O
Northern,O
Ireland,O
:,O
nine,O
novel,O
mutations,O
including,O
T312S,O
",",O
a,O
common,O
allele,O
that,O
confers,O
a,O
mild,O
phenotype,O
.,O
A,O
candidate,O
DNA,O
sequence,O
with,O
many,O
of,O
the,O
properties,O
predicted,O
for,O
the,O
retinoblastoma,Disease
susceptibility,O
(,O
RB1,O
),O
locus,O
has,O
been,O
cloned,O
(,O
S,O
.,O
H,O
.,O
Friend,O
",",O
R,O
.,O
Bernards,O
",",O
S,O
.,O
Rogelj,O
",",O
R,O
.,O
A,O
.,O
Weinberg,O
",",O
J,O
.,O
M,O
.,O
Rapaport,O
",",O
D,O
.,O
M,O
.,O
Albert,O
",",O
and,O
T,O
.,O
P,O
.,O
Dryja,O
",",O
Nature,O
[,O
London,O
],O
323,O
643,O
-,O
645,O
",",O
1986,O
),O
.,O
The,O
predicted,O
protein,O
environment,O
in,O
which,O
the,O
mutation,O
occurs,O
is,O
compared,O
to,O
that,O
of,O
the,O
adult,O
-,O
onset,O
Tay,Disease
-,Disease
Sachs,Disease
disease,Disease
mutation,O
caused,O
by,O
a,O
Gly269,O
-,O
-,O
>,O
Ser,O
substitution,O
in,O
exon,O
7,O
.,O
CETP,Disease
deficiency,Disease
appears,O
to,O
be,O
a,O
frequent,O
cause,O
of,O
increased,O
HDL,O
levels,O
in,O
the,O
population,O
of,O
Japan,O
",",O
possibly,O
because,O
of,O
a,O
founder,O
effect,O
.,O
He,O
showed,O
short,Disease
stature,Disease
",",O
obesity,Disease
",",O
mild,O
developmental,Disease
delay,Disease
",",O
cryptorchidism,Disease
",",O
and,O
some,O
mild,O
dysmorphic,Disease
features,Disease
.,O
Our,O
data,O
support,O
the,O
hypothesis,O
that,O
DM,Disease
is,O
a,O
contiguous,O
gene,O
syndrome,O
associated,O
with,O
the,O
partial,O
loss,O
of,O
both,O
DMPK,O
and,O
SIX5,O
.,O
.,O
We,O
describe,O
three,O
novel,O
mutations,O
(,O
R58fs,O
",",O
R330S,O
",",O
and,O
H371R,O
),O
and,O
one,O
common,O
AKU,Disease
mutation,O
(,O
M368V,O
),O
",",O
detected,O
by,O
mutational,O
and,O
polymorphism,O
analysis,O
of,O
the,O
HGO,O
gene,O
in,O
five,O
Finnish,O
AKU,Disease
pedigrees,O
.,O
Identification,O
of,O
WASP,O
mutations,O
in,O
patients,O
with,O
Wiskott,Disease
-,Disease
Aldrich,Disease
syndrome,Disease
and,O
isolated,Disease
thrombocytopenia,Disease
reveals,O
allelic,O
heterogeneity,O
at,O
the,O
WAS,Disease
locus,O
.,O
This,O
mutation,O
may,O
be,O
valuable,O
for,O
developing,O
models,O
of,O
dominantly,Disease
inherited,Disease
neurodegeneration,Disease
",",O
as,O
the,O
early,O
age,O
of,O
onset,O
of,O
symptoms,O
suggests,O
that,O
this,O
mutation,O
may,O
be,O
particularly,O
deleterious,O
to,O
the,O
magnocellular,O
neuron,O
.,O
.,O
Myotonic,Disease
dystrophy,Disease
:,O
the,O
role,O
of,O
the,O
CUG,O
triplet,O
repeats,O
in,O
splicing,O
of,O
a,O
novel,O
DMPK,O
exon,O
and,O
altered,O
cytoplasmic,O
DMPK,O
mRNA,O
isoform,O
ratios,O
.,O
A,O
normal,O
male,O
with,O
an,O
inherited,O
deletion,O
of,O
one,O
exon,O
within,O
the,O
DMD,Disease
gene,O
.,O
HPRT,Disease
-,Disease
deficient,Disease
mice,O
generated,O
using,O
mouse,O
embryonic,O
stem,O
cells,O
exhibit,O
none,O
of,O
the,O
behavioral,O
symptoms,O
associated,O
with,O
the,O
Lesch,Disease
-,Disease
Nyhan,Disease
syndrome,Disease
.,O
Age,O
penetrance,O
is,O
greater,O
for,O
BRCA1,Disease
-,Disease
linked,Disease
than,Disease
for,Disease
BRCA2,Disease
-,Disease
linked,Disease
cancers,Disease
in,O
this,O
population,O
.,O
Chimeric,O
transcription,O
factors,O
",",O
created,O
by,O
gene,O
fusions,O
as,O
the,O
result,O
of,O
chromosomal,O
translocations,O
",",O
have,O
been,O
implicated,O
in,O
the,O
pathogenesis,O
of,O
several,O
pathologically,O
disparate,O
solid,Disease
tumors,Disease
.,O
Motor,Disease
incoordination,Disease
",",O
immune,Disease
deficiencies,Disease
",",O
and,O
an,O
increased,O
risk,O
of,O
cancer,Disease
are,O
the,O
characteristic,O
features,O
of,O
the,O
hereditary,Disease
disease,Disease
ataxia,Disease
-,Disease
telangiectasia,Disease
(,O
A,Disease
-,Disease
T,Disease
),O
",",O
which,O
is,O
caused,O
by,O
mutations,O
in,O
the,O
ATM,O
gene,O
.,O
Abnormal,O
myotonic,Disease
dystrophy,Disease
protein,O
kinase,O
levels,O
produce,O
only,O
mild,O
myopathy,Disease
in,O
mice,O
.,O
No,O
deletions,O
were,O
detected,O
in,O
seven,O
cases,O
of,O
popliteal,Disease
pterygia,Disease
syndrome,Disease
",",O
76,O
cases,O
of,O
mixed,O
syndromic,Disease
forms,Disease
of,Disease
cleft,Disease
lip,Disease
and,Disease
palate,Disease
",",O
and,O
178,O
cases,O
of,O
nonsyndromic,Disease
cleft,Disease
lip,Disease
and,Disease
palate,Disease
.,O
Fatal,O
pyoderma,Disease
gangrenosum,Disease
in,O
association,O
with,O
C7,Disease
deficiency,Disease
.,O
Furthermore,O
",",O
compared,O
with,O
noncarriers,O
",",O
APC,O
I1307K,O
carriers,O
had,O
increased,O
numbers,O
of,O
adenomas,Disease
and,O
colorectal,Disease
cancers,Disease
per,O
patient,O
(,O
P,O
=,O
.,O
03,O
),O
",",O
as,O
well,O
as,O
a,O
younger,O
age,O
at,O
diagnosis,O
.,O
Mutations,O
in,O
the,O
fibrinogen,O
aalpha,O
gene,O
account,O
for,O
the,O
majority,O
of,O
cases,O
of,O
congenital,Disease
afibrinogenemia,Disease
.,O
Germline,O
VHL,Disease
gene,O
mutations,O
predispose,O
to,O
the,O
development,O
of,O
retinal,Disease
",",Disease
cerebellar,Disease
and,Disease
spinal,Disease
haemangioblastomas,Disease
",",O
renal,Disease
cell,Disease
carcinoma,Disease
and,O
phaeochromocytoma,Disease
.,O
The,O
molecular,O
details,O
of,O
ATM,O
function,O
in,O
the,O
nervous,O
system,O
are,O
unclear,O
",",O
although,O
the,O
neurological,Disease
lesion,Disease
in,O
ataxia,Disease
-,Disease
telangiectasia,Disease
becomes,O
apparent,O
early,O
in,O
life,O
",",O
suggesting,O
a,O
developmental,O
origin,O
.,O
We,O
have,O
used,O
single,O
strand,O
conformation,O
polymorphism,O
analysis,O
to,O
study,O
the,O
27,O
exons,O
of,O
the,O
RB1,O
gene,O
in,O
individuals,O
from,O
a,O
family,O
showing,O
mild,O
expression,O
of,O
the,O
retinoblastoma,Disease
phenotype,O
.,O
Genotype,O
-,O
phenotype,O
correlations,O
in,O
families,O
with,O
deletions,O
in,O
the,O
von,Disease
Hippel,Disease
-,Disease
Lindau,Disease
(,O
VHL,Disease
),O
gene,O
.,O
Mutations,O
associated,O
with,O
variant,O
phenotypes,O
in,O
ataxia,Disease
-,Disease
telangiectasia,Disease
.,O
Following,O
the,O
finding,O
of,O
a,O
185delAG,O
frameshift,O
mutation,O
in,O
several,O
Ashkenazi,O
Jewish,O
breast,O
/,O
ovarian,O
families,O
",",O
we,O
have,O
determined,O
the,O
frequency,O
of,O
this,O
mutation,O
in,O
858,O
Ashkenazim,O
seeking,O
genetic,O
testing,O
for,O
conditions,O
unrelated,O
to,O
cancer,Disease
",",O
and,O
in,O
815,O
reference,O
individuals,O
not,O
selected,O
for,O
ethnic,O
origin,O
.,O
Deficiency,Disease
of,Disease
terminal,Disease
complement,Disease
components,Disease
is,O
generally,O
associated,O
with,O
recurrent,O
neisseria,Disease
infections,Disease
.,O
Using,O
an,O
immunocytochemical,O
technique,O
on,O
blood,O
smears,O
",",O
we,O
recently,O
developed,O
a,O
novel,O
test,O
for,O
identification,O
of,O
patients,O
with,O
fragile,Disease
X,Disease
syndrome,Disease
.,O
Familial,Disease
discoid,Disease
lupus,Disease
erythematosus,Disease
associated,O
with,O
heterozygote,O
C2,Disease
deficiency,Disease
.,O
Alterations,O
of,O
the,O
length,O
or,O
amino,O
acid,O
composition,O
of,O
the,O
A,Disease
-,Disease
T,Disease
gene,O
product,O
affect,O
the,O
A,Disease
-,Disease
T,Disease
clinical,O
phenotype,O
in,O
different,O
ways,O
.,O
Most,O
colon,Disease
cancers,Disease
arise,O
from,O
mutations,O
in,O
the,O
gene,O
encoding,O
adenomatous,Disease
polyposis,Disease
coli,Disease
(,O
APC,Disease
),O
",",O
a,O
protein,O
required,O
for,O
ubiquitin,O
-,O
mediated,O
degradation,O
of,O
beta,O
-,O
catenin,O
",",O
but,O
a,O
small,O
percentage,O
of,O
colon,Disease
and,Disease
some,Disease
other,Disease
cancers,Disease
harbour,O
beta,O
-,O
catenin,O
-,O
stabilizing,O
mutations,O
.,O
We,O
show,O
here,O
that,O
Brca1,O
+,O
/,O
-,O
mice,O
are,O
normal,O
and,O
fertile,O
and,O
lack,O
tumors,Disease
by,O
age,O
eleven,O
months,O
.,O
Loss,O
of,O
the,O
ataxia,Disease
-,Disease
telangiectasia,Disease
gene,O
product,O
causes,O
oxidative,O
damage,O
in,O
target,O
organs,O
.,O
Because,O
the,O
intact,O
chromosome,O
7,O
",",O
opposite,O
the,O
deleted,O
homolog,O
",",O
maintains,O
the,O
correct,O
imprint,O
in,O
somatic,O
cells,O
of,O
PWS,Disease
and,O
AS,Disease
mice,O
and,O
establishes,O
the,O
correct,O
imprint,O
in,O
male,O
and,O
female,O
germ,O
cells,O
of,O
AS,Disease
mice,O
",",O
homologous,O
association,O
and,O
replication,O
asynchrony,O
are,O
not,O
part,O
of,O
the,O
imprinting,O
mechanism,O
.,O
Age,O
of,O
onset,O
in,O
Huntington,Disease
disease,Disease
:,O
sex,O
specific,O
influence,O
of,O
apolipoprotein,O
E,O
genotype,O
and,O
normal,O
CAG,O
repeat,O
length,O
.,O
Our,O
data,O
support,O
a,O
tumour,Disease
suppressor,O
mechanism,O
for,O
BRCA1,O
;,O
somatic,O
mutations,O
and,O
LOH,O
may,O
result,O
in,O
inactivation,O
of,O
BRCA1,O
in,O
at,O
least,O
a,O
small,O
number,O
of,O
ovarian,Disease
cancers,Disease
.,O
.,O
Genetic,O
and,O
environmental,O
variance,O
components,O
were,O
assessed,O
with,O
the,O
program,O
Mx,O
",",O
using,O
data,O
from,O
this,O
and,O
previous,O
studies,O
of,O
twins,O
with,O
AS,Disease
.,O
One,O
further,O
B27,O
negative,O
patients,O
had,O
a,O
sister,O
with,O
ankylosing,Disease
spondylitis,Disease
and,O
ulcerative,Disease
colitis,Disease
and,O
a,O
mother,O
with,O
ulcerative,Disease
colitis,Disease
.,O
DESIGN,O
AND,O
SETTING,O
Retrospective,O
cohort,O
study,O
of,O
a,O
consecutive,O
series,O
of,O
933,O
ovarian,Disease
cancers,Disease
diagnosed,O
and,O
treated,O
at,O
our,O
institution,O
",",O
which,O
is,O
a,O
comprehensive,O
cancer,Disease
center,O
as,O
designated,O
by,O
the,O
National,O
Cancer,Disease
Institute,O
",",O
over,O
a,O
12,O
-,O
year,O
period,O
(,O
December,O
1986,O
to,O
August,O
1998,O
),O
.,O
Furthermore,O
",",O
based,O
on,O
our,O
clinical,O
experience,O
",",O
nursing,O
appears,O
to,O
be,O
safe,O
for,O
lactating,O
women,O
with,O
FMF,Disease
who,O
continue,O
to,O
take,O
colchicine,O
.,O
The,O
breast,Disease
and,Disease
ovarian,Disease
cancer,Disease
susceptibility,O
gene,O
",",O
BRCA1,O
",",O
has,O
been,O
cloned,O
and,O
shown,O
to,O
encode,O
a,O
zinc,O
-,O
finger,O
protein,O
of,O
unknown,O
function,O
.,O
Huntington,Disease
disease,Disease
without,O
CAG,O
expansion,O
:,O
phenocopies,O
or,O
errors,O
in,O
assignment,O
?,O
Muscle,O
expression,O
of,O
G6PD,Disease
deficiency,Disease
has,O
been,O
investigated,O
in,O
Mediterranean,O
",",O
Seattle,O
-,O
like,O
and,O
A,O
-,O
variants,O
.,O
Individuals,O
with,O
subtotal,Disease
complement,Disease
C6,Disease
deficiency,Disease
possess,O
a,O
C6,O
molecule,O
that,O
is,O
14,O
%,O
shorter,O
than,O
normal,O
C6,O
and,O
present,O
in,O
low,O
but,O
detectable,O
concentrations,O
(,O
1,O
-,O
2,O
%,O
of,O
the,O
normal,O
mean,O
),O
.,O
The,O
corresponding,O
mutant,O
recombinant,O
protein,O
",",O
rvWF,O
(,O
G561S,O
),O
",",O
formed,O
normal,O
multimers,O
and,O
exhibited,O
the,O
same,O
functional,O
defect,O
as,O
the,O
patients,O
plasma,O
vWF,O
",",O
confirming,O
that,O
this,O
mutation,O
causes,O
von,Disease
Willebrand,Disease
disease,Disease
type,Disease
B,Disease
.,O
Prostate,Disease
cancer,Disease
clusters,O
in,O
some,O
families,O
",",O
and,O
an,O
estimated,O
5,O
%,O
-,O
10,O
%,O
of,O
all,O
cases,O
are,O
estimated,O
to,O
result,O
from,O
inheritance,O
of,O
prostate,O
cancer,O
-,O
susceptibility,O
genes,O
.,O
High,O
residual,O
arylsulfatase,O
A,O
(,O
ARSA,O
),O
activity,O
in,O
a,O
patient,O
with,O
late,Disease
-,Disease
infantile,Disease
metachromatic,Disease
leukodystrophy,Disease
.,O
Cutaneous,Disease
and,Disease
ocular,Disease
pigmentation,Disease
were,O
evaluated,O
in,O
29,O
individuals,O
with,O
the,O
Prader,Disease
-,Disease
Willi,Disease
syndrome,Disease
(,O
PWS,Disease
),O
.,O
Absent,O
bacteriolysis,O
remains,O
the,O
only,O
consistent,O
defect,O
associated,O
with,O
recurrent,O
neisserial,Disease
infections,Disease
and,O
absence,O
of,O
one,O
of,O
the,O
late,O
-,O
acting,O
complement,O
components,O
.,O
.,O
CONCLUSIONS,O
The,O
reproductive,O
outcome,O
in,O
maternal,Disease
phenylketonuria,Disease
is,O
dependent,O
on,O
prenatal,O
metabolic,O
control,O
and,O
postnatal,O
environmental,O
circumstances,O
.,O
Germline,O
mutations,O
in,O
the,O
tumor,Disease
suppressor,O
gene,O
",",O
BRCA1,O
",",O
predispose,O
individuals,O
to,O
breast,Disease
and,Disease
ovarian,Disease
cancers,Disease
.,O
Identification,O
of,O
an,O
altered,O
splice,O
site,O
in,O
Ashkenazi,O
Tay,Disease
-,Disease
Sachs,Disease
disease,Disease
.,O
It,O
showed,O
",",O
furthermore,O
",",O
that,O
phenotypic,O
differences,O
between,O
ALD,Disease
and,O
AMN,Disease
are,O
not,O
necessarily,O
the,O
consequence,O
of,O
allelic,O
heterogeneity,O
due,O
to,O
different,O
mutations,O
within,O
the,O
same,O
gene,O
.,O
Our,O
data,O
suggest,O
that,O
the,O
C,O
to,O
A,O
mutation,O
at,O
the,O
penultimate,O
nucleotide,O
of,O
exon,O
6,O
of,O
the,O
CYP27,O
gene,O
not,O
only,O
causes,O
the,O
deficiency,Disease
in,Disease
the,Disease
sterol,Disease
27,Disease
-,Disease
hydroxylase,Disease
activity,Disease
",",O
but,O
also,O
partially,O
leads,O
to,O
alternative,O
pre,O
-,O
mRNA,O
splicing,O
of,O
the,O
gene,O
.,O
Linkage,O
analysis,O
of,O
26,O
Canadian,O
breast,Disease
and,Disease
breast,Disease
-,Disease
ovarian,Disease
cancer,Disease
families,O
.,O
The,O
prevention,O
of,O
Tay,Disease
-,Disease
Sachs,Disease
disease,Disease
(,O
GM2,Disease
gangliosidosis,Disease
",",Disease
type,Disease
1,Disease
),O
depends,O
on,O
the,O
identification,O
of,O
carriers,O
of,O
the,O
gene,O
for,O
this,O
autosomal,Disease
recessive,Disease
disorder,Disease
.,O
Four,O
novel,O
PEPD,O
alleles,O
causing,O
prolidase,Disease
deficiency,Disease
.,O
Both,O
A,Disease
-,Disease
T,Disease
homozygotes,O
and,O
heterozygotes,O
showed,O
significantly,O
increased,O
levels,O
of,O
radiation,O
-,O
induced,O
chromatid,O
damage,O
relative,O
to,O
that,O
of,O
normal,O
controls,O
.,O
The,O
adenomatous,Disease
polyposis,Disease
coli,Disease
(,Disease
APC,Disease
),Disease
tumour,Disease
-,O
suppressor,O
protein,O
controls,O
the,O
Wnt,O
signalling,O
pathway,O
by,O
forming,O
a,O
complex,O
with,O
glycogen,O
synthase,O
kinase,O
3beta,O
(,O
GSK,O
-,O
3beta,O
),O
",",O
axin,O
/,O
conductin,O
and,O
betacatenin,O
.,O
We,O
assembled,O
the,O
YAC,O
clones,O
into,O
overlapping,O
sets,O
by,O
hybridizing,O
them,O
to,O
a,O
large,O
number,O
of,O
DNA,O
probes,O
from,O
the,O
HD,Disease
region,O
",",O
including,O
the,O
STSs,O
.,O
Because,O
conventional,O
Piga,O
gene,O
knockout,O
is,O
associated,O
with,O
high,O
embryonic,Disease
lethality,Disease
in,O
chimeric,O
mice,O
",",O
we,O
used,O
the,O
Cre,O
/,O
loxP,O
system,O
.,O
We,O
hypothesize,O
that,O
structural,O
rearrangement,O
of,O
14q,O
is,O
directly,O
related,O
to,O
abnormal,O
growth,O
of,O
lymphocytes,O
and,O
that,O
it,O
may,O
be,O
a,O
step,O
toward,O
the,O
development,O
of,O
lymphoid,Disease
malignancies,Disease
.,O
The,O
Rb1,O
gene,O
has,O
been,O
implicated,O
with,O
retinoblastoma,Disease
and,O
is,O
located,O
on,O
human,O
Chromosome,O
(,O
Chr,O
),O
13q14,O
.,O
Familial,Disease
adenomatous,Disease
polyposis,Disease
(,O
FAP,Disease
),O
is,O
an,O
inherited,O
predisposition,O
to,O
colorectal,Disease
cancer,Disease
characterized,O
by,O
the,O
development,O
of,O
numerous,O
adenomatous,Disease
polyps,Disease
predominantly,O
in,O
the,O
colorectal,O
region,O
.,O
Ataxia,Disease
-,Disease
telangiectasia,Disease
(,O
A,Disease
-,Disease
T,Disease
),O
is,O
an,O
autosomal,Disease
recessive,Disease
syndrome,Disease
associated,O
with,O
a,O
greatly,O
increased,O
incidence,O
of,O
malignant,Disease
neoplasms,Disease
in,O
homozygous,O
affected,O
individuals,O
.,O
We,O
report,O
a,O
rare,O
case,O
of,O
paternally,O
transmitted,O
congenital,Disease
myotonic,Disease
dystrophy,Disease
(,O
DM,Disease
),O
.,O
We,O
report,O
here,O
the,O
linkage,O
relationship,O
of,O
the,O
myotonic,Disease
dystrophy,Disease
(,O
DM,Disease
),O
locus,O
to,O
twelve,O
of,O
these,O
markers,O
as,O
studied,O
in,O
45,O
families,O
with,O
DM,Disease
.,O
Mutation,O
spectrum,O
in,O
the,O
CHM,Disease
gene,O
of,O
Danish,O
and,O
Swedish,O
choroideremia,Disease
patients,O
.,O
In,O
one,O
family,O
there,O
was,O
evidence,O
of,O
non,O
-,O
penetrance,O
and,O
susceptibility,O
to,O
both,O
gastric,Disease
and,Disease
colorectal,Disease
cancer,Disease
;,O
thus,O
",",O
in,O
addition,O
to,O
six,O
cases,O
of,O
gastric,Disease
cancer,Disease
",",O
a,O
CDH1,O
mutation,O
carrier,O
developed,O
colorectal,Disease
cancer,Disease
at,O
age,O
30,O
years,O
.,O
The,O
mean,O
HDL,O
-,O
cholesterol,O
concentration,O
in,O
the,O
CTX,Disease
plasmas,O
was,O
14,O
.,O
Deficiency,Disease
of,Disease
C5,Disease
is,O
compatible,O
with,O
good,O
health,O
",",O
but,O
it,O
can,O
be,O
associated,O
with,O
repeated,O
disseminated,O
gonococcal,Disease
infection,Disease
Inherited,Disease
defects,Disease
in,O
the,O
peroxisomal,O
ATP,O
-,O
binding,O
cassette,O
(,O
ABC,O
),O
transporter,O
adrenoleukodystrophy,Disease
protein,O
(,O
ALDP,O
),O
lead,O
to,O
the,O
lethal,O
peroxisomal,Disease
disorder,Disease
X,Disease
-,Disease
linked,Disease
adrenoleukodystrophy,Disease
(,O
X,Disease
-,Disease
ALD,Disease
),O
",",O
for,O
which,O
no,O
efficient,O
treatment,O
has,O
been,O
established,O
so,O
far,O
.,O
Twenty,O
-,O
five,O
first,O
-,O
degree,O
relatives,O
with,O
ankylosing,Disease
spondylitis,Disease
were,O
all,O
B27,O
positive,O
.,O
The,O
significance,O
of,O
this,O
association,O
is,O
controversial,O
",",O
though,O
the,O
association,O
of,O
C2,Disease
deficiency,Disease
with,O
certain,O
histocompatibility,O
antigens,O
suggests,O
possible,O
linkage,O
to,O
immune,O
response,O
genes,O
.,O
Founding,O
BRCA1,O
mutations,O
in,O
hereditary,Disease
breast,Disease
and,Disease
ovarian,Disease
cancer,Disease
in,O
southern,O
Sweden,O
.,O
Germline,O
mutations,O
in,O
the,O
RB1,O
gene,O
confer,O
hereditary,O
predisposition,O
to,O
retinoblastoma,Disease
.,O
This,O
could,O
be,O
because,O
the,O
68,O
Val,O
-,O
-,O
>,O
Met,O
mutation,O
happened,O
to,O
arise,O
in,O
an,O
A,O
gene,O
in,O
the,O
first,O
instance,O
",",O
or,O
because,O
the,O
68,O
Val,O
-,O
-,O
>,O
Met,O
mutation,O
alone,O
is,O
not,O
sufficient,O
to,O
cause,O
G6PD,Disease
deficiency,Disease
.,O
In,O
specific,O
C5,O
titrations,O
",",O
however,O
",",O
it,O
was,O
noted,O
that,O
when,O
limited,O
amounts,O
of,O
C5,O
were,O
assayed,O
in,O
the,O
presence,O
of,O
low,O
dilutions,O
of,O
either,O
C5D,Disease
serum,O
",",O
curving,O
rather,O
than,O
linear,O
dose,O
-,O
response,O
plots,O
were,O
consistently,O
obtained,O
",",O
suggesting,O
some,O
inhibitory,O
effect,O
.,O
Recently,O
",",O
deletions,O
of,O
all,O
or,O
part,O
of,O
exon,O
12,O
have,O
been,O
identified,O
in,O
individuals,O
with,O
Kniest,Disease
dysplasia,Disease
",",O
suggesting,O
that,O
mutations,O
within,O
this,O
region,O
of,O
the,O
protein,O
may,O
primarily,O
result,O
in,O
the,O
Kniest,Disease
dysplasia,Disease
phenotype,O
.,O
These,O
findings,O
are,O
consistent,O
with,O
the,O
hypothesis,O
that,O
certain,O
alleles,O
could,O
prevent,O
or,O
modify,O
the,O
clinical,O
manifestations,O
of,O
BPAD,Disease
and,O
perhaps,O
other,O
related,O
affective,Disease
disorders,Disease
.,O
MAGEL2,O
is,O
expressed,O
predominantly,O
in,O
brain,O
",",O
the,O
primary,O
tissue,O
affected,O
in,O
PWS,Disease
and,O
in,O
several,O
fetal,O
tissues,O
as,O
shown,O
by,O
northern,O
blot,O
analysis,O
.,O
In,O
conjunction,O
with,O
information,O
from,O
2,O
NDP,Disease
patients,O
who,O
have,O
a,O
deletion,O
for,O
DXS7,O
but,O
not,O
for,O
DSX426,O
",",O
our,O
data,O
indicate,O
that,O
the,O
NDP,Disease
gene,O
lies,O
between,O
DXS7,O
and,O
DXS426,O
on,O
proximal,O
Xp,O
.,O
In,O
a,O
study,O
of,O
G6PD,Disease
deficient,Disease
patients,O
who,O
presented,O
with,O
clinical,O
favism,Disease
in,O
Spain,O
",",O
we,O
have,O
found,O
a,O
new,O
polymorphic,O
variant,O
that,O
we,O
have,O
called,O
G6PD,O
Malaga,O
",",O
whose,O
only,O
abnormality,O
is,O
a,O
542,O
A,O
-,O
-,O
>,O
T,O
(,O
181,O
Asp,O
-,O
-,O
>,O
Val,O
),O
mutation,O
.,O
Screening,O
for,O
the,O
G6PD,Disease
deficiency,Disease
was,O
carried,O
out,O
at,O
the,O
Maternity,O
Division,O
of,O
the,O
Galliera,O
Hospital,O
in,O
Genoa,O
",",O
Italy,O
.,O
Similarly,O
",",O
while,O
the,O
cumulative,O
data,O
revealed,O
a,O
predominance,O
of,O
missense,O
mutations,O
among,O
the,O
WASP,O
gene,O
lesions,O
observed,O
in,O
boys,O
with,O
isolated,Disease
thrombocytopenia,Disease
",",O
missense,O
mutations,O
were,O
not,O
exclusively,O
associated,O
with,O
milder,O
WAS,Disease
phenotypes,O
",",O
but,O
also,O
comprised,O
a,O
substantial,O
portion,O
(,O
38,O
%,O
),O
of,O
the,O
WASP,O
gene,O
defects,O
found,O
in,O
patients,O
with,O
severe,O
disease,O
.,O
These,O
findings,O
",",O
as,O
well,O
as,O
the,O
detection,O
of,O
identical,O
WASP,O
mutations,O
in,O
patients,O
with,O
disparate,O
phenotypes,O
",",O
reveal,O
a,O
lack,O
of,O
phenotype,O
concordance,O
with,O
genotype,O
in,O
WAS,Disease
and,O
thus,O
imply,O
that,O
phenotypic,O
outcome,O
in,O
this,O
disease,O
cannot,O
be,O
reliably,O
predicted,O
solely,O
on,O
the,O
basis,O
of,O
WASP,O
genotypes,O
.,O
.,O
HLA,O
B27,O
and,O
the,O
genetics,O
of,O
ankylosing,Disease
spondylitis,Disease
.,O
Loss,O
of,O
E,O
-,O
cadherin,O
function,O
has,O
been,O
implicated,O
in,O
the,O
pathogenesis,O
of,O
sporadic,O
colorectal,Disease
and,Disease
other,Disease
cancers,Disease
",",O
and,O
our,O
findings,O
provide,O
evidence,O
that,O
germline,O
CDH1,O
mutations,O
predispose,O
to,O
early,O
onset,O
colorectal,Disease
cancer,Disease
.,O
The,O
discovery,O
of,O
a,O
large,O
kindred,O
with,O
a,O
heritable,O
deficiency,Disease
of,Disease
the,Disease
fifth,Disease
component,Disease
of,Disease
complement,Disease
(,O
C5,O
),O
has,O
permitted,O
the,O
accumulation,O
of,O
new,O
clinical,O
",",O
genetic,O
and,O
immunologic,O
data,O
concerning,O
the,O
role,O
of,O
C5,O
in,O
human,O
subjects,O
.,O
The,O
DMPK,O
gene,O
of,O
severely,O
affected,O
myotonic,Disease
dystrophy,Disease
patients,O
is,O
hypermethylated,O
proximal,O
to,O
the,O
largely,O
expanded,O
CTG,O
repeat,O
.,O
We,O
conclude,O
that,O
paternal,O
transmission,O
of,O
congenital,Disease
DM,Disease
is,O
rare,O
and,O
preferentially,O
occurs,O
with,O
onset,O
of,O
DM,Disease
past,O
30,O
years,O
in,O
the,O
father,O
.,O
.,O
The,O
observation,O
of,O
typical,O
mutations,O
in,O
STM7,O
/,O
X25,O
(,O
GAA,O
expansions,O
),O
in,O
this,O
patient,O
demonstrates,O
that,O
the,O
two,O
genetically,O
different,O
forms,O
of,O
FRDA,Disease
cannot,O
be,O
distinguished,O
clinically,O
.,O
.,O
BRCA1,O
is,O
associated,O
with,O
a,O
human,O
SWI,O
/,O
SNF,O
-,O
related,O
complex,O
:,O
linking,O
chromatin,O
remodeling,O
to,O
breast,Disease
cancer,Disease
.,O
The,O
786,O
-,O
0,O
cell,O
line,O
",",O
like,O
many,O
cancer,Disease
cells,O
",",O
fails,O
to,O
exit,O
the,O
cell,O
cycle,O
upon,O
serum,O
withdrawal,O
.,O
A,O
survey,O
instrument,O
is,O
used,O
to,O
assess,O
temperature,O
regulation,O
characteristics,O
in,O
children,O
with,O
Prader,Disease
-,Disease
Willi,Disease
syndrome,Disease
(,O
PWS,Disease
),O
compared,O
to,O
3,O
control,O
groups,O
sibs,O
of,O
PWS,Disease
patients,O
(,O
SIB,O
),O
",",O
neurodevelopmentally,Disease
handicapped,Disease
children,O
(,O
ND,O
),O
",",O
and,O
age,O
and,O
gender,O
matched,O
well,O
children,O
(,O
WC,O
),O
.,O
Two,O
groups,O
of,O
subjects,O
with,O
hyperbilirubinaemia,Disease
of,O
non,O
-,O
immunological,O
origin,O
were,O
examined,O
(,O
a,O
),O
302,O
newborn,O
babies,O
of,O
Sardinian,O
extraction,O
(,O
on,O
cord,O
blood,O
),O
and,O
(,O
b,O
),O
201,O
newborn,O
babies,O
of,O
south,O
Italian,O
ancestry,O
(,O
on,O
peripheral,O
blood,O
),O
.,O
We,O
recently,O
showed,O
that,O
alkaptonuria,Disease
(,O
AKU,Disease
),O
is,O
caused,O
by,O
loss,O
-,O
of,O
-,O
function,O
mutations,O
in,O
the,O
homogentisate,O
1,O
",",O
2,O
dioxygenase,O
gene,O
(,O
HGO,O
),O
.,O
We,O
now,O
report,O
that,O
this,O
segment,O
is,O
additionally,O
the,O
target,O
of,O
somatic,O
mutations,O
in,O
mesenchymal,Disease
tumors,Disease
among,O
patients,O
having,O
no,O
apparent,O
predisposition,O
to,O
retinoblastoma,Disease
and,O
no,O
previous,O
evidence,O
of,O
retinoblastoma,Disease
.,O
The,O
identical,O
5,O
',O
splice,O
-,O
site,O
acceptor,O
mutation,O
in,O
five,O
attenuated,Disease
APC,Disease
families,O
from,O
Newfoundland,O
demonstrates,O
a,O
founder,O
effect,O
.,O
We,O
assessed,O
the,O
I1307K,O
prevalence,O
in,O
Israeli,O
Jews,O
of,O
differing,O
ethnic,O
origin,O
and,O
risk,O
for,O
colorectal,Disease
cancer,Disease
.,O
Although,O
these,O
mutations,O
have,O
been,O
well,O
characterized,O
",",O
little,O
is,O
known,O
about,O
the,O
function,O
of,O
the,O
APC,Disease
gene,O
product,O
.,O
Homozygosity,O
mapping,O
in,O
a,O
family,O
with,O
microcephaly,Disease
",",O
mental,Disease
retardation,Disease
",",O
and,O
short,Disease
stature,Disease
to,O
a,O
Cohen,Disease
syndrome,Disease
region,O
on,O
8q21,O
.,O
3,O
-,O
8q22,O
.,O
1,O
:,O
redefining,O
a,O
clinical,O
entity,O
.,O
Recent,O
progress,O
has,O
resulted,O
in,O
part,O
of,O
the,O
gene,O
mutated,O
in,O
Duchenne,Disease
and,Disease
the,Disease
milder,Disease
Becker,Disease
muscular,Disease
dystrophies,Disease
being,O
cloned,O
and,O
has,O
suggested,O
that,O
the,O
gene,O
itself,O
extends,O
over,O
1,O
",",O
000,O
to,O
2,O
",",O
000,O
kilobases,O
(,O
kb,O
),O
.,O
Myotonic,Disease
dystrophy,Disease
(,O
DM,Disease
),O
is,O
caused,O
by,O
a,O
CTG,O
expansion,O
in,O
the,O
3,O
untranslated,O
region,O
of,O
the,O
DM,Disease
gene,O
.,O
Familial,Disease
deficiency,Disease
of,Disease
the,Disease
seventh,Disease
component,Disease
of,Disease
complement,Disease
associated,O
with,O
recurrent,O
meningococcal,Disease
infections,Disease
.,O
It,O
is,O
expected,O
that,O
the,O
majority,O
of,O
clear,O
examples,O
of,O
the,O
breast,Disease
-,Disease
ovarian,Disease
syndrome,Disease
will,O
be,O
associated,O
with,O
germ,O
-,O
line,O
mutations,O
in,O
the,O
coding,O
region,O
of,O
BRCA1,O
.,O
.,O
Analbuminemia,Disease
was,O
fortuitously,O
detected,O
in,O
a,O
nonedematous,O
12,O
-,O
year,O
-,O
old,O
American,O
Indian,O
girl,O
with,O
atopic,Disease
dermatitis,Disease
",",O
mild,O
bronchial,Disease
asthma,Disease
",",O
a,O
mild,O
seizure,Disease
disorder,Disease
",",O
and,O
hyperlipoproteinemia,Disease
with,O
a,O
corneal,Disease
arcus,Disease
.,O
Our,O
data,O
support,O
the,O
hypothesis,O
that,O
ALD,Disease
is,O
a,O
frequent,O
cause,O
of,O
idiopathic,O
Addisons,Disease
disease,Disease
in,O
children,O
and,O
adults,O
.,O
.,O
This,O
finding,O
",",O
in,O
association,O
with,O
3,O
other,O
instances,O
of,O
single,O
breaks,O
at,O
11p13,O
and,O
aniridia,Disease
",",O
supports,O
the,O
assignment,O
of,O
AN2,O
to,O
11p13,O
.,O
The,O
recent,O
isolation,O
of,O
the,O
responsible,O
gene,O
(,O
adenomatous,Disease
polyposis,Disease
coli,Disease
or,O
APC,Disease
),O
has,O
facilitated,O
the,O
search,O
for,O
germ,O
line,O
mutations,O
in,O
affected,O
individuals,O
.,O
Interestingly,O
",",O
the,O
I1307K,O
APC,O
polymorphism,O
",",O
associated,O
with,O
an,O
increased,O
risk,O
of,O
colorectal,Disease
cancer,Disease
",",O
is,O
also,O
present,O
in,O
this,O
family,O
.,O
Two,O
variants,O
of,O
a,O
genetic,O
deficiency,Disease
of,Disease
complement,Disease
protein,Disease
C2,Disease
(,O
C2D,O
),O
have,O
been,O
previously,O
identified,O
.,O
Tightly,O
linked,O
flanking,O
markers,O
for,O
the,O
Lowe,Disease
oculocerebrorenal,Disease
syndrome,Disease
",",O
with,O
application,O
to,O
carrier,O
assessment,O
.,O
The,O
molecular,O
mechanisms,O
by,O
which,O
the,O
expanded,O
repeat,O
causes,O
the,O
clinically,O
variable,O
and,O
multisystemic,Disease
disease,Disease
",",O
myotonic,Disease
dystrophy,Disease
",",O
are,O
not,O
understood,O
.,O
Mutations,O
in,O
the,O
human,O
phenylalanine,O
hydroxylase,O
gene,O
producing,O
phenylketonuria,Disease
or,O
hyperphenylalaninemia,Disease
have,O
now,O
been,O
identified,O
in,O
many,O
patients,O
from,O
various,O
ethnic,O
groups,O
.,O
In,O
the,O
present,O
report,O
we,O
analyze,O
40,O
(,O
12,O
original,O
and,O
28,O
newly,O
identified,O
),O
Swedish,O
families,O
with,O
hereditary,Disease
prostate,Disease
cancer,Disease
(,O
HPC,Disease
),O
that,O
",",O
on,O
the,O
basis,O
of,O
40,O
markers,O
spanning,O
a,O
25,O
-,O
cM,O
interval,O
within,O
1q24,O
-,O
25,O
",",O
have,O
evidence,O
of,O
linkage,O
.,O
Four,O
of,O
the,O
homozygous,O
subjects,O
had,O
previously,O
been,O
given,O
a,O
diagnosis,O
of,O
hemochromatosis,Disease
",",O
and,O
12,O
had,O
not,O
.,O
In,O
the,O
remaining,O
two,O
-,O
thirds,O
of,O
the,O
tumors,Disease
only,O
one,O
mutation,O
was,O
found,O
",",O
consistent,O
with,O
the,O
loss,O
-,O
of,O
-,O
heterozygosity,O
theory,O
of,O
tumorigenesis,O
.,O
Chediak,Disease
-,Disease
Higashi,Disease
syndrome,Disease
(,O
CHS,Disease
),O
is,O
an,O
inherited,Disease
disorder,Disease
caused,O
by,O
mutations,O
in,O
the,O
lysosomal,O
trafficking,O
regulator,O
gene,O
",",O
LYST,O
.,O
Pericentral,Disease
scotomas,Disease
were,O
present,O
and,O
the,O
ERG,O
was,O
markedly,O
abnormal,O
.,O
In,O
comparison,O
with,O
the,O
usual,O
EDMD,Disease
phenotype,O
",",O
patients,O
with,O
P183,O
missense,O
mutations,O
have,O
a,O
later,O
age,O
at,O
onset,O
of,O
first,O
symptoms,O
",",O
elbow,Disease
contractures,Disease
",",O
ankle,Disease
contractures,Disease
",",O
upper,Disease
limb,Disease
weakness,Disease
and,O
lower,Disease
limb,Disease
weakness,Disease
",",O
but,O
there,O
is,O
no,O
difference,O
for,O
the,O
age,O
at,O
onset,O
of,O
cardiac,Disease
involvement,Disease
.,O
In,O
the,O
case,O
of,O
the,O
prenatal,O
diagnosis,O
",",O
the,O
fetus,O
was,O
shown,O
by,O
cytogenetic,O
analysis,O
to,O
be,O
a,O
female,O
",",O
who,O
we,O
predict,O
will,O
be,O
a,O
noncarrier,O
of,O
PMD,Disease
based,O
on,O
her,O
genotype,O
with,O
the,O
PLP,O
intragenic,O
polymorphism,O
.,O
.,O
An,O
obligate,O
carrier,O
of,O
the,O
Wiskott,Disease
-,Disease
Aldrich,Disease
syndrome,Disease
(,O
WAS,Disease
),O
who,O
was,O
also,O
heterozygous,O
for,O
the,O
A,O
and,O
B,O
types,O
of,O
X,O
-,O
linked,O
glucose,O
-,O
6,O
-,O
phosphate,O
dehydrogenase,O
was,O
found,O
.,O
ALD,Disease
hemizygotes,O
showed,O
increased,O
levels,O
of,O
hexacosanoate,O
(,O
C26,O
fatty,O
acid,O
),O
which,O
represented,O
0,O
.,O
Mutation,O
in,O
the,O
gene,O
encoding,O
the,O
recently,O
isolated,O
WASP,O
protein,O
has,O
now,O
been,O
identified,O
as,O
the,O
genetic,Disease
defect,Disease
responsible,O
for,O
the,O
X,Disease
-,Disease
linked,Disease
Wiskott,Disease
-,Disease
Aldrich,Disease
syndrome,Disease
(,O
WAS,Disease
),O
",",O
a,O
primary,O
immunodeficiency,Disease
disease,Disease
associated,O
with,O
extensive,O
phenotypic,O
variability,O
.,O
The,O
substitutions,O
at,O
cDNA,O
1376,O
and,O
1388,O
account,O
for,O
over,O
50,O
%,O
of,O
the,O
43,O
samples,O
examined,O
indicating,O
a,O
high,O
prevalence,O
of,O
these,O
two,O
alleles,O
among,O
G6PD,Disease
-,Disease
deficient,Disease
Chinese,O
.,O
BACKGROUND,O
Recently,O
",",O
mutations,O
in,O
the,O
retinal,Disease
degeneration,Disease
slow,O
(,O
rds,O
),O
gene,O
which,O
codes,O
for,O
peripherin,O
-,O
rds,O
have,O
been,O
implicated,O
as,O
a,O
cause,O
of,O
autosomal,Disease
dominant,Disease
retinitis,Disease
pigmentosa,Disease
.,O
Haplotype,O
studies,O
in,O
Wilson,Disease
disease,Disease
.,O
To,O
investigate,O
the,O
nature,O
of,O
somatic,O
von,Disease
Hippel,Disease
-,Disease
Lindau,Disease
(,O
VHL,Disease
),O
mutations,O
",",O
we,O
analyzed,O
173,O
primary,O
sporadic,O
human,O
renal,Disease
cell,Disease
carcinomas,Disease
for,O
mutations,O
of,O
the,O
VHL,Disease
tumor,Disease
suppressor,O
gene,O
",",O
using,O
polymerase,O
chain,O
reaction,O
(,O
PCR,O
),O
and,O
single,O
-,O
strand,O
conformational,O
polymorphism,O
analysis,O
(,O
SSCP,O
),O
of,O
DNA,O
.,O
The,O
location,O
of,O
the,O
germ,O
-,O
line,O
mutations,O
seems,O
to,O
correlate,O
with,O
the,O
two,O
clinical,O
types,O
;,O
germ,O
-,O
line,O
mutations,O
in,O
five,O
FAP,Disease
patients,O
with,O
profuse,O
polyps,Disease
were,O
observed,O
between,O
codon,O
1250,O
and,O
codon,O
1464,O
",",O
whereas,O
mutations,O
in,O
17,O
FAP,Disease
patients,O
with,O
fewer,O
polyps,Disease
were,O
observed,O
in,O
the,O
other,O
regions,O
of,O
the,O
APC,Disease
gene,O
.,O
Cytogenetic,O
studies,O
support,O
the,O
presence,O
of,O
a,O
DGS,Disease
critical,O
region,O
in,O
band,O
22q11,O
.,O
Classical,Disease
phenylketonuria,Disease
is,O
an,O
autosomal,Disease
recessive,Disease
disease,Disease
caused,O
by,O
a,O
deficiency,Disease
of,Disease
hepatic,Disease
phenylalanine,Disease
hydroxylase,Disease
(,O
PAH,O
),O
.,O
The,O
Zellweger,Disease
spectrum,Disease
of,Disease
disease,Disease
",",O
encompassing,O
Zellweger,Disease
syndrome,Disease
and,O
the,O
progressively,O
milder,O
phenotypes,O
of,O
neonatal,Disease
adrenoleukodystrophy,Disease
and,O
infantile,Disease
Refsum,Disease
disease,Disease
",",O
is,O
due,O
to,O
a,O
failure,O
to,O
form,O
functional,O
peroxisomes,O
.,O
Third,O
",",O
a,O
proportion,O
of,O
Sey,O
/,O
+,O
Smalleye,O
mice,O
",",O
heterozygous,O
for,O
a,O
nonsense,O
mutation,O
in,O
murine,O
Pax,O
-,O
6,O
",",O
have,O
an,O
ocular,O
phenotype,O
resembling,O
Peters,Disease
anomaly,Disease
.,O
In,O
contrast,O
to,O
alleles,O
that,O
cause,O
early,O
-,O
onset,O
MLD,Disease
",",O
the,O
arginine84,O
to,O
glutamine,O
substitution,O
is,O
associated,O
with,O
some,O
residual,O
ARSA,O
activity,O
.,O
In,O
the,O
Japanese,O
population,O
",",O
however,O
",",O
there,O
has,O
been,O
no,O
report,O
demonstrating,O
the,O
contribution,O
of,O
IDDM2,O
to,O
the,O
pathogenesis,O
of,O
IDDM,Disease
.,O
Myotonic,Disease
dystrophy,Disease
(,O
DM,Disease
),O
is,O
caused,O
by,O
a,O
CTG,O
repeat,O
expansion,O
in,O
the,O
3UTR,O
of,O
the,O
DM,Disease
protein,O
kinase,O
(,O
DMPK,O
),O
gene,O
.,O
The,O
nosology,O
of,O
the,O
inborn,Disease
errors,Disease
of,Disease
myelin,Disease
metabolism,Disease
has,O
been,O
stymied,O
by,O
the,O
lack,O
of,O
molecular,O
genetic,O
analysis,O
.,O
Phenylketonuria,Disease
(,O
PKU,Disease
),O
",",O
a,O
disorder,Disease
of,Disease
amino,Disease
acid,Disease
metabolism,Disease
prevalent,O
among,O
Caucasians,O
and,O
other,O
ethnic,O
groups,O
",",O
is,O
caused,O
primarily,O
by,O
a,O
deficiency,Disease
of,Disease
the,Disease
hepatic,Disease
enzyme,Disease
phenylalanine,Disease
hydroxylase,Disease
(,O
PAH,O
),O
.,O
The,O
molecular,O
basis,O
of,O
C6,Disease
deficiency,Disease
in,O
the,O
western,O
Cape,O
",",O
South,O
Africa,O
.,O
The,O
Long,O
-,O
Evans,O
Cinnamon,O
(,O
LEC,O
),O
rat,O
shows,O
similarity,O
to,O
Wilson,Disease
disease,Disease
in,O
many,O
clinical,O
and,O
biochemical,O
features,O
.,O
Electrophoresis,O
of,O
cell,O
extracts,O
revealed,O
the,O
absence,O
of,O
the,O
A,O
form,O
of,O
acid,O
lipase,O
",",O
consistent,O
with,O
the,O
diagnosis,O
of,O
Wolman,Disease
disease,Disease
.,O
Novel,O
mutations,O
of,O
the,O
ATP7B,O
gene,O
in,O
Japanese,O
patients,O
with,O
Wilson,Disease
disease,Disease
.,O
2,O
shows,O
that,O
the,O
DM,Disease
locus,O
is,O
distal,O
to,O
APOC2,O
.,O
A,O
sex,O
-,O
dependent,O
penetrance,O
of,O
primary,Disease
HPT,Disease
",",O
resulting,O
in,O
predominantly,O
male,O
-,O
affected,O
cases,O
was,O
evident,O
in,O
the,O
two,O
families,O
.,O
Studies,O
of,O
the,O
HLA,O
antigens,O
in,O
all,O
the,O
22,O
subjects,O
and,O
in,O
three,O
spouses,O
indicated,O
no,O
close,O
linkage,O
between,O
the,O
CM,Disease
deficienty,Disease
and,O
the,O
HLA,O
system,O
.,O
HLA,O
-,O
B27,O
accounts,O
for,O
a,O
minority,O
of,O
the,O
overall,O
genetic,O
susceptibility,O
to,O
AS,Disease
.,O
To,O
evaluate,O
the,O
role,O
of,O
I1307K,O
in,O
cancer,Disease
",",O
we,O
genotyped,O
5,O
",",O
081,O
Ashkenazi,O
volunteers,O
in,O
a,O
community,O
survey,O
.,O
In,O
the,O
present,O
study,O
",",O
we,O
report,O
the,O
use,O
of,O
fluorescence,O
in,O
situ,O
hybridization,O
(,O
FISH,O
),O
as,O
a,O
method,O
to,O
detect,O
and,O
characterize,O
VHL,Disease
germline,O
deletions,O
.,O
Oedemic,Disease
buccal,Disease
mucosa,Disease
(,O
leucoedema,Disease
),O
and,O
gingival,Disease
overgrowths,Disease
were,O
more,O
frequent,O
in,O
AGU,Disease
patients,O
than,O
in,O
controls,O
(,O
p,O
<,O
0,O
.,O
001,O
),O
.,O
Primary,Disease
dystonias,Disease
are,O
movement,Disease
disorders,Disease
with,O
dystonia,Disease
as,O
a,O
major,O
symptom,O
.,O
Difficulties,O
in,O
the,O
ascertainment,O
of,O
C9,Disease
deficiency,Disease
:,O
lessons,O
to,O
be,O
drawn,O
from,O
a,O
compound,O
heterozygote,O
C9,Disease
-,Disease
deficient,Disease
subject,O
.,O
Two,O
-,O
thirds,O
of,O
DMD,Disease
patients,O
carry,O
detectable,O
deletions,O
in,O
their,O
dystrophin,O
gene,O
.,O
Previous,O
family,O
studies,O
suggested,O
that,O
these,O
individuals,O
may,O
be,O
compound,O
heterozygotes,O
for,O
the,O
common,O
mutant,O
TSD,Disease
gene,O
and,O
a,O
rare,O
(,O
allelic,O
),O
mutant,O
gene,O
.,O
A,O
somatic,O
mutation,O
in,O
the,O
X,O
linked,O
PIGA,O
gene,O
is,O
responsible,O
for,O
the,O
deficiency,Disease
of,Disease
glycosyl,Disease
phosphatidylinositol,Disease
(,Disease
GPI,Disease
),Disease
-,Disease
anchored,Disease
proteins,Disease
on,O
blood,O
cells,O
from,O
patients,O
with,O
paroxysmal,Disease
nocturnal,Disease
hemoglobinuria,Disease
.,O
A,O
family,O
in,O
which,O
two,O
male,O
siblings,O
were,O
affected,O
with,O
Wiskott,Disease
-,Disease
Aldrich,Disease
syndrome,Disease
(,O
WAS,Disease
),O
was,O
studied,O
using,O
G,O
-,O
6,O
-,O
PD,O
isoenzymes,O
as,O
an,O
X,O
-,O
linked,O
marker,O
in,O
order,O
to,O
investigate,O
the,O
nature,O
of,O
cellular,O
abnormalities,O
.,O
We,O
developed,O
methods,O
to,O
detect,O
the,O
three,O
mutations,O
in,O
the,O
HEXA,O
gene,O
that,O
occur,O
with,O
high,O
frequency,O
among,O
Ashkenazi,O
Jews,O
two,O
mutations,O
cause,O
infantile,O
Tay,Disease
-,Disease
Sachs,Disease
disease,Disease
",",O
and,O
the,O
third,O
causes,O
the,O
adult,O
-,O
onset,O
form,O
of,O
the,O
disease,O
.,O
Surprisingly,O
",",O
she,O
has,O
suffered,O
only,O
mild,O
haemolysis,Disease
and,O
has,O
never,O
experienced,O
massive,O
spontaneous,O
haemolysis,Disease
.,O
These,O
data,O
provide,O
support,O
for,O
the,O
"""",O
out,O
of,O
Africa,O
"""",O
model,O
for,O
the,O
origin,O
of,O
modern,O
humans,O
and,O
suggest,O
that,O
the,O
rare,O
ancestral,O
DM,Disease
mutation,O
event,O
may,O
have,O
occurred,O
after,O
the,O
migration,O
from,O
Africa,O
",",O
hence,O
the,O
absence,O
of,O
DM,Disease
in,O
sub,O
-,O
Saharan,O
Negroid,O
peoples,O
.,O
.,O
Analysis,O
of,O
poly,O
(,O
A,O
),O
+,O
RNA,O
showed,O
dramatic,O
decreases,O
of,O
both,O
the,O
mutant,O
and,O
normal,O
DM,Disease
kinase,O
RNAs,O
",",O
and,O
these,O
changes,O
were,O
disease,O
-,O
specific,O
.,O
The,O
recent,O
cloning,O
of,O
BRCA1,O
allows,O
for,O
the,O
direct,O
detection,O
of,O
mutations,O
",",O
but,O
the,O
feasibility,O
of,O
presymptomatic,O
screening,O
for,O
cancer,Disease
susceptibility,O
is,O
unknown,O
.,O
Low,O
frequency,O
of,O
BRCA1,O
germline,O
mutations,O
in,O
45,O
German,O
breast,Disease
/,Disease
ovarian,Disease
cancer,Disease
families,O
.,O
Six,O
of,O
the,O
eight,O
patients,O
with,O
the,O
infantile,O
",",O
severe,O
form,O
of,O
the,O
disease,O
presented,O
cardiac,Disease
involvement,Disease
",",O
a,O
feature,O
rarely,O
associated,O
with,O
GM1,Disease
-,Disease
gangliosidosis,Disease
.,O
These,O
analyses,O
identified,O
two,O
novel,O
single,O
-,O
nucleotide,O
polymorphisms,O
(,O
INV4,O
+,O
31A,O
-,O
-,O
>,O
G,O
and,O
INV11,O
+,O
18A,O
-,O
-,O
>,O
G,O
),O
and,O
six,O
novel,O
AKU,Disease
mutations,O
(,O
INV1,O
-,O
1G,O
-,O
-,O
>,O
A,O
",",O
W60G,O
",",O
Y62C,O
",",O
A122D,O
",",O
P230T,O
",",O
and,O
D291E,O
),O
",",O
which,O
further,O
illustrates,O
the,O
remarkable,O
allelic,O
heterogeneity,O
found,O
in,O
AKU,Disease
.,O
Mutation,O
of,O
MSH3,O
in,O
endometrial,Disease
cancer,Disease
and,O
evidence,O
for,O
its,O
functional,O
role,O
in,O
heteroduplex,O
repair,O
.,O
Identification,O
of,O
a,O
single,O
nucleotide,O
change,O
in,O
the,O
hypoxanthine,O
-,O
guanine,O
phosphoribosyltransferase,O
gene,O
(,O
HPRTYale,O
),O
responsible,O
for,O
Lesch,Disease
-,Disease
Nyhan,Disease
syndrome,Disease
.,O
CONCLUSIONS,O
Lorenzos,O
oil,O
therapy,O
had,O
no,O
effect,O
on,O
patients,O
with,O
evidence,O
of,O
inflammatory,Disease
brain,Disease
lesions,Disease
.,O
One,O
of,O
the,O
principal,O
features,O
of,O
the,O
DM,Disease
mutation,O
is,O
an,O
extraordinarily,O
high,O
level,O
of,O
somatic,O
mosaicism,O
",",O
due,O
to,O
an,O
extremely,O
high,O
degree,O
of,O
somatic,O
instability,O
both,O
within,O
and,O
between,O
different,O
tissues,O
.,O
The,O
study,O
evaluated,O
4,O
patients,O
with,O
FMF,Disease
who,O
had,O
been,O
taking,O
colchicine,O
on,O
a,O
long,O
-,O
term,O
basis,O
.,O
Phenylketonuria,Disease
(,O
PKU,Disease
),O
and,O
mild,Disease
hyperphenylalaninemia,Disease
(,O
MHP,Disease
),O
are,O
allelic,Disease
disorders,Disease
caused,O
by,O
mutations,O
in,O
the,O
gene,O
encoding,O
phenylalanine,O
hydroxylase,O
(,O
PAH,O
),O
.,O
Linkage,O
studies,O
in,O
this,O
family,O
suggested,O
a,O
close,O
linkage,O
between,O
the,O
C2,Disease
deficiency,Disease
gene,O
and,O
genes,O
coding,O
for,O
B18,O
",",O
Dw2,O
",",O
and,O
BfS,O
antigens,O
.,O
Lipid,O
metabolism,O
was,O
studied,O
in,O
cultured,O
skin,O
fibroblasts,O
from,O
patients,O
with,O
the,O
inherited,Disease
disorder,Disease
",",O
Sjogren,Disease
-,Disease
Larsson,Disease
syndrome,Disease
(,O
SLS,Disease
),O
.,O
Mutations,O
in,O
the,O
human,O
EGR2,O
gene,O
have,O
recently,O
been,O
associated,O
with,O
the,O
inherited,Disease
peripheral,Disease
neuropathies,Disease
Charcot,Disease
-,Disease
Marie,Disease
-,Disease
Tooth,Disease
type,Disease
1,Disease
",",O
Dejerine,Disease
-,Disease
Sottas,Disease
syndrome,Disease
and,O
congenital,Disease
hypomyelinating,Disease
neuropathy,Disease
.,O
We,O
then,O
analyzed,O
the,O
occurrence,O
of,O
RCC,Disease
in,O
VHL,Disease
families,O
",",O
based,O
on,O
the,O
nature,O
of,O
mutations,O
.,O
Hereditary,Disease
Ovarian,Disease
Cancer,Disease
Clinical,O
Study,O
Group,O
.,O
This,O
mutation,O
is,O
identical,O
to,O
the,O
disease,O
-,O
causing,O
mutation,O
in,O
patients,O
with,O
hereditary,Disease
hemochromatosis,Disease
.,O
We,O
used,O
heteroduplex,O
analysis,O
to,O
identify,O
sequence,O
anomalies,O
in,O
five,O
individuals,O
with,O
Kniest,Disease
dysplasia,Disease
.,O
Aniridia,Disease
in,O
man,O
and,O
Small,O
eye,O
in,O
mice,O
are,O
semidominant,Disease
developmental,Disease
disorders,Disease
caused,O
by,O
mutations,O
within,O
the,O
paired,O
box,O
gene,O
PAX6,O
.,O
We,O
have,O
used,O
this,O
technique,O
to,O
analyze,O
BRCA1,O
in,O
162,O
families,O
with,O
a,O
history,O
of,O
breast,Disease
and,Disease
/,Disease
or,Disease
ovarian,Disease
cancer,Disease
and,O
identified,O
12,O
distinct,O
mutations,O
in,O
35,O
families,O
.,O
.,O
Prenatal,O
diagnosis,O
of,O
Wolman,Disease
disease,Disease
.,O
The,O
heterozygous,O
family,O
members,O
did,O
not,O
have,O
the,O
ALPS,Disease
phenotype,O
",",O
indicating,O
that,O
the,O
disease,O
-,O
causing,O
FAS,O
mutation,O
in,O
this,O
family,O
is,O
autosomal,O
recessive,O
.,O
.,O
The,O
adenomatous,Disease
polyposis,Disease
coli,Disease
gene,O
(,O
APC,O
),O
is,O
mutated,O
in,O
familial,Disease
adenomatous,Disease
polyposis,Disease
and,O
in,O
sporadic,O
colorectal,Disease
tumors,Disease
.,O
The,O
other,O
family,O
members,O
had,O
heterozygous,O
C2,Disease
deficiency,Disease
and,O
each,O
member,O
had,O
the,O
HLA,O
-,O
A25,O
",",O
B18,O
",",O
DR2,O
(,O
w15,O
),O
haplotype,O
.,O
Therefore,O
",",O
the,O
isolation,O
of,O
new,O
genes,O
in,O
this,O
region,O
remains,O
crucial,O
for,O
a,O
better,O
understanding,O
of,O
the,O
molecular,O
basis,O
of,O
PWS,Disease
.,O
Hypoxanthine,Disease
-,Disease
guanine,Disease
phosphoribosyltransferase,Disease
deficiency,Disease
:,O
analysis,O
of,O
HPRT,O
mutations,O
by,O
direct,O
sequencing,O
and,O
allele,O
-,O
specific,O
amplification,O
.,O
The,O
event,O
triggering,O
malignant,O
proliferation,O
in,O
70,O
%,O
of,O
retinoblastoma,Disease
tumours,Disease
is,O
loss,O
of,O
heterozygosity,O
for,O
chromosome,O
13q14,O
",",O
whereby,O
the,O
normal,O
retinoblastoma,Disease
gene,O
(,O
RB1,O
),O
allele,O
is,O
lost,O
and,O
an,O
already,O
mutated,O
RB1,O
allele,O
remains,O
in,O
the,O
tumour,Disease
.,O
We,O
examined,O
somatic,O
mutations,O
of,O
the,O
adenomatous,Disease
polyposis,Disease
coli,Disease
(,O
APC,Disease
),O
gene,O
in,O
63,O
colorectal,Disease
tumors,Disease
(,O
16,O
adenomas,Disease
and,O
47,O
carcinomas,Disease
),O
developed,O
in,O
familial,Disease
adenomatous,Disease
polyposis,Disease
(,O
FAP,Disease
),O
and,O
non,O
-,O
FAP,O
patients,O
.,O
Direct,O
evidence,O
that,O
mutation,O
of,O
the,O
KHK,O
structural,O
gene,O
is,O
the,O
cause,O
of,O
essential,Disease
fructosuria,Disease
was,O
also,O
obtained,O
.,O
The,O
same,O
residue,O
is,O
often,O
mutated,O
in,O
the,O
Brutons,O
tyrosine,O
kinase,O
(,O
Btk,O
),O
gene,O
in,O
patients,O
with,O
an,O
X,Disease
-,Disease
linked,Disease
agammaglobulinemia,Disease
.,O
The,O
dark,O
-,O
adapted,O
electroretinogram,O
(,O
ERG,O
),O
of,O
patients,O
with,O
Duchenne,Disease
and,Disease
Becker,Disease
muscular,Disease
dystrophy,Disease
(,O
DMD,Disease
/,O
BMD,Disease
),O
shows,O
a,O
marked,O
reduction,O
in,O
b,O
-,O
wave,O
amplitude,O
.,O
This,O
difference,O
in,O
mutation,O
sites,O
may,O
affect,O
the,O
clinical,O
features,O
of,O
GLD,Disease
.,O
Most,O
importantly,O
",",O
among,O
mice,O
with,O
established,O
MCF,Disease
-,Disease
7,Disease
tumours,Disease
",",O
peritoneal,O
treatment,O
with,O
a,O
retroviral,O
vector,O
expressing,O
wild,O
-,O
type,O
BRCA1,O
significantly,O
inhibits,O
tumour,Disease
growth,O
and,O
increased,O
survival,O
.,O
.,O
We,O
report,O
here,O
the,O
identification,O
of,O
a,O
unique,O
de,O
novo,O
L1,O
insertion,O
in,O
the,O
muscle,O
exon,O
1,O
in,O
DMD,O
in,O
three,O
XLDCM,Disease
patients,O
from,O
two,O
unrelated,O
Japanese,O
families,O
.,O
Genetic,O
linkage,O
map,O
of,O
six,O
polymorphic,O
DNA,O
markers,O
around,O
the,O
gene,O
for,O
familial,Disease
adenomatous,Disease
polyposis,Disease
on,O
chromosome,O
5,O
.,O
Pendred,Disease
patients,O
in,O
three,O
non,O
-,O
consanguineous,O
families,O
were,O
shown,O
to,O
be,O
compound,O
heterozygotes,O
for,O
L236P,O
and,O
T416P,O
.,O
The,O
FRDA,Disease
gene,O
encodes,O
a,O
widely,O
expressed,O
210,O
-,O
aa,O
protein,O
",",O
frataxin,O
",",O
which,O
is,O
located,O
in,O
mitochondria,O
and,O
is,O
severely,O
reduced,O
in,O
FRDA,Disease
patients,O
.,O
These,O
findings,O
provide,O
evidence,O
that,O
PLS,Disease
and,O
HMS,Disease
are,O
allelic,O
variants,O
of,O
cathepsin,O
C,O
gene,O
mutations,O
.,O
.,O
The,O
fragile,O
site,O
is,O
not,O
associated,O
with,O
mental,Disease
retardation,Disease
",",O
it,O
does,O
not,O
give,O
abnormal,O
results,O
when,O
subjected,O
to,O
Southern,O
analysis,O
with,O
probe,O
pfxa3,O
which,O
detects,O
the,O
unstable,O
DNA,O
sequence,O
characteristic,O
of,O
fragile,Disease
X,Disease
syndrome,Disease
.,O
Although,O
this,O
patient,O
did,O
not,O
have,O
a,O
detectable,O
deletion,O
within,O
PAX6,O
",",O
her,O
aniridia,Disease
may,O
have,O
resulted,O
from,O
a,O
disruption,O
of,O
the,O
distal,O
chromatin,O
domain,O
containing,O
either,O
enhancers,O
or,O
regulators,O
for,O
PAX6,O
.,O
Liver,O
biopsy,O
is,O
also,O
used,O
to,O
establish,O
the,O
presence,O
or,O
absence,O
of,O
cirrhosis,Disease
",",O
which,O
can,O
affect,O
prognosis,O
and,O
management,O
.,O
28,O
that,O
bridge,O
the,O
DMD,Disease
gene,O
.,O
Ten,O
of,O
the,O
twelve,O
markers,O
have,O
been,O
shown,O
to,O
be,O
proximal,O
to,O
the,O
DM,Disease
gene,O
and,O
two,O
",",O
PRKCG,O
and,O
D19S22,O
",",O
distal,O
but,O
at,O
distances,O
of,O
approximately,O
25,O
cM,O
and,O
15,O
cM,O
",",O
respectively,O
.,O
We,O
have,O
determined,O
the,O
structure,O
of,O
GLDC,O
and,O
of,O
its,O
pseudogene,O
(,O
psiGLDC,O
),O
and,O
studied,O
their,O
expression,O
for,O
a,O
molecular,O
analysis,O
of,O
NKH,Disease
.,O
In,O
the,O
fifth,O
family,O
",",O
FISH,O
analysis,O
demonstrated,O
the,O
deletion,O
of,O
the,O
entire,O
VHL,Disease
gene,O
.,O
These,O
results,O
provide,O
further,O
evidence,O
that,O
inherited,Disease
breast,Disease
and,Disease
ovarian,Disease
cancer,Disease
can,O
occur,O
as,O
a,O
consequence,O
of,O
a,O
wide,O
array,O
of,O
BRCA1,O
mutations,O
.,O
The,O
three,O
novel,O
AKU,Disease
mutations,O
are,O
most,O
likely,O
specific,O
for,O
the,O
Finnish,O
population,O
and,O
have,O
originated,O
recently,O
.,O
.,O
Our,O
findings,O
represent,O
the,O
only,O
case,O
in,O
which,O
the,O
molecular,O
basis,O
of,O
the,O
protein,Disease
-,Disease
import,Disease
deficiency,Disease
in,O
human,O
peroxisomal,Disease
disorders,Disease
is,O
understood,O
.,O
In,O
vitro,O
transfection,O
studies,O
indicated,O
that,O
the,O
inclusion,O
of,O
120,O
bp,O
of,O
the,O
5,O
UTR,O
in,O
the,O
cDNA,O
construct,O
and,O
the,O
presence,O
of,O
a,O
frameshift,O
mutation,O
at,O
nucleotide,O
2349,O
prevented,O
expression,O
of,O
the,O
HD,Disease
cDNA,O
.,O
Late,O
-,O
onset,O
familial,Disease
Mediterranean,Disease
fever,Disease
(,O
FMF,Disease
),O
:,O
a,O
subset,O
with,O
distinct,O
clinical,O
",",O
demographic,O
",",O
and,O
molecular,O
genetic,O
characteristics,O
.,O
Our,O
findings,O
provide,O
a,O
basis,O
for,O
further,O
characterisation,O
of,O
the,O
role,O
of,O
the,O
kinase,O
in,O
protein,O
assembly,O
processes,O
or,O
signal,O
mediation,O
at,O
synaptic,O
sites,O
and,O
ultimately,O
for,O
the,O
understanding,O
of,O
the,O
complex,O
pathophysiology,O
of,O
DM,Disease
.,O
.,O
Glucose,Disease
-,Disease
6,Disease
-,Disease
PHOSPHATE,Disease
dehydrogenase,Disease
(,Disease
G6PD,Disease
;,Disease
EC,Disease
1,Disease
.,Disease
1,Disease
.,Disease
1,Disease
.,Disease
49,Disease
),Disease
deficiency,Disease
is,O
the,O
most,O
common,O
human,O
enzymopathy,Disease
",",O
affecting,O
more,O
than,O
200,O
million,O
people,O
worldwide,O
.,O
A,O
C,O
-,O
to,O
-,O
T,O
transition,O
in,O
exon,O
4,O
of,O
the,O
PLP,O
gene,O
was,O
found,O
in,O
2,O
affected,O
males,O
and,O
two,O
obligate,O
carriers,O
in,O
a,O
German,O
family,O
with,O
Pelizaeus,Disease
-,Disease
Merzbacher,Disease
disease,Disease
.,O
The,O
results,O
suggest,O
that,O
the,O
prenatal,O
diagnosis,O
of,O
Wolman,Disease
disease,Disease
be,O
made,O
using,O
the,O
radioassay,O
of,O
acid,O
lipase,O
and,O
/,O
or,O
electrophoresis,O
.,O
.,O
This,O
represents,O
the,O
first,O
evidence,O
of,O
linkage,O
disequilibrium,O
between,O
APOC2,O
and,O
the,O
DM,Disease
locus,O
.,O
The,O
arginine,O
188,O
mutation,O
is,O
the,O
most,O
common,O
galactosemia,Disease
mutation,O
characterized,O
to,O
date,O
.,O
These,O
observations,O
indicated,O
that,O
C9,O
may,O
play,O
a,O
critical,O
role,O
in,O
haemolytic,Disease
attacks,Disease
in,O
patients,O
with,O
PNH,Disease
and,O
that,O
characteristic,O
haemolysis,Disease
in,O
PNH,Disease
may,O
be,O
tempered,O
by,O
coexisting,O
C9,Disease
deficiency,Disease
.,O
.,O
CHRPE,Disease
lesions,O
are,O
almost,O
always,O
absent,O
if,O
the,O
mutation,O
occurs,O
before,O
exon,O
9,O
",",O
but,O
are,O
systematically,O
present,O
if,O
it,O
occurs,O
after,O
this,O
exon,O
.,O
APC,O
is,O
not,O
",",O
therefore,O
",",O
a,O
classical,O
tumor,Disease
suppressor,O
.,O
Mutations,O
in,O
the,O
glycine,O
decarboxylase,O
gene,O
(,O
GLDC,O
),O
cause,O
nonketotic,Disease
hyperglycinemia,Disease
(,O
NKH,Disease
),O
",",O
an,O
in,Disease
-,Disease
born,Disease
error,Disease
of,Disease
metabolism,Disease
characterized,O
by,O
severe,O
neurological,Disease
disturbance,Disease
.,O
Three,O
pedigrees,O
of,O
lip,Disease
pits,Disease
in,O
the,O
literature,O
show,O
no,O
clefts,O
among,O
a,O
significant,O
number,O
of,O
affected,O
individuals,O
.,O
Analysis,O
of,O
deletions,O
in,O
DNA,O
from,O
patients,O
with,O
Becker,Disease
and,Disease
Duchenne,Disease
muscular,Disease
dystrophy,Disease
.,O
A,O
high,O
frequency,O
of,O
individuals,O
who,O
appeared,O
to,O
be,O
TSD,Disease
heterozygotes,O
was,O
detected,O
(,O
Kelly,O
et,O
al,O
.,O
",",O
1975,O
),O
.,O
The,O
Breast,Disease
Cancer,Disease
Linkage,O
Consortium,O
.,O
A,O
hot,O
spot,O
for,O
PTEN,O
mutation,O
in,O
CD,Disease
was,O
identified,O
in,O
exon,O
5,O
that,O
contains,O
the,O
PTPase,O
core,O
motif,O
",",O
with,O
13,O
of,O
30,O
(,O
43,O
%,O
),O
CD,Disease
mutations,O
identified,O
in,O
this,O
exon,O
.,O
Intact,O
SLS,Disease
fibroblasts,O
incubated,O
in,O
the,O
presence,O
of,O
[,O
1,O
-,O
14C,O
],O
palmitate,O
accumulated,O
more,O
radioactive,O
hexadecanol,O
than,O
did,O
normal,O
cells,O
",",O
whereas,O
incorporation,O
of,O
radioactivity,O
into,O
other,O
cellular,O
lipids,O
was,O
unaltered,O
.,O
This,O
distribution,O
of,O
emerin,O
was,O
similar,O
to,O
that,O
of,O
lamin,O
A,O
",",O
a,O
candidate,O
gene,O
for,O
an,O
autosomal,O
form,O
of,O
EDMD,Disease
.,O
Aspartylglucosaminuria,Disease
(,O
AGU,Disease
),O
is,O
a,O
recessive,O
autosomally,O
inherited,O
lysosomal,Disease
storage,Disease
disorder,Disease
due,O
to,O
deficiency,Disease
of,Disease
the,Disease
enzyme,Disease
aspartylglucosaminidase,Disease
(,O
AGA,O
),O
.,O
Dermatofibrosarcoma,Disease
protuberans,Disease
(,O
DFSP,Disease
),O
displays,O
chromosomal,O
rearrangements,O
involving,O
chromosome,O
17,O
and,O
22,O
",",O
which,O
fuse,O
the,O
collagen,O
type,O
Ialpha1,O
(,O
COLIA1,O
),O
gene,O
to,O
the,O
platelet,O
-,O
derived,O
growth,O
factor,O
(,O
PDGF,O
),O
B,O
-,O
chain,O
(,O
PDGFB,O
),O
gene,O
.,O
Sequencing,O
of,O
exon,O
3,O
of,O
the,O
beta,O
-,O
catenin,O
gene,O
(,O
CTNNB1,O
),O
revealed,O
an,O
activating,O
mutation,O
in,O
one,O
of,O
the,O
tumor,Disease
samples,O
.,O
X,Disease
-,Disease
linked,Disease
Adrenoleukodystrophy,Disease
(,O
X,Disease
-,Disease
ALD,Disease
),O
is,O
the,O
most,O
frequent,O
peroxisomal,Disease
disease,Disease
.,O
To,O
assess,O
the,O
risk,O
of,O
this,O
common,O
APC,Disease
allelic,O
variant,O
in,O
colorectal,O
carcinogenesis,O
",",O
we,O
have,O
analyzed,O
a,O
large,O
cohort,O
of,O
unselected,O
Ashkenazi,O
Jewish,O
subjects,O
with,O
adenomatous,Disease
polyps,Disease
and,O
.,O
or,O
colorectal,Disease
cancer,Disease
",",Disease
for,O
the,O
APC,O
I1307K,O
polymorphism,O
.,O
However,O
",",O
some,O
of,O
these,O
patients,O
can,O
transmit,O
retinoblastoma,Disease
predisposition,O
to,O
their,O
offspring,O
.,O
Experimental,O
hemochromatosis,Disease
due,O
to,O
MHC,O
class,O
I,O
HFE,Disease
deficiency,Disease
:,O
immune,O
status,O
and,O
iron,O
metabolism,O
.,O
Mice,O
that,O
expressed,O
expanded,O
CUG,O
repeats,O
developed,O
myotonia,Disease
and,O
myopathy,Disease
",",O
whereas,O
mice,O
expressing,O
a,O
nonexpanded,O
repeat,O
did,O
not,O
.,O
We,O
have,O
estimated,O
the,O
haplotype,O
distribution,O
of,O
mutant,O
and,O
normal,O
phenylalanine,O
hydroxylase,O
(,O
PAH,O
),O
alleles,O
for,O
17,O
Turkish,O
phenylketonuria,Disease
(,O
PKU,Disease
),O
families,O
20,O
normal,O
and,O
27,O
mutated,O
PAH,O
alleles,O
could,O
be,O
identified,O
.,O
CONCLUSIONS,O
Among,O
women,O
with,O
breast,Disease
cancer,Disease
and,O
a,O
family,O
history,O
of,O
the,O
disease,O
",",O
the,O
percentage,O
with,O
BRCA1,O
coding,O
-,O
region,O
mutations,O
is,O
less,O
than,O
the,O
45,O
percent,O
predicted,O
by,O
genetic,O
-,O
linkage,O
analysis,O
.,O
However,O
",",O
a,O
modified,O
expression,O
of,O
the,O
WAS,Disease
gene,O
producing,O
a,O
mild,O
phenotypic,O
variant,O
cannot,O
be,O
excluded,O
entirely,O
.,O
.,O
A,O
probe,O
for,O
the,O
5,O
end,O
of,O
the,O
Duchenne,Disease
muscular,Disease
dystrophy,Disease
(,O
DMD,Disease
),O
gene,O
was,O
used,O
to,O
study,O
expression,O
of,O
the,O
gene,O
in,O
normal,O
human,O
muscle,O
",",O
myogenic,O
cell,O
cultures,O
",",O
and,O
muscle,O
from,O
patients,O
with,O
DMD,Disease
.,O
In,O
view,O
of,O
the,O
rarity,O
and,O
marked,O
heterogeneity,O
of,O
mutations,O
in,O
the,O
ND,Disease
gene,O
",",O
the,O
present,O
apparently,O
unrelated,O
Japanese,O
families,O
who,O
have,O
lived,O
in,O
the,O
same,O
area,O
for,O
over,O
two,O
centuries,O
presumably,O
share,O
the,O
origin,O
of,O
the,O
mutation,O
.,O
.,O
Morphological,Disease
abnormalities,Disease
resembling,O
cirrhosis,Disease
developed,O
in,O
the,O
majority,O
of,O
the,O
livers,O
from,O
homozygous,O
mutants,O
older,O
than,O
7,O
months,O
of,O
age,O
.,O
Index,O
cases,O
for,O
the,O
present,O
study,O
were,O
found,O
two,O
different,O
ways,O
through,O
a,O
series,O
of,O
consecutive,O
ovarian,Disease
cancers,Disease
(,O
n,O
=,O
16,O
),O
and,O
through,O
our,O
family,O
cancer,Disease
clinic,O
(,O
n,O
=,O
14,O
),O
.,O
We,O
analyzed,O
the,O
entire,O
protein,O
-,O
coding,O
sequence,O
of,O
this,O
gene,O
by,O
reverse,O
-,O
transcription,O
PCR,O
",",O
SSCP,O
",",O
and,O
DNA,O
sequencing,O
in,O
five,O
patients,O
with,O
different,O
clinical,O
expression,O
of,O
X,Disease
-,Disease
ALD,Disease
and,O
in,O
their,O
female,O
relatives,O
;,O
these,O
clinical,O
expressions,O
were,O
cerebral,O
childhood,O
ALD,Disease
",",O
adrenomyeloneuropathy,Disease
(,O
AMN,Disease
),O
",",O
and,O
"""",O
Addison,Disease
disease,Disease
only,Disease
"""",O
(,O
ADO,Disease
),O
phenotype,O
.,O
A,O
common,O
human,O
skin,Disease
tumour,Disease
is,O
caused,O
by,O
activating,O
mutations,O
in,O
beta,O
-,O
catenin,O
.,O
GCH1,O
mutation,O
in,O
a,O
patient,O
with,O
adult,O
-,O
onset,O
oromandibular,Disease
dystonia,Disease
.,O
Late,O
infantile,O
metachromatic,Disease
leukodystrophy,Disease
in,O
Israel,O
.,O
Identification,O
of,O
a,O
novel,O
R21X,O
mutation,O
in,O
the,O
liver,O
-,O
type,O
arginase,O
gene,O
(,O
ARG1,O
),O
in,O
four,O
Portuguese,O
patients,O
with,O
argininemia,Disease
.,O
An,O
altered,O
beta,O
-,O
alanine,O
",",O
uracil,O
and,O
thymine,O
homeostasis,O
might,O
underlie,O
the,O
various,O
clinical,Disease
abnormalities,Disease
encountered,O
in,O
patients,O
with,O
DPD,Disease
deficiency,Disease
.,O
Mutations,O
in,O
the,O
SMAD4,O
/,O
DPC4,O
tumor,Disease
suppressor,O
gene,O
",",O
a,O
key,O
signal,O
transducer,O
in,O
most,O
TGFbeta,O
-,O
related,O
pathways,O
",",O
are,O
involved,O
in,O
50,O
%,O
of,O
pancreatic,Disease
cancers,Disease
.,O
Recombination,O
events,O
that,O
locate,O
myotonic,Disease
dystrophy,Disease
distal,O
to,O
APOC2,O
on,O
19q,O
.,O
Our,O
findings,O
also,O
indicate,O
a,O
new,O
mechanism,O
for,O
disease,O
severity,O
if,O
a,O
broader,O
spectrum,O
of,O
mutations,O
is,O
selected,O
in,O
tumors,Disease
",",O
the,O
somatic,O
mutation,O
rate,O
is,O
effectively,O
higher,O
and,O
more,O
tumors,Disease
grow,O
.,O
.,O
Mutations,O
at,O
the,O
PAX6,O
locus,O
are,O
found,O
in,O
heterogeneous,O
anterior,Disease
segment,Disease
malformations,Disease
including,O
Peters,Disease
',Disease
anomaly,Disease
.,O
Recurrent,O
middle,Disease
ear,Disease
infections,Disease
",",O
a,O
high,O
pain,O
threshold,O
",",O
and,O
a,O
great,O
skill,O
with,O
jigsaw,O
puzzles,O
were,O
reported,O
.,O
Here,O
we,O
report,O
(,O
1,O
),O
identification,O
of,O
another,O
mutation,O
",",O
on,O
a,O
haplotype,O
9,O
chromosome,O
",",O
which,O
converts,O
codon,O
65,O
from,O
isoleucine,O
(,O
ATT,O
),O
to,O
threonine,O
(,O
ACT,O
),O
",",O
(,O
2,O
),O
expression,O
analysis,O
of,O
the,O
I65T,O
mutation,O
in,O
COS,O
cells,O
demonstrating,O
75,O
%,O
loss,O
of,O
both,O
immunoreactive,O
protein,O
and,O
enzyme,O
activity,O
",",O
and,O
(,O
3,O
),O
expression,O
analysis,O
of,O
the,O
most,O
prevalent,O
PKU,Disease
allele,O
(,O
M1V,O
),O
in,O
eastern,O
Quebec,O
",",O
showing,O
nondetectable,O
levels,O
of,O
PAH,O
protein,O
and,O
activity,O
",",O
a,O
finding,O
compatible,O
with,O
a,O
mutation,O
in,O
the,O
translation,O
initiation,O
codon,O
.,O
Three,O
major,O
criteria,O
",",O
saccade,O
amplitude,O
",",O
saccade,O
velocity,O
",",O
and,O
presence,O
of,O
gaze,Disease
-,Disease
evoked,Disease
nystagmus,Disease
",",O
permitted,O
the,O
correct,O
assignment,O
of,O
90,O
%,O
of,O
the,O
SCA1,Disease
",",O
90,O
%,O
of,O
the,O
SCA2,Disease
",",O
and,O
93,O
%,O
of,O
the,O
patients,O
with,O
SCA3,Disease
to,O
their,O
genetically,O
confirmed,O
patient,O
group,O
and,O
",",O
therefore,O
",",O
may,O
help,O
orient,O
diagnoses,O
of,O
SCA1,Disease
",",O
SCA2,Disease
",",O
and,O
SCA3,Disease
at,O
early,O
clinical,O
stages,O
of,O
the,O
diseases,O
.,O
.,O
